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ABSTRACT
XENOPUS ADAM13 AND ADAM19 ARE IMPORTANT FOR PROPER
CONVERGENCE AND EXTENSION OF THE NOTOCHORD

FEBRUARY 2011
RUSSELL D. NEUNER, B.S., PENNSYLVANIA STATE UNIVERSITY
Ph.D., UNIVERSITY OF MASSACHCUSETTS AMHERST
Directed by: Professor Dominique Alfandari

Gastrulation is a fundamental process that reorganizes the primary germ layers to
shape the internal and external features of an early embryo. Morphogenetic movements
underlying this process can be classified into a variety of different types of cellular
movements. I will focus on investigating in this thesis two types of cell movements in
the dorsal mesoderm; mediolateral cell intercalation and convergence and extension.
During gastrulation, mesoderm cells send protrusions to gain traction on neighboring
cells and the surrounding extracellular matrix; a process called mediolateral cell
intercalation. Mesoderm cells use this type of cell movement to converge and extend the
dorsal mesoderm tissue during gastrulation; a process called convergence and extension.
These morphogenetic movements are essential to form the early embryo and are
important for later development.
There are a number of different proteins involved in regulating the morphogenetic
movements during gastrulation.

The Planar Cell Polarity Signaling Pathway helps

establish individual cell polarity and is activated in dorsal mesoderm cells undergoing
convergence and extension. In addition, dorsal mesoderm cells migrate by using integrin
receptors and the surrounding extracellular matrix to correctly position the mesoderm in
the embryo. I will focus my efforts on analyzing the function of ADAM proteins during
Xenopus laevis gastrulation. The ADAM family of metalloproteases is important for a
variety of biological processes. ADAM proteins function as ectodomain sheddases by
cleaving membrane bound proteins involved in signal transduction, cell-cell adhesion,
vi

and cell-extracellular matrix adhesion. I will focus on investigating the roles of two
ADAM family members; ADAM13 and ADAM19 during gastrulation. Both ADAM13
and ADAM19 are expressed in the dorsal mesoderm during gastrulation. Throughout
early embryonic development, ADAM13 is expressed in the somitic mesoderm and
cranial neural crest cells. ADAM19 is expressed in dorsal, neural and mesodermal
derived structures such as the neural tube, notochord, the somitic mesoderm, and cranial
neural crest cells.
Since ADAM13 and ADAM19 are expressed in similar tissues, I investigated if
both proteins functionally interacted. I show that a loss of ADAM13 protein in the
embryo reduces the level of ADAM19 protein by 50%. In the opposite experiment, a
loss of ADAM19 protein in the embryo reduces the level of ADAM13 protein by 50%.
This suggests that both ADAM13 and ADAM19 are required to maintain proper protein
levels in the embryo. This might be explained through their physical interaction in a cell.
The ADAM19 Proform binds to the ADAM13 Proform in cultured cells. Through
domain analysis, I show that ADAM19 binds specifically to the cysteine-rich domain of
ADAM13. When co-overexpressed in a cell, the level of Mature ADAM13 (compared to
the Proform) is reduced suggesting a complex form of regulation. I propose a few
models that discuss how ADAM19 may function as a chaperone to stabilize and regulate
the further processing of ADAM13 protein.
Some of the unpublished work discussed in this thesis focuses on the roles of
ADAM13 and ADAM19 in the dorsal mesoderm during gastrulation. Specific emphasis
is made on investigating the axial mesoderm during notochord formation. I show that
ADAM19 affects gene expression important for the A-P polarity of the notochord while
ADAM13 does not. The changes in gene expression can be partially rescued by the EGF
ligand Neuregulin1, a known substrate for ADAM19 in the mouse. ADAM13 and
ADAM19 are important for convergence and extension movements of the axial
mesoderm during gastrulation. Specifically, a loss of ADAM13 or ADAM19 causes a
delay in mediolateral cell intercalation resulting in a significantly wider notochord
compared to control embryos.

These defects occur without affecting dishevelled

intracellular localization or the activation of the PCP signaling pathway. However, a loss
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of ADAM13 or ADAM19 reduces dorsal mesoderm cell spreading on a fibronectin
substrate through 51 integrin.
To conclude, the work presented in this thesis focuses on the similarities and
differences of ADAM13 and ADAM19 in the early embryo. Although ADAM13 and
ADAM19 are required for normal morphogenetic movements during gastrulation, my
data suggests they have different functions. ADAM13 appears to function in regulating
cell movements while ADAM19 appears to function in regulating cell signaling.

I

propose a few models that discuss how each ADAM metalloprotease may function in the
dorsal mesoderm and contribute to convergence and extension movements during
gastrulation.
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CHAPTER I

INTRODUCTION

Abstract
Gastrulation is a morphogenetic process that reorganizes the primary germ layers
(ectoderm, mesoderm, and endoderm) to shape the internal and external features of an
early embryo.

The morphogenetic movements that drive this process of early

development are mediolateral cell intercalation and convergence and extension in the
dorsal mesoderm. As a result of these movements, the paraxial mesoderm and axial
mesoderm develop during gastrulation to form the somites and notochord, respectively.
This is important to properly lengthen the embryo along its anterior-posterior axis. There
are a large number of molecules that regulate convergence and extension during
gastrulation. I have focused my efforts on understanding how one protein family called
ADAM metalloproteases contribute to these morphogenetic movements and function
during gastrulation.

SECTION I: General Background of Gastrulation in Amphibians

Approximately 150 years ago, a German scientist named Ernst Haeckel observed
and illustrated for the first time one of the earliest phases in Metazoan embryonic
development called gastrulation. Haeckel proposed the term “gastraea” to describe an
early embryo that has a structurally simple hollow diploblastic ovoid embryonic shape
1

(Haeckel, 1875). In the early 1920‟s, the Amphibian embryo became a prominent model
organism for experimental embryologists. This was largely due to the influence of
another German scientist, Hans Spemann, and his discovery of the organizing center
(Spemann and Mangold, 1924). The organizing center is a group of cells that express
specific molecules important for patterning the dorsal side of the embryo.

These

experiments were performed by transplanting organizer cells into the ventral side of a
host embryo. What they observed was the formation of a two headed, dual-axis tadpole.
Spemann‟s work had huge significance in the field of embryology by stimulating a
search, which continues to this day, to investigate the identity of the organizer signals
(Oelgeschlager et al., 2003). Concurrently, the work of Walter Vogt helped establish an
initial understanding of fate mapping in the early embryo (Vogt, 1925). The work of
these early pioneers paved the way for more modern scientists such as Pieter Nieuwkoop
to investigate a more elaborate fate mapping in the early embryo (Nieuwkoop and Faber,
1967) and for Ray Keller to investigate in detail the morphogenetic movements during
Xenopus laevis gastrulation (Keller, 1975). Today a lot of the same principles and
methodology are still used extensively in the Xenopus gastrula. Gastrulation can be
defined as a morphogenetic process that reorganizes the primary germ layers (ectoderm,
mesoderm, and endoderm) to shape the internal and external features of an early embryo.
After fertilization, the embryo undergoes a series of cleavages that divide a large
single cell into a hollow ball of a few thousand cells called a blastula. At this point, the
process of gastrulation begins and is marked by the appearance of the dorsal blastopore
lip. The dorsal lip itself is the initial structure that forms a circular opening on the vegetal
pole of the embryo called the blastopore. The blastopore closes through a variety of
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different cell movements during gastrulation (Figure 1.1).

The four evolutionarily

conserved movements include internalization, epiboly, convergence and extension
(Solnica-Krezel, 2005).

Internalization marks the beginning of gastrulation and in

amphibians, creates the dorsal blastopore lip.

The dorsal lip is composed of large

“bottle” cells that apically constrict to initiate the involution of the prospective mesoderm
(Hardin and Keller, 1988). The involuting mesoderm enters through the blastopore and
migrates inside the embryo. This process is essential to correctly position the three germ
layers for proper embryonic development.

Epiboly movements spread tissue by

increasing the surface area and decreasing thickness. The driving force behind epiboly
occurs when cells interdigitate themselves between deep and superficial layers; a process
known as radial intercalation (Keller, 1980).
The dorsal mesoderm undergoes dynamic movements to converge and extend the
tissue along the anterior-posterior axis; a process called convergence and extension
(Keller et al., 1985). Dorsal mesoderm cells undergo this type of movement by forming
mediolateral polarized protrusions to gain traction on neighboring cells and the
surrounding extracellular matrix (ECM). This cellular behavior is known as mediolateral
cell intercalation.

The dorsal mesoderm can be microdissected from a gastrulating

embryo and cultured ex vivo in a „Keller Sandwich‟ (Keller and Danilchik, 1988) and an
„Open Face Explant‟ (Wilson et al., 1989). When cultured ex vivo, the dorsal mesoderm
retains the ability to undergo convergence and extension movements. On the ventral side
of the gastrulating embryo, the lateral and ventral mesoderms undergo dynamic
movements to converge the tissue without extension; a process called convergence and
thickening (Keller and Danilchik, 1988).

These two complementary morphogenetic
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movements during gastrulation cause the blastopore to close asymmetrically towards the
ventral side of the embryo (Figure 1.2) (Keller and Shook, 2008).
Once gastrulation is complete, the developing embryo enters the neurulation
phase as the neural tube forms. The neural tube develops from the neuroectoderm on the
dorsal side of the embryo. In addition to neural tube closure, the paraxial mesoderm
forms the developing somites and the axial mesoderm continues to form the developing
notochord during this phase. Mediolateral cell intercalation continues during neurulation
in the paraxial mesoderm, axial mesoderm and the neural tissue. This drives the process
of convergence and extension to properly lengthen the embryo along the anteriorposterior axis. These cellular movements are essential for the embryo to develop and
survive to the tailbud stage.
At the molecular level, the major signaling pathways important for mesoderm
induction are Fibroblast Growth Factor (FGF) signaling (Kimelman et al., 1988) and
Transforming Growth Factor  (TGF) signaling (Thomsen et al., 1990). FGF and TGF
are known as morphogens because they are signaling molecules that produce specific
responses in a cell. How morphogens act on a cell depends on their concentration in the
cellular microenvironment. The addition of either FGF or TGF to naïve animal cap
cells isolated from the blastula stage will cause cells to develop into mesoderm tissue,
such as muscle and notochord. FGF or TGF treated explants are not only induced to
express mesoderm specific genes but can also undergo convergence and extension
movements (Kimelman and Maas, 1992; Thomsen et al., 1990). There are a large
number of molecules that regulate convergence and extension during gastrulation (Table
1 in (Solnica-Krezel, 2005)). The major signaling pathway that is critical for regulating

4

convergence and extension is the Non-canonical Wnt signaling pathway (or Planar Cell
Polarity (PCP) Pathway) (Yin et al., 2008). The PCP signaling pathway is extensively
studied in the fly and shown to be evolutionarily conserved in vertebrates. This signaling
pathway is important for establishing individual cell polarity in the dorsal mesoderm
(Tada and Kai, 2009). Cell polarity is established through the localization of specific
PCP components to the medial and lateral edges of cells undergoing mediolateral cell
intercalation (Jiang et al., 2005; Zallen and Wieschaus, 2004). A gain or loss of function
to any of the signaling components in the PCP pathway results in convergence and
extension defects (Roszko et al., 2009). An observed feature of these embryos is a
shortened anterior-posterior body axis.
Convergence and extension movements also involve the regulation of cell
adhesion molecules. During gastrulation, the involuting mesoderm enters the blastopore
and migrates on the inner surface of the blastocoel roof. This migration event is highly
dependent upon the extracellular matrix protein, fibronectin, which localizes along the
blastocoel roof (Boucaut and Darribere, 1983; Lee et al., 1984). The interaction between
fibronectin and its integrin receptor, 51, also contributes to convergence and extension
movements (Davidson et al., 2006; Rozario et al., 2009). For example, depletion of
fibronectin by an antisense morpholino randomizes mediolateral cell protrusions resulting
in convergence and extension defects (Davidson et al., 2006). In addition, the disruption
of fibronectin to 51 integrin by the microinjection of a function blocking antibody
randomizes mediolateral cell protrusions resulting in convergence and extension defects
(Davidson et al., 2006). Furthermore, it is suggested that the interaction between 51
integrin and fibronectin may cross talk with the PCP signaling pathway to regulate
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convergence and extension movements (Marsden and DeSimone, 2001). In particular,
disruption of the PCP components Vangl2 and Frizzled7 by dominant negative RNA
injection impairs proper fibronectin matrix assembly during gastrulation (Goto et al.,
2005).
Convergence and extension movements also involve the regulation of cell-cell
adhesion proteins such as cadherins and protocadherins (Hammerschmidt and Wedlich,
2008). For example, the Xenopus paraxial protocadherin C (PAPC) regulates cell-cell
adhesion by downregulating the adhesive activity of C-cadherin (Chen and Gumbiner,
2006). PAPC can also physically interact with Sprouty2, a known inhibitor of the PCP
signaling pathway, to promote convergence and extension movements during gastrulation
(Wang et al., 2008). Recent work in zebrafish has also analyzed the role of matrix
metalloproteases in cell movements during gastrulation (Coyle et al., 2008). Membranetype I matrix metalloprotease (MT1-MMP/MMP14) regulates mediolateral cell
intercalation by affecting dorsal mesoderm cell polarity. Loss of MMP14 results in
convergence and extension defects without affecting mesoderm patterning. Furthermore,
MMP14 can degrade a fibronectin matrix in a gastrulating zebrafish embryo (Latimer and
Jessen, 2009). This suggests that fibronectin remodeling via MMP14 may be important
for regulating cell polarity and mediolateral cell intercalation in the zebrafish embryo.
Our lab studies another zinc metalloprotease protein family called ADAM
metalloproteases. I will focus my efforts on analyzing the function of ADAM proteins
during Xenopus laevis gastrulation.

6

SECTION II: Introduction to the ADAM Family of Metalloproteases

General ADAM background

Members of the A Disintegrin And Metalloprotease (ADAM) family of zinc
metalloproteases are best characterized for their enzymatic processing of other membrane
bound proteins; a process called ectodomain shedding (Alfandari et al., 2009;
Schlondorff and Blobel, 1999).

Members of the ADAM family function in signal

transduction through their cleavage of signaling molecules such as epidermal growth
factor (EGF), tumor necrosis factor- (TNF- and Notch (Dyczynska et al., 2007; Ohtsu
et al., 2006; Pan and Rubin, 1997; Yan et al., 2002). ADAM members also function in
cell-cell adhesion through their cleavage of cadherins (Maretzky et al., 2005; McCusker
et al., 2009; Reiss et al., 2005; Uemura et al., 2006), and cell-extracellular matrix
adhesion through their processing of ECM molecules (Alfandari et al., 2001; Millichip et
al., 1998). ADAM metalloproteases exist in two main states; an enzymatically inactive
state called the Proform and an enzymatically active state called the Mature form (Figure
1.3). The difference between the two forms is that a Prodomain is present in the Nterminus of the Proform. The Prodomain interacts with the metalloprotease active site
rendering the ADAM catalytically inactive. The prodomain is cleaved by a Furin-like
enzyme in the Golgi complex which releases the inhibition on the active site (Loechel et
al., 1998). This allows the ADAM Mature form to become catalytically active (Figure
1.3).
There are more than 30 members in the ADAM family of metalloproteases and
they can be divided into three major classes. The first class contains the principle
7

sheddases (ADAM10 and ADAM17) that are known to cleave the majority of the ADAM
substrates. For example, ADAM10 cleaves heparin-binding EGF (HB-EGF) to activate
the EGF signaling cascade and resultant gene expression (Yan et al., 2002). The second
class is the mesenchymal ADAMs or the meltrin subfamily (ADAM9, 12, 13, 19, 33) that
are known to be involved in skeletal muscle, bone and heart development. For example,
ADAM19 knockout mice exhibit severe defects in heart morphogenesis leading to their
perinatal death (Zhou et al., 2004). The third class is the non-proteolytic ADAMs
(ADAM11, 22, 23) because they lack a conserved sequence within the active site of their
metalloprotease domain rendering these members catalytically inactive. Members of this
class have an important role in neural development. For example, ADAM22 forms a
complex with the epilepsy-related ligand and its receptor in neurons to regulate synaptic
transmissions in the brain (Fukata et al., 2006).
In addition to their main role as ectodomain sheddases, ADAM members can
physically interact with integrin receptors in a cell via their disintegrin domains (Lu et al.,
2007). This interaction affects cell-extracellular matrix adhesion (Huang et al., 2005) and
cell migration (Chen et al., 2008). Recently, a potential function of the cytoplasmic
domain of ADAM members has emerged. Numerous proline-rich and SH3 binding
motifs contained within the cytoplasmic domain are found to interact with intracellular
proteins such as the cytoplasmic domains of ADAM12, ADAM15 and ADAM19 with
FISH (Abram et al., 2003) and the cytoplasmic domain of ADAM22 with 14-3-3 (Zhu
et al., 2002). The cytoplasmic domain can function independently of the extracellular
region for ADAM10 (Tousseyn et al., 2009) and ADAM13 (Cousin et al., submitted
2010). For ADAM10, it was proposed that a two-step processing event occurs. The first
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cleavage by another ADAM member occurs within the cysteine-rich domain releasing the
extracellular fragment of ADAM10. This triggers a second cleavage by -secretase at the
plasma membrane for the intracellular release of the ADAM10 cytoplasmic domain. The
released cytoplasmic domain translocates into the nucleus where it is believed to function
(Tousseyn et al., 2009). For ADAM13, our lab has shown that -secretase also cleaves
the cytoplasmic domain of ADAM13. The released cytoplasmic domain translocates into
the nucleus to regulate gene transcription of approximately 2000 different genes.
Furthermore, our lab is the first to show that the ADAM13 cytoplasmic domain functions
in vivo and is essential for proper cranial neural crest cell migration in Xenopus laevis
embryos (Cousin et al., submitted 2010).

ADAM Family Members Function in Xenopus Gastrulation

Members of the meltrin subfamily of ADAMs, specifically ADAM9, ADAM13
and ADAM19, are expressed during gastrulation (Alfandari et al., 1997; Cai et al., 1998;
Neuner et al., 2009). ADAM12 and ADAM15 have not been cloned yet in Xenopus
laevis but are expressed during gastrulation of a closely related phylogenic species;
Xenopus tropicalis (Wei et al., 2010). ADAM9 is ubiquitously expressed in all cells,
while ADAM13 and ADAM19 are restricted to the dorsal mesoderm. Through a loss of
function approach by microinjection of an antisense morpholino oligonucleotide, our lab
has shown that single knock down of ADAM9 or ADAM19 does not affect blastopore
closure. However, knock down of ADAM13 delays gastrulation by approximately two
hours.

This suggests that ADAM9 and ADAM19 do not function in regulating

blastopore closure during gastrulation, while ADAM13 does. ADAM19 does however
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affect early gene expression at the gastrula stage and will be discussed further in Chapter
II of this thesis (Figure 2.4).
ADAM10 is also expressed during gastrulation; however a potential function has
never been investigated (Pan and Rubin, 1997). ADAM10 is one of the most studied
ADAM family members because of its essential role in the Notch/Delta signaling
pathway (Pan and Rubin, 1997). The Notch/Delta signaling pathway has recently been
shown to regulate morphogenetic movements as both activation or inhibition of this
pathway delays blastopore closure and affects the segregation of the three germ layers
(Revinski et al., 2010). Thus, it is possible that ADAM10 functions in segregating the
three germ layers during gastrulation.
This thesis will focus on investigating the role of two ADAM family members,
ADAM13 and ADAM19, during gastrulation. Specific emphasis will be on analyzing the
morphogenetic movements that form the notochord. In final, I will attempt to understand
whether ADAM13 and ADAM19 function independently of each other or whether they
have overlapping functions during gastrulation.

SECTION III: Overview of the Work Presented in this Thesis

I began this project five years ago with the initial characterization of ADAM19.
The goal at the onset of the project was to identify another meltrin subfamily member
that could compensate for ADAM13 function, specifically in the cranial neural crest. Of
the other meltrin subfamily members, ADAM19 had the highest sequence homology at
the amino acid level to ADAM13 making it an ideal candidate. At the time there was
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nothing known about the role of ADAM19 in Xenopus laevis. Therefore, the second goal
of this project was broad and it was to characterize ADAM19 in the early embryo. This
was critical in order to identify a biologically relevant substrate to ADAM19 proteolytic
activity in the embryo. The initial experiments were to clone full length Xenopus laevis
ADAM19 and determine its expression pattern. At the time there were no ADAM19
antibodies available that could be used to study the endogenous protein in Xenopus.
Thus, one of the first major objectives was to generate a number of antibodies that could
recognize different structural domains of the ADAM19 protein. I successfully made
three antibodies to the ADAM19 protein and they are briefly described:
1. 2C5 E1: Mouse monoclonal antibody directed against the cytoplasmic domain of
ADAM19.
2. C2 and C3: Rabbit polyclonal antibody directed against both variants (C2 and C3)
of the cytoplasmic domain of ADAM19.
3. DC19: Goat polyclonal antibody directed against the disintegrin-cysteine rich
domains of ADAM19.
The cytoplasmic domain was selected because this domain amongst other ADAM family
members is the most variable at the amino acid level. This would minimize the potential
of cross reactivity with other ADAM family members. The disintegrin-cysteine rich
domain was selected because this domain amongst other ADAM family members is the
most conserved at the amino acid level and would increase our chances of ADAM19
detection. The generation and screening of all three antibodies is described in Appendix
I.
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Chapter II describes the results of the initial characterization of ADAM19 in the
early embryo. I show that ADAM19 is expressed in dorsal, neural and mesodermal
derived structures during early embryogenesis. Through a loss of function approach
using an antisense morpholino oligonucleotide to ADAM19, I show that ADAM19
affects gene expression important for the anterior-posterior (A-P) polarity of the
notochord during gastrulation. The changes in gene expression are accompanied by a
decrease in phosphorylated AKT, a downstream target of the EGF signaling pathway. At
the neurula stage, loss of ADAM19 affects neural crest induction by a reduction in Sox8
and Slug gene expression.

At the tailbud stage, loss of ADAM19 affects muscle

differentiation by a reduction in myosin light chain (MLC) gene expression and a
reduction in 12/101 protein level. Lastly, I show that loss of ADAM19 affects somite
organization and perturbs fibronectin localization at the intersomitic boundary.
Chapter III focuses on ADAM13 and ADAM19 protein regulation in cultured
cells and in the embryo. I show that a loss of ADAM13 protein reduces the level of
ADAM19 protein by 50%. In addition, a loss of ADAM19 protein reduces the level of
ADAM13 protein by 50%. This suggests that both ADAM13 and ADAM19 are required
to maintain a proper protein level in the embryo.

I propose this outcome may be

explained by the physical interaction of ADAM13 and ADAM19 in a cell. When cooverexpressed the ADAM19 Proform binds to the ADAM13 Proform in a cell. Through
protein domain analysis, I show that ADAM19 binds specifically to the Cysteine-Rich
Domain of ADAM13. When co-overexpressed in a cell, the level of Mature ADAM13
(compared to the Proform) is reduced suggesting a complex form of regulation. Lastly, I
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describe a few models that could explain how ADAM19 regulates the level of ADAM13
in a cell.
Chapter IV describes ADAM13 and ADAM19 function in the dorsal mesoderm,
with specific emphasis on the notochord. Through a loss of function approach using
antisense morpholino oligonucleotides to ADAM13 or ADAM19, I show that ADAM19
affects gene expression important for the A-P polarity of the notochord while ADAM13
does not. The changes in gene expression can be partially rescued by the EGF ligand
Neuregulin1, a known substrate for ADAM19 in the mouse. I show that a loss of
ADAM13 or ADAM19 affects convergence and extension movements during notochord
formation. Specifically, a loss of ADAM13 or ADAM19 causes a delay in mediolateral
cell intercalation resulting in significantly wider notochords compared to control
embryos. This defect occurs without affecting dishevelled intracellular localization or the
activation of the PCP signaling pathway. However, a loss of ADAM13 or ADAM19
reduces dorsal mesoderm cell spreading on a fibronectin substrate through 51 integrin.
Chapter V will explore the similarities and differences of ADAM13 and
ADAM19 in the dorsal mesoderm during gastrulation. Although both ADAM13 and
ADAM19 affect convergence and extension movements, I hypothesize their contribution
may involve different mechanisms.

ADAM19 mediated shedding of Neuregulin1

maintains Brachyury expression in the notochord. ADAM13 affects dorsal mesoderm
cell adhesion to fibronectin through 51 integrin. In final, a few models will explain
how ADAM13 and ADAM19 function in the dorsal mesoderm and contribute to
convergence and extension movements.
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Figure 1.1: The Different Types of Cell Movement during Gastrulation. (A)
Diagrams the four main types of cell movements; Epiboly, Internalization, Convergence
and Extension. The final tissue shape is compared to the original (dashed rectangle). (B)
Radial Intercalation. Mesoderm cells from deep tissue layers interdigitate between deep
and superficial cell layers to thin the overall tissue. (C) Directed Migration. Involuting
mesoderm cells respond to an environmental signal via a net migration or displacement in
a single direction. (D) Involution. Mesoderm cells of the dorsal blastopore lip turn in
upon themselves to create this type of cell movement. (E) Invagination. This is the
beginning step to involution where cells change shape in order to fold inward. (F)
Ingression. Involuting mesoderm cells undergo an EMT and migrate along the blastocoel
roof through this type of cell movement. (G) Mediolateral Cell Intercalation. Dorsal
mesoderm cells become polarized in the mediolateral axis to gain traction in order to
converge and extend a tissue. This figure was taken from (Solnica-Krezel, 2005).
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Figure 1.2: Illustration of Gastrulation in the Xenopus laevis Embryo. (A)
The vegetal view of the early Xenopus gastrula (left) compared to the early
neurula (right). The morphogenetic movements during gastrulation to properly
form the notochord (dark grey) and somitic mesoderm (light grey) along the
anterior-posterior axis (A-P arrow) are shown. The overall directionality of
blastopore closure is depicted (black arrows inside blastopore). (B) The process
of convergence and extension in the dorsal mesoderm of an open face explant
cultured ex vivo. This figure is modified from (Keller and Shook, 2008).
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Figure 1.3: Schematic Diagram of an ADAM Family Member.
The
extracellular region of an ADAM protein contains five amino acid domains. The
prodomain (Pro, grey) binds to the Metalloprotease domain through a cysteine
switch mechanism rendering the enzyme inactive called the ADAM Proform (A).
The prodomain is cleaved by a Furin-like enzyme which releases the inhibition
allowing for the ADAM to become proteolytically active called the ADAM Mature
form (B) (Loechel et al., 1998). The Metalloprotease domain (Met, yellow)
contains the zinc active site (green dot). A glutamic acid mutation to an alanine
(E/A) at residue #341 renders the ADAM Metalloprotease proteolytically inactive.
This can act as a “dominant negative” form by competitively binding to substrates
and sequestering them from the endogenous ADAM. The Disintegrin domain (Dis,
red) interact with integrins, an important property for cell adhesion. Together with
the Cysteine-rich domain (CR, blue) interacts directly with protein substrates. The
EGF-like domain contains a number of EGF amino acid repeats, yet its function has
not been determined. Most ADAM family members have a single pass
transmembrane domain (TM, black) containing a Cytoplasmic domain (Cyto,
orange). The Cytoplasmic domain contains proline-rich and SH3 binding motifs
that function within intracellular signaling.
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CHAPTER II

XENOPUS ADAM19 IS INVOLVED IN NEURAL, NEURAL CREST AND
MUSCLE DEVELOPMENT

Most of the work presented in this chapter is published in the journal
Mechanism of Development (Neuner et al., 2009)
*Data generated by myself are depicted in Figures 2.2 (A-D); 2.3; 2.4; 2.5A; 2.6A; 2.7A;
2.8G; 2.8A,B; Table 2.1
*Data generated by other members of the Alfandari Lab are depicted in Figures 2.1;
2.2(E-I); 2.3B; 2.4B, C; 2.7B; 2.8(A-F, H); 2.9C
*The only unpublished figures are Figure 2.2(A, B) and 2.9(A, B).

Abstract
ADAM19 is a member of the meltrin subfamily of ADAM metalloproteases. In
Xenopus, ADAM19 is present as a maternal transcript. Zygotic expression begins during
gastrulation in the dorsal blastopore lip and increases through neurulation and tailbud
formation. ADAM19 is expressed in dorsal, neural and mesodermal derived structures
such as the neural tube, the notochord, and the somites. Using a Morpholino knock down
approach, I show that a reduction of ADAM19 protein in gastrula stage embryos reduces
Brachyury expression in the notochord concomitant with an increase in the dorsal
markers, Goosecoid and Chordin. The changes in gene expression are accompanied by a
decrease in phosphorylated AKT, a downstream target of the EGF signaling pathway.
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The changes in gene expression occur while the blastopore closes at the same rate as the
control embryos. During neurulation and tailbud formation, ADAM19 knock down
reduces neural fates as determined by the expression of N-tubulin and NRP1 but not
Sox2. In the somitic mesoderm, the expression of MLC is also decreased while MyoD is
not. ADAM19 knock down affects neural crest induction as determined by the reduction
in Sox8 and Slug gene expression prior to cell migration. Neural crest induction is also
decreased in embryos treated with an EGF receptor inhibitor suggesting that this pathway
is necessary for neural crest cell induction. Using targeted knock down of ADAM19 I
show that ADAM19 function is required in the neural crest and that the migration of the
cranial neural crest is perturbed. In addition, I show that a reduction in ADAM19 protein
affects somite organization, reduces 12-101 protein expression and perturbs fibronectin
localization at the intersomitic boundary. There was nothing known about ADAM19 in
Xenopus laevis development prior to our published work described in this Chapter.

SECTION I: Introduction

Post-translational modification of proteins is a critical step in most biological
processes.

Among these modifications, cleavage of cell surface proteins controls a

diverse range of cellular processes such as cell signaling, cell adhesion and cell
migration. Members of the ADAM family function in signal transduction through their
cleavage of signaling molecules such as epidermal growth factor (EGF), tumor necrosis
factor- (TNF- and Notch (Dyczynska et al., 2007; Ohtsu et al., 2006; Pan and Rubin,
1997; Yan et al., 2002). ADAM members also function in cell-cell adhesion through
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their cleavage of cadherins (Maretzky et al., 2005; McCusker et al., 2009; Reiss et al.,
2005; Uemura et al., 2006), and cell-extracellular matrix adhesion through their
processing of ECM molecules (Alfandari et al., 2001; Millichip et al., 1998).
ADAM19 is a member of the meltrin subfamily and is shown, in mouse, to cleave
TNF-, Kit1 Ligand, TRANCE, HB-EGF, and Neuregulin-1 (Chesneau et al., 2003;
Horiuchi et al., 2005; Kawaguchi et al., 2007; Shirakabe et al., 2001). The knockout
(KO) of ADAM19 causes defects in heart development, believed to be due to defective
HB-EGF signaling (Kurohara et al., 2004; Zhou et al., 2004).

Conditional KO of

ADAM19 specifically in the cardiac neural crest cells reproduced the heart phenotype,
suggesting that ADAM19 is critical for cardiac neural crest cell specification but not
migration (Komatsu et al., 2007). In mouse, the major enzyme responsible for the
cleavage of both HB-EGF and Neuregulin-1 appears to be ADAM17. In addition, mice
lacking ADAM17 show very similar heart defects to ADAM19 KO mice (Sahin et al.,
2004). Furthermore, a double knock out of both ADAM17 and ADAM19 results in a
more severe phenotype, demonstrating a possible overlapping function of these ADAMs
during embryonic development (Horiuchi et al., 2005).

Fibroblasts derived from

ADAM19 KO mice are able to process both Neuregulin-1 and HB-EGF, suggesting that
the ADAM19 substrate responsible for the cardiac defects remains to be identified.
To test whether ADAM19 has a unique role during early embryonic development,
I cloned the Xenopus laevis homologue and analyzed its expression pattern. ADAM19 is
present at low levels as a maternal transcript with zygotic expression beginning during
gastrulation and localizing to the dorsal blastopore lip. During later stages of embryonic
development, ADAM19 is expressed in the dorsal mesoderm, neuroectoderm and neural
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crest cells. Loss of function experiments using an antisense morpholino knock down
approach reveal that ADAM19 is essential for the specification of the dorsal mesoderm,
neuronal derivatives and cranial neural crest cells. The apparent lack of an overlapping
function for ADAM19 in Xenopus laevis may help resolve the biologically relevant
substrate for ADAM19 during early embryonic development.

Results

SECTION II: ADAM19 Expression Pattern in Xenopus laevis

I cloned the Xenopus laevis homologue of ADAM19 using degenerate
oligonucleotides to human, mouse, quail, and the genomic sequence of Xenopus
tropicalis.

The full-length sequence was generated by 5‟ and 3‟ RACE PCR and

assembled from multiple PCR amplicons. The deduced amino acid sequence is 49%
identical to human ADAM19 and 84% identical to Xenopus tropicalis ADAM19. I found
two variants in the cytoplasmic domain at the amino acid level, one of which is most
common to the Xenopus tropicalis sequence (Genbank accession # EU770696).
I investigated ADAM19 expression throughout development using real-time PCR.
I used poly(A) purified messenger RNA to eliminate any trace of genomic DNA in our
samples.

ADAM19 is expressed as a maternal transcript with zygotic expression

beginning from gastrulation through early tailbud formation (Figure 2.1). The expression
level of ADAM19 at gastrulation is low but is confirmed by in situ hybridization where it
appears restricted to the dorsal lip of the blastopore (Figure 2.2A).
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Using whole mount in situ hybridization, I investigated the distribution of
ADAM19 mRNA during gastrulation, neurulation and tailbud formation (Figure 2.2). To
avoid background staining due to either antibody or substrate precipitation in the
blastocoel cavity, I performed in situ hybridization on bisected gastrula embryos. At the
late gastrula (stage 12), the mRNA encoding ADAM19 is localized to the dorsal lip of the
blastopore where the dorsal mesoderm invaginates (Figure 2.2A). During early tailbud
stages, ADAM19 is expressed in the dorsal region of the embryo including the neural
tissue and the dorsal mesoderm. ADAM19 is detected in the neural tube, the notochord,
and the cement gland (Figure 2.2B, C and F). In the mesoderm, ADAM19 is expressed
both in the segmented (somite) and non-segmented (caudal) dorsal mesoderm (Figure
2.2G and H). When stained embryos are observed in PBS rather than Murray‟s clear to
visualize superficial staining, ADAM19 is detected in the segments of the cranial neural
crest cells (CNC) (Figure 2.2I). The expression in the CNC cells was confirmed by
Reverse Transcriptase PCR on explants dissected from stage 17 embryos (Figure 2.2I
insert). At stage 26, ADAM19 expression is evident in the cement gland, the brain, the
somites, the otic vesicle and the branchial arches (Figure 2.2D). At late tailbud (stage
36), ADAM19 is still expressed in the entire head, the branchial arches, the somites and
the pronephros (Figure 2.2E). The staining intensity decreases in the somite and by
contrast appears stronger in the neural tube.
To determine the role of ADAM19 in early development, I designed antisense
morpholino oligonucleotides corresponding to the sequence near the ATG start codon for
ADAM19 and common to all amplicons identified (Table 2.2). I also generated two
ADAM19 polyclonal antibodies in order to study the ADAM19 protein (Appendix I).
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One antibody was directed against the disintegrin-cysteine rich domains of ADAM19 and
raised in the goat called DC19. The other antibody was directed against both variants of
the cytoplasmic domain of ADAM19 and raised in rabbit called C2 and C3.

All

antibodies recognized the cloned full length ADAM19 protein in transfected Cos-7
extract and embryos injected with the ADAM19 mRNA (Figure 2.3C and data not
shown).

When the antibodies are used in combination by immunoprecipitation in

embryos at stage 22, a 120 kilodalton (kDa) polypeptide and a 90 kDa polypeptide are
recognized.

Based on the predicted molecular weights, the 120 kDa polypeptide

corresponds to the endogenous ADAM19 Proform and the 90 kDa polypeptide
corresponds to the endogenous ADAM19 Mature form.

In embryos injected with

ADAM19 MO (MO19) both polypeptides recognized by the antibody are reduced by 90
to 100%, depending on the injection, when normalized to GAPDH (Figure 2.3A and B).
In addition to the endogenous protein, MO19 prevents translation of the
ADAM19 mRNA while a morpholino to ADAM13 (MO13) does not (Figure 2.3C, lane
5 versus lane 6). Mutation of four nucleotides in the ADAM19 mRNA allows translation
of the protein in injected embryos (Figure 2.3C, lane 4). While translation of ADAM19
mRNA is still affected by the MO19 (Figure 2.3C, lane 2 versus lane 4), the mRNA
translates into an excess amount of ADAM19 protein compared to the endogenous
protein level (Figure 2.3C, lane 4 versus lane 1). I believe that the four nucleotides
changes (out of 26 total) may still allow partial binding of the morpholino to the mRNA
when both are concentrated in a tube before the injection. This construct is named
ADAM19 Rescue (A19R) and is used in all of the rescue experiments described in this
thesis. Before performing knock down analysis in MO19 injected embryos, I tested by
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microinjection for toxicity of 1, 5, 10, 25 and 50 nanogram (ng) dosages of MO19 per
embryos. At the highest dose of 50 ng per embryos, I observed that early cleavage and
gastrulation movements were unaffected.

However, at the end of neurulation a

significant percentage failed to close their neural tube and died (data not shown). While
the 50 ng MO19 dose produced significant death, I did not see a more significant
decrease in the level of ADAM19 protein compared to the 10 ng MO19 dose. For this
reason I selected 10 ng as an optimal dosage to use in all subsequent experiments
described in this thesis.

SECTION III: ADAM19 Affects Early Patterning during Gastrulation

ADAM19 is expressed in the dorsal mesoderm during gastrulation. The dorsal
mesoderm undergoes dynamic cell movements to close the blastopore during
gastrulation. To investigate the role of ADAM19 in blastopore closure, I measured the
size of the blastopore during gastrulation in MO19 embryos compared to controls. Using
the average diameter of the blastopore, I found that embryos injected with MO19 closed
the blastopore at the same rate as embryos injected with a control morpholino (CMO)
(Figure 2.4).
Although ADAM19 does not affect blastopore closure, I investigated the role of
ADAM19 in early gene expression during gastrulation. I performed whole mount in situ
hybridization for Brachyury (Xbra), Chordin, and Goosecoid expression to visualize the
mesoderm in MO19 injected embryos at the late gastrula stage (Figure 2.5). Brachyury is
a T-box transcription factor that is expressed in all mesoderm tissues during gastrulation
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(Cunliffe and Smith, 1992). Brachyury is critical for gastrulation movements and for
establishing the anterior-posterior axis in the early embryo. Our results show that Xbra is
expressed in the ventral and lateral mesoderm but is absent in the notochord of 63% of
the embryos with reduced ADAM19 protein (n=30) (Figure 2.5A). To test whether the
dorsal mesoderm was entirely missing, I assessed Chordin and Goosecoid expression in
the notochord and cephalic mesenchyme, respectively. Goosecoid is a paired homeobox
transcription factor that is expressed in anterior, dorsal mesoderm during gastrulation
(Cho et al., 1991). As a homeobox gene, goosecoid is critical for the early patterning of
anterior dorsal mesoderm in the embryo. Chordin is a secreted Bone Morphogenetic
Protein (BMP) antagonist that is expressed in the axial mesoderm during gastrulation
(Sasai et al., 1994). Chordin is a dorsalizing factor because it binds and inhibits proteins
that induce ventral tissue such as BMP in the early embryo (Sasai et al., 1994). At the
late gastrula stage, I found that most MO19 embryos (65% n=30) had a wider, more
anterior shift in the localization of Chordin expression while 35% showed a similar
staining to the controls. A more detailed analysis into Xbra and Chordin expression will
be presented in Chapter IV of this thesis. Furthermore, 76% of the embryos injected with
MO19 had the same level of Goosecoid staining while the remaining 24% (n=20) showed
a wider expression. Another notochord marker (not-1) was not affected by the knock
down of ADAM19 (data not shown). These results show that the dorsal mesoderm and
the notochord are present in embryos with a reduced level of ADAM19 but that the
patterning of the notochord may be altered.
Using quantitative real-time PCR, I tested the level of expression of these genes in
embryos injected with a CMO, MO19 and a combination of MO19 and ADAM19 Rescue
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mRNA (Figure 2.5B). The results confirm a small reduction of Xbra expression (16%
decrease) possibly due to the absence of expression in the notochord. In contrast, I found
that both Chordin and Goosecoid levels were increased by approximately two fold in
embryos with reduced ADAM19 protein suggesting that there is an increase in specific
dorsal mesoderm markers. These changes in gene expression were all rescued by the coinjection of ADAM19 Rescue mRNA.
Since the expression of Xbra in the notochord is absent, I performed a targeted
injection at the 8-cell stage with -galactosidase as a lineage tracer. The cells with a
reduced level of ADAM19 were still able to incorporate into the notochord and the
somites, suggesting that ADAM19 expression is not essential for the formation of these
tissues (data not shown).

SECTION IV: ADAM19 Affects Neural Patterning and Neural Crest Induction

To investigate the role of ADAM19 in neural induction, I performed in situ
hybridization using Sox2 as a general neural marker in gastrula stage embryos. The
results show that MO19 does not prevent neural induction (Figure 2.5A). While the
overall expression of Sox2 was not affected, careful analysis revealed some subtle
changes. For example, Sox2 expression in control embryos is lighter in the neural plate
directly above the notochord (future floor plate, Figure 2.5A, red arrowhead). This
decrease of Sox2 at the midline is not visible in 30% of the embryos injected with MO19
(n=30), suggesting that a reduction in ADAM19 protein may affect axial tissue patterning
across the mesoderm/neuroectoderm tissue boundary. However at that point, it is not
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clear whether the affect on the neural plate is direct or an indirect result of defective
signaling from the notochord.
To further investigate the role of ADAM19 in the neural tissue, I performed in
situ hybridization using N-tubulin, Sox2, and NRP-1 at the tailbud stage (stage 24). Sox2
and NRP1 were used as general neural markers and N-tubulin as a marker of neuronal
precursors. Embryos were injected in one blastomere of the two-cell stage with 10 ng of
either CMO or MO19 with mRNA encoding -galactosidase (Figure 2.7A).

The

expression of Sox2 was unaffected by a reduction in ADAM19 protein while both Ntubulin and NRP1 appear reduced on the injected side (Figure 2.7A). The reduction of
N-tubulin expression was confirmed by quantitative real-time PCR at both stage 17 and
stage 24 (Figure 2.7B). While the decrease was small (30%), it was highly reproducible
(p-value<0.05) and was fully rescued by the injection of ADAM19 Rescue mRNA. This
suggests that only a fraction of neurons expressing N-tubulin are affected by the
ADAM19 knock down. In contrast to N-tubulin, ADAM19 knock down had no effect on
Sox2 expression at both stage 17 or stage 24 confirming the in situ hybridization results.
ADAM19 is also expressed in the CNC cells. I investigated the role of ADAM19
in neural crest induction at the open neural plate stage (Stage 15) before CNC migration.
I performed in situ hybridization and real time PCR for the expression of two early neural
crest markers, Sox8 and Slug (Figure 2.6). Our results show that both Sox8 and Slug
expression are reduced in the MO19 injected half of the embryos compared to the
uninjected half serving as an internal control (Figure 2.6A). Real time PCR shows a
reduction of approximately two fold for Sox8 (50% reduction) and Slug (40% reduction;
Figure 2.6B). In contrast, the neural marker Sox2 increased at this stage. Since the
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neural crest is induced at the border of the neural plate, it is likely that the cells that are
not induced to become neural crest will remain neural and maintain Sox2 expression.
To investigate the role of ADAM19 in CNC cell migration, I performed targeted
injection of the MO19 together with GFP mRNA at the 16-cell stage in a dorso-lateral
animal blastomere. The dorso-lateral animal blastomere will give rise to the cranial
neural crest. Cell migration was evaluated by observing the distribution of GFP in the
different CNC segments (Figure 2.6C). Our results show that, while GFP is present in all
segments of the CNC that migrate in control embryos, no migration was observed in 33%
of the embryos injected with MO19. Together these results show that ADAM19 is
required for neural crest cell induction and affects CNC cell migration. Moreover, our
results show that there is a significant reduction of xTwist expression in the MO19
injected side (Figure 2.7A, arrowhead).

To investigate if ADAM19 affects CNC

specification or solely xTwist expression, I determined ADAM11 expression as a marker
of CNC by quantitative PCR. While Twist is a widely used marker for CNC by in situ
hybridization, it also labels other cells at the tailbud stage. On the other hand, ADAM11
is more restricted with expression in both the CNC and one line of dorsal neurons (Cai et
al., 1998). Confirming the in situ hybridization, I observed a decrease of ADAM11
expression at both stage 17 (58%) and stage 24 (50%) (Figure 2.7B). This expression can
be rescued with ADAM19 rescue mRNA.
To investigate whether the reduction of the neural and neural crest markers were
due to the reduction of ADAM19 in these tissues or a secondary effect of the dorsal
mesoderm patterning, I injected MO19 in both dorsal animal blastomeres at the 8-cell
stage to target only ectodermal derivatives (Figure 2.7B, right graph). Only 1 ng of
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MO19 was injected in each cell at the 8-cell stage to adjust for the reduction in cell size.
The results show that a reduction of ADAM19 protein in the ectoderm is sufficient to
reduce N-tubulin and ADAM11 in the same proportion as those observed when the
MO19 is injected at the one cell stage. In contrast no change was observed in the somitic
mesoderm marker Myosin Light Chain (MLC), confirming the proper targeting of our
injection. These results suggest that ADAM19 is required in the neural ectoderm and
neural crest cells to perform its function.

SECTION V: Role of ADAM19 in Somitic Cell Organization and Muscle
Differentiation

The expression of ADAM19 increases at neurula and tailbud stages and is mainly
concentrated in the dorsal mesoderm and neural tissue. To determine if ADAM19 plays
a role in somite development, I performed in situ hybridization using MLC and MyoD at
the tailbud stage (st.24) (Figure 2.7A). The results show that ADAM19 knock down
dramatically reduces MLC expression in the somites. In contrast, MyoD, which is also
expressed in the somites, did not appear to be reduced on the injected side. Furthermore,
MyoD staining shows that the correct segmentation of the somites is achieved even in
embryos with reduced ADAM19 protein.

The reduction of MLC expression was

confirmed by quantitative PCR at stage 17 (93% decrease) and at stage 24 (58%
decrease) (Figure 2.7B).

Expression of MLC was rescued by the co-injection of

ADAM19 mRNA (Figure 2.7B). In fact, the same pattern of gene expression (reduction
of MLC but no changes in MyoD) was also observed at stage 15 (data not shown). These

28

results suggest that a reduction in the ADAM19 protein level does not affect early
induction and segmentation (MyoD) of the somitic mesoderm but may interfere with the
differentiation of the muscle (MLC).
To further investigate the role of ADAM19 in somite formation, I used our
ADAM19 antibody (C3) to detect the protein localization on sections of tailbud stage
embryos (Figure 2.8). I found that ADAM19 localizes to the notochord, the intersomitic
boundary and the ventral half of the neural tube (Figure 2.8A-C). In addition, I found
staining within the branchial arches (Figure 2.8A). The distribution of the protein is
consistent with the mRNA expression pattern (Figure 2.2) and provides new information
about where the protein may be functioning in these tissues. I performed the same
staining on embryos injected in one side with MO19. The most dramatic change is the
complete absence of ADAM19 staining at the intersomitic junction (Figure 2.8D). As
seen for the in situ hybridization with MyoD (Figure 2.7A), the segmentation of the
somites is apparent in both sides of the embryos. While the segmentation is unaffected,
the organization of the cells within each somite is abnormal in embryos with reduced
ADAM19 protein. Furthermore, the nuclei on the control side are aligned at the center of
each cell, however this alignment is disrupted on the side with reduced ADAM19 protein
(Figure 2.8D). In addition to these somite defects, staining with the mAb 12-101, a
marker of muscle differentiation, is decreased on the MO19 injected side (Figure 2.8E).
This decrease was observed in the posterior somites but not in the most anterior somites
suggesting a delay in 12-101 expression rather than a complete inhibition (data not
shown). Moreover, the decrease of 12-101 expression was confirmed by western blot on
embryos injected at the one cell stage with MO19 (Figure 2.8G).
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To visualize the intersomitic boundary of embryos injected with MO19, I
performed staining with antibodies to fibronectin (FN).

The staining confirms the

presence of somite boundaries in the injected side similar to the control side.
Interestingly, I also found that some of the intersomitic boundaries lacked FN (Figure
2.8F). This was confirmed by whole mount immunostain where the entire embryo can be
visualized at once (Figure 2.8H). Using this technique, I found that the fibronectin
staining was present but slightly abnormal. The defect was seen only in the somites
located between the “chevron” and the “straight” shaped somites (approximately 7th
somite). Compared to this mild and restricted FN defect, the abnormal distribution of the
nuclei affected a larger number of somites. Together, the results presented in Figure 2.7
and 2.8 show that a reduction of the ADAM19 protein affects both the organization and
differentiation of somite cells into muscle but not the initial induction of the paraxial
mesoderm or the segmentation.

SECTION VI: ADAM19 Affects EGF Signaling during Gastrulation

In mouse, ADAM19 can cleave members of the EGF family of ligands, including
Neuregulin-1 (Chesneau et al., 2003; Horiuchi et al., 2005; Kawaguchi et al., 2007;
Shirakabe et al., 2001). Upon cleavage the EGF ligands bind to the EGF receptor and
activate a signaling cascade involving AKT/PKB (protein kinase B). To investigate if
Xenopus ADAM19 plays a role in the EGF signaling pathway, I performed western blot
analysis of late gastrula stage embryos injected with either CMO or MO19. Our results
show that phosphorylated AKT (AKTp) is decreased significantly in embryos with
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reduced ADAM19 protein (Figure 2.9).

In contrast, neither phosphorylated MAPK

(MAPKp) nor the cytoplasmic adaptor protein PACSIN2 was reduced. To investigate
whether the EGF signaling pathway was involved in neural crest cell induction, I used a
pharmacological inhibitor of the EGF receptor (AG1478, 100 µM). I treated embryos
during gastrulation between stage 10 and stage 12 with AG1478 compared to a DMSO
control treatment. In addition, I also used a broad-spectrum inhibitor of metalloproteases
called Marimastat (10 µM) to inhibit most ADAM protease activity (Orth et al., 2004).
Based on the blastopore size, neither inhibitor affected gastrulation movements (data not
shown).

However using real time PCR, I found that Marimastat and AG1478

significantly decreased Slug expression (Figure 2.9C).

This result confirms the

importance of the EGF signaling pathway and metalloprotease activity in neural crest cell
induction. As a control, I performed western blot with the AKTp antibody and found a
50% reduction in embryos treated with the EGF receptor inhibitor confirming its activity
in vivo. Similar to what was observed with MO19 (Figure 2.9B), I also found that
Marimastat reduced the level of phosphorylated AKT (data not shown), suggesting that
metalloprotease activity, possibly of ADAM19, is important for EGF signaling during
gastrulation.
SECTION VII: Discussion

ADAM19 Expression and Function in the Early Embryo

This chapter describes the cloning and molecular analysis of the Xenopus laevis
homologue of ADAM19.

Maternal ADAM19 mRNA is present during the initial

cleavage stages. Zygotic expression is first detected during gastrulation in the dorsal
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mesoderm of the dorsal blastopore lip. During later development, ADAM19 mRNA is
localized to dorsal, neural and mesodermal derived structures including the neural tube,
the notochord, and the somites. Loss of function experiments using antisense morpholino
oligonucleotides shows a reduction of Brachyury in the notochord of gastrula stage
embryos and an increase in the dorsal mesoderm markers Goosecoid and Chordin.
During neurulation and tailbud formation a reduction of ADAM19 protein results in the
reduction of neuronal, neural crest and somitic markers. The segmentation of somites is
not perturbed but the organization of cells within an individual somite is disrupted.
Lastly, I present evidence that the EGF signaling pathway is affected by ADAM19 knock
down.
ADAM19 mRNA is expressed during early mouse embryonic development in a
pattern similar to the one described here for Xenopus. ADAM19 is present in dorsal
tissues including the spinal cord, the craniofacial and dorsal root ganglia, and the
peripheral nervous system.

In the mouse, ADAM19 is also present in mesenchymal

condensation of the tailbud and the heart (Kurisaki et al., 1998). ADAM19 KO mice die
perinatally due to defects observed in heart formation (Kurohara et al., 2004; Zhou et al.,
2004), confirming the importance of ADAM19 in heart morphogenesis.

The heart

defects were shown to be due to a lack of the ADAM19 protein in cardiac neural crest
cells rather than in the endothelial cells (Komatsu et al., 2007). The cardiac neural crest
cell migration was not affected by the lack of ADAM19; however the ability of the cells
to participate in heart morphogenesis was perturbed.

In Xenopus, a reduction of

ADAM19 protein affects early gene expression in the gastrula, neurula and early tailbud
stage. I have also observed a decrease in the expression of three cardiac specific genes
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during heart formation (Appendix II), suggesting that ADAM19 is also involved in heart
morphogenesis in amphibians. It is interesting to note that ADAM12 (meltrin-) was not
found during early embryogenesis in Xenopus laevis, while ADAM9 and ADAM13 are
both expressed in overlapping patterns with ADAM19 (Alfandari et al., 1997; Cai et al.,
1998). This suggests that ADAM9, ADAM13 and ADAM19 may have overlapping
functions during Xenopus laevis gastrulation.
In addition to the prominent role of ADAM19 in cardiac morphogenesis, the
ADAM19 KO mice also have minor defects found in other tissues.

Most of the

ADAM19 KO mice (~80%) die perinatally due to defects shown in heart development.
However, approximately 20% survive to adulthood and appear healthy and fertile. If the
adult ADAM19 KO mice become pregnant, they die late in pregnancy due to an inability
to compensate for the increased circulatory demands (Zhou et al., 2004). ADAM19 is
highly enriched in the placenta during pregnancy and believed to be involved in
trophoblast invasion of rhesus monkeys, Macaca mulatta, (Wang et al., 2005) and in
humans (Zhao et al., 2009). This strongly suggests that ADAM19 may function in the
placenta during pregnancy. Another group has reported that some ADAM19 KO mice
carrying a mixed genetic background of 129/Sv and C57BL/6 survive to adulthood but
have defects in the peripheral nervous system (Kurohara et al., 2004). The differentiation
of Schwann cells from promyelin to myelinating stages is drastically delayed in
ADAM19 KO mice upon sciatic nerve injury. It is interesting to note, that this defect is
due to a delay in the AKT-dependent upregulation of Krox20. These results further
support the role of ADAM19 in the AKT signaling pathway.
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Role of ADAM19 in Early Patterning of the Embryo

A reduction of ADAM19 in gastrula stage embryos results in a decrease of
Brachyury expression in the notochord and an increase of the dorsal mesoderm markers,
Goosecoid and Chordin.

This result is consistent with the observation that the

upregulation of Goosecoid can repress Brachyury expression (Boucher et al., 2000).
Thus ADAM19, which is expressed in the dorsal mesoderm, may participate in restricting
Goosecoid gene expression. On the other hand, ADAM19 may be important to maintain
Brachyury expression in the notochord. At the moment, it is not clear whether Goosecoid
overexpression is preventing Brachyury expression in the notochord or if these are
independently affected by ADAM19.

Further analysis into ADAM19 function on

Brachyury expression will be investigated in Chapter IV of this thesis. Previous work
has shown that high doses of TGF- can induce Goosecoid and Chordin at the same time
repress Brachyury expression (Latinkic and Smith, 1999; Latinkic et al., 1997). Thus
ADAM19 knock down may increase TGF- signaling in the early embryo. This suggests
that ADAM19 function is to negatively regulate TGF- signaling. In mouse, ADAM12
promotes TGF- signaling by interacting with the TGF- type II receptor to control its
subcellular localization (Atfi et al., 2007). Therefore ADAM19 may also interact with
the TGF- receptor but decrease rather than increase TGF- signaling. In addition, the
EGF-CFC/FLR1 protein was shown to modulate TGF- signaling via nodal related
proteins (Cheng et al., 2003; Dorey and Hill, 2006; Yabe et al., 2003). Cleavage of FLR1 by ADAM19 may reduce TGF- signaling at the end of gastrulation coinciding with
the disappearance of FLR-1 mRNA expression. Thus there are several possible ways that
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ADAM19 may control TGF- signaling during gastrulation. Furthermore, the expression
patterns of Brachyury and Chordin in the axial mesoderm, as been shown to control the
anterior-posterior (A-P) polarity of the notochord. Chordin localizes to the anterior
notochord while Brachyury localizes to the posterior notochord (Ninomiya et al., 2004).
This suggests that embryos with reduced ADAM19 protein have notochords that are
“anterior-ized” compared to control embryos. Further analysis into the A-P polarity of
the notochord will be investigated in Chapter IV of this thesis.
Through various gene expression patterns for the notochord, paraxial mesoderm
and neural ectoderm, I have found that the separation between the axial and paraxial
tissues may be delayed or impaired in embryos with reduced ADAM19 protein. ADAM
metalloproteases can cleave cell-cell adhesion molecules such as cadherins or
protocadherins (Maretzky et al., 2005; McCusker et al., 2009; Reiss et al., 2005). The
role of the protocadherins AXPC and PAPC in notochord and somite formation is
elegantly demonstrated in Xenopus (Chen and Gumbiner, 2006; Kim et al., 2000; Kim et
al., 1998; Kuroda et al., 2002; Unterseher et al., 2004; Wang et al., 2008) and it is
possible that the activity of these proteins is regulated by proteolytic processing.
Therefore, ADAM19 may be involved in separating the axial mesoderm from paraxial
mesoderm by cleaving cell adhesion molecules such as protocadherins.

Role of ADAM19 in EGF Signaling of the Embryo

The EGF signaling pathway is the best characterized signaling pathway involving
ADAM19 (Blobel, 2005). In mice, ADAM19 can cleave some members of the EGF
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ligand family including Neuregulin1- (NRG1). In Xenopus, NRG1 is expressed as a
maternal transcript with zygotic expression beginning during gastrulation through tailbud
formation (Chung and Chung, 1999; Yang et al., 1999; Yang et al., 1998a). Purified
recombinant NRG1 can induce naïve animal cap cells to become mesoderm and express
Brachyury (Chung and Chung, 1999).

Therefore, ADAM19 mediated cleavage of

NRG1 in the dorsal mesoderm may be important for maintaining Brachyury expression
in the notochord. NRG1signals through the EGF receptors ErbB3/B4 tyrosine kinases
to activate the MAPK and PI3K/AKT signaling pathways (Esper et al., 2006).
Furthermore, the ErbB signaling pathway also contributes to convergence and extension
movements during gastrulation (Nie and Chang, 2007b). However, a knock down of
ErbB3 or ErbB4 did not inhibit Brachyury expression in the notochord, suggesting that
ADAM19 function may act through a different signaling pathway (Nie and Chang,
2007a; Nie and Chang, 2007b). I have found that ADAM19 knock down decreases
AKTp, a downstream component of the EGF signaling pathway. In addition, the EGF
receptor inhibitor AG1478 affects neural crest gene expression similar to the ADAM19
knock down.

These results suggest that ADAM19 is important for EGF receptor

activation and that the EGF signaling pathway is important for neural crest cell induction.

Role of ADAM19 in Neural, Neural Crest and Muscle Development

During neurulation and tailbud formation, embryos with reduced ADAM19
protein show a reduction of N-tubulin and NRP1 in the neural tissue and MLC in the
somites.

Interestingly, for both the dorsal mesoderm and neural tissue, the overall
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induction is not affected as shown by the expression of Sox2 in the neural tube and
MyoD in the dorsal mesoderm. This suggests that ADAM19 may function only as a
modifier rather than a master regulator of cell fate. ADAM19 knock down reduces the
expression of CNC cell markers xTwist, Sox8, Slug and ADAM11. In situ hybridization
using xTwist reveals that at least some CNC maintain xTwist expression and are capable
of migration. However, our lab has shown that CNC with a reduced level of ADAM19
do not migrate as efficiently as wild type cells in vivo. Together with the conditional
ADAM19 KO mice in the cardiac neural crest, ADAM19 may be required for both neural
crest cell induction and function. This could be due to either a direct affect on migration
or the observed defect in neural crest induction. Additional experiments are required to
test these two hypotheses. Once again, Neuregulin appears as an attractive candidate as a
substrate for ADAM19 because Neuregulin can induce both neural and muscle specific
markers in Xenopus animal cap assays (Chung and Chung, 1999). Moreover, the role of
NRG1 in neuronal cell specification has been studied extensively (Britsch et al., 1998;
Cameron et al., 2001).
In the paraxial mesoderm, a reduction of ADAM19 protein does not prevent
muscle induction or somite segmentation. In addition, the fibronectin rich extracellular
matrix is deposited at the intersomitic boundary. While the general organization of the
somites does not depend on ADAM19, cell organization within each somite appears to be
affected by a reduction of ADAM19 protein. Specifically, the morphotype suggests that
cell rotation may be delayed or abnormal. Together with somite organization, at least
two markers of muscle differentiation (MLC and 12-101) are reduced in ADAM19 knock
down embryos. It is not clear at the moment whether the effects on cell organization and
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muscle differentiation are linked. As for the early gastrulation defects, either a signaling
role for ADAM19 or a structural role via cleavage of a cell adhesion molecule could
account for the defects seen following ADAM19 knock down. Loss of function and
complementation experiments using the putative substrates for ADAM19 will be
necessary to determine which of the signaling pathways ADAM19 regulates.

The

Xenopus system may provide a unique way to dissect in vivo the role of ADAM19 in
early embryonic development.

SECTION VIII: Materials and Methods

Embryo Culture
Xenopus laevis eggs were fertilized and the resultant embryos were de-jellied in 2%
cysteine and cultured as previously described (Newport and Kirschner, 1982a; Newport
and Kirschner, 1982b).

Staging of embryos was according to (Nieuwkoop, 1967a;

Nieuwkoop, 1967b).

Cloning of ADAM19
Degenerate oligonucleotide primers were designed from sequences conserved in human,
mouse, quail, and Xenopus tropicalis. PCR was carried out with cDNA from stage 20,
stage 36 and adult liver using S1 (amino acids LNIRIAL) and AS3 (amino acids
CNNNKN) at an annealing temperature of 50C. The corresponding PCR product was
cloned into TOPO-TA (Invitrogen) and sequenced. Specific primers were designed and
used in 5‟ and 3‟ RACE-PCR with the Generacer kit (Invitrogen) according to the
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manufacturer‟s instructions. Clones from at least 3 independent PCR reactions were
sequenced to obtain the full length ADAM19.

Quantitative PCR
Total RNA was isolated from 5 embryos according to (Chomczynski and Sacchi, 1987)
followed by LiCl precipitation and poly A purification using the Oligotex kit (Qiagen)
according to the manufacturer instructions. The cDNA was reversed transcribed using the
Quantum Qscript kit (Quanta Biosciences). All PCR reactions were carried out using
SYBR green (Takara) on a MX3005P light cycler (Stratagene). All experiments were
repeated at least 3 times on separate injection days and the real time PCR was also
performed in triplicate on separate days to maximize variation due to PCR efficiency.
The results were analyzed using the 2-CT method (Livak and Schmittgen, 2001) and are
presented as the Log2 fold change. All data were normalized using alpha tubulin. The
list of the real time PCR primers is shown in Table 2.1.

Plasmid Constructs and mRNA Microinjection
Full-length Xenopus ADAM19 was amplified by PCR using 2.5 units of Pfu DNA
polymerase (Stratagene) and cloned into the pCS2+ vector (Turner and Weintraub, 1994).
Rescue ADAM19 mRNA was generated using a sense oligonucleotide containing 4
nucleotide

silent

mutations

at

the

MO

binding

site

(5‟

–

CATGGAAGGTGCAACAGGAGTC – 3‟, mutation are in bold). Non-rescue ADAM19
mRNA corresponds to the original cDNA sequence. The pCS2-ADAM19 construct was
linearized by NotI and transcribed by SP6 RNA polymerase. All mRNA was prepared for
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microinjection as described in (Cousin et al., 2000). Transcripts were injected close to
the animal pole region at the indicated dosages and embryo stages stated in the figure
legends. For embryos where one blastomere at the two-cell stage was injected, the
uninjected half of the embryo served as an internal control for each embryo.

Antisense Morpholino experiments
An antisense Morpholino (MO) was synthesized (Gene Tools Carvalis, OR) just
upstream of the ATG start codon for ADAM19 (MO19). The sequence was selected to
be complementary with all the 5‟ cDNA clone obtained by RACE PCR and is also a
perfect match to the published sequence for ADAM19 in Xenopus tropicalis. A control
MO (CMO) was used to test for non-specific toxicity in the dose response experiments.
The sequences of the morpholinos used in this dissertation are in Table 2.1. Serial
dilutions of MO19 (50 ng to 1 ng) were injected in 5 nl volume into wild-type embryos to
test for toxicity. A dosage of 10 ng of MO19 was selected and was shown to inhibit
translation of 1 ng of the wild type ADAM19 mRNA in embryos while allowing
translation of a messenger containing the 4 nt mismatch. When the MO where injected in
a subset of cells to target specific tissues, -galactosidase or GFP-myc RNA was injected
to trace the lineage with reduced ADAM19 protein.

Whole Mount -galactosidase Detection and In Situ Hybridization
Embryos were fixed in MEMFA (0.1 M MOPS pH 7.4, 2 mM EGTA pH 8, 1 mM
MgSO4, and 3.7% formaldehyde) for 1hr at 20oC. They were washed in PBS and stained
at 37oC in PBS solution containing 1 mg/ml X-gal, 20 mM K3Fe(CN)6, 20 mM
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K4Fe(CN)6, and 2 mM MgCl2. The embryos were dehydrated in methanol and stored at 20oC. Whole mount in situ hybridization was performed exactly as described previously
using albino or wild-type embryos (Harland, 1991).

Western Blot Analysis
Embryo protein extraction and western blot analysis were performed exactly as described
previously (Alfandari et al., 1997).

Monoclonal antibody to PACSIN2 (3D8) and

GAPDH (Millipore) was used as a loading control as described previously (Cousin et al.,
2000). For quantification, blots were detected using chemiluminescence on a G-Box
HR16 (Syngene) and analyzed using the Genetool analysis software. Alternatively for
weaker signals, the blots were exposed on X-ray films for various time points and the
films were scanned and analyzed by densitometry using the same software.

Immunofluorescence and Whole Mount Immunostain
Embryos were fixed using either MEMFA or DENTS (20% DMSO in 80% Methanol)
and stored in methanol before sectioning. Embedding was performed by increasing doses
of 15% fish skin gelatin (Sigma) and 15% sucrose in PBS. After a final impregnation
overnight at 4 oC, embryos were mounted in OCT (Tissue Teck). Cryosections (14 to 16
µm) were blocked in PBS containing 20% goat serum and 1% BSA (Sigma). Primary
antibodies were used at 10 µg/ml and secondary antibodies (Jackson Immunoresearch)
were used at 5 µg/ml. Slides were mounted using Vectashield (Vector) and imaged using
a Zeiss Axiovert 200M inverted microscope equipped with a Ludl XY-stage control and a
Hamamatsu Orca camera. Images were taken using the ApoTome structured light
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illumination system (Zeiss) and the AxioVision software (Zeiss). Whole mount
immunostaining was performed as previously described (Dent et al., 1989).

Time Lapse Imaging
Embryos at late blastula stage were individually placed in holes made in an agarose
coated plastic dish. Time lapse movies were made using an Axiovert inverted microscope
(Zeiss) equipped with a Ludl XY-stage control and an Orca camera (Hamamatsu) and
controlled by the OpenLab software (Improvision). Measurements were done using the
same software.
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Figure 2.1: ADAM19 expression. Quantitative real-time PCR expression
of ADAM19 during early Xenopus development. Polyadenylated RNA
from 2.5 embryos was used to make cDNA. PCR amplification was
performed on a light cycler for 40 cycles. (A) The amplification product
from both the control (-RT) and the experimental (+RT) were separated on
a 2% agarose gel. (B) The relative abundance of the ADAM19 mRNA
was measured by the 2(-CT) method (Livak and Schmittgen, 2001) using
stage 10 as a value of 1. Values are not adjusted to a control gene but to
identical number of embryos. The CT values for each reaction are given
below the graph. No CT values were obtained for the -RT control of each
stage. ADAM19 mRNA is present as a maternal transcript at stage 2.
Zygotic transcription starts during gastrulation and increases during
neurulation (Stage 16) continuing into early tailbud stage (Stage 21).
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Figure 2.2: ADAM19 mRNA distribution. Whole mount in situ hybridization using a
probe corresponding to Xenopus ADAM19. (A) Lateral view of a bisected gastrula with
the dorsal side to the left and the animal pole at the top (ap). (B; G) Dorsal views of early
tailbud stage embryos with the anterior at the top. (C; D; E; I) Lateral views of tailbud
stage embryos with anterior to the left. (F) Ventral view of an early tailbud stage embryo.
Photographs in A, F and I were taken with embryos in PBS to visualize superficial rather
than internal staining. All other embryos were imaged in Murray‟s clear. (A) ADAM19 is
first expressed in the dorsal mesoderm of the gastrula, with the most intense signal in the
dorsal blastopore lip (dbl). (B; F; G; H) At early tailbud stage, ADAM19 is found in the
dorsal mesoderm including the notochord (n), somites (s), the cement gland (cg) and the
neural tube (nt). (C; D; I) ADAM19 expression in these tissues persists during tailbud
formation. In the anterior, ADAM19 is expressed in the brain (br), the otic (ot) and optic
(o) vesicles as well as CNC segments and branchial arches (ba). (E) At stage 36, the
expression in the pronephros (p) is also detected.
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Figure 2.3: Morpholino oligonucleotide knock down of ADAM19. Western blot of
protein extract from embryos injected with a control morpholino or a morpholino to
either ADAM13 (MO13) or ADAM19 (MO19). The morpholinos (10 ng) were injected
at the one cell-stage and embryos were extracted at stage 22. (A) Immunoprecipitation of
ADAM19 using the goat DC19 antibody separated by SDS-PAGE and probed with a
rabbit polyclonal antibody to the ADAM19 cytoplasmic domain (AP ADAM19 C3). A
monoclonal antibody to GAPDH was used as a loading control. (B) The densitometric
analysis of the blot depicted in A shows that the ADAM19 protein is reduced by
approximately 100% by the MO19 when normalized to the GAPDH expression level. (C)
The MO19 is capable of preventing translation of 1 ng of ADAM19 mRNA when coinjected in embryos (A19NR) but not a messenger with 4 mutations in the sequence
corresponding to the MO19 (A19R). The ADAM13 morpholino does not affect
ADAM19 translation.
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Figure 2.4: ADAM19 is not required for blastopore closure. Timelapse imaging of gastrula stage embryos injected with either a control MO
(CMO) or MO19. Embryos were microinjected with 10 ng of MO at the
one-cell stage and allowed to develop through the end of gastrulation. The
blastopore size in micrometers was measured using the OpenLab software
at three different time points during gastrulation. The values represent the
average of three different experiments using 8 embryos each for the
control and the experimental. Error bars correspond to standard deviation
from the mean. Representative images are shown below the histogram.
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Figure 2.5: Gene Expression analysis of ADAM19 knock down at the gastrula stage.
(A) Embryos were microinjected with 10 ng of either the MO19 or a control MO at the
one-cell stage and allowed to develop until gastrula stage (stage 12 and 13). Whole
mount in situ hybridization were performed using the markers Brachyury, Sox2 (Xbra
Sox2, stage 12), and Chordin and Goosecoid (Chd and Gsc, stage 13). For all embryos,
the dorsal view is presented with the anterior up. The red arrowheads point to the
notochord. The number of embryos and the frequency of the phenotype depicted in the
photographs are indicated in the text. (B) Quantitative real-time PCR was performed on
embryos injected with either MO19 alone or together with ADAM19 Rescue mRNA
(MO19+A19R). The relative abundance of Chordin (Chd), Goosecoid (Gsc) and
Brachyury (XBra) gene expression was measured by the 2-CT method using either
embryos injected with the control MO or non-injected and normalized to alpha-tubulin.
There was no effect of the control MO to gene expression. The asterisks represent
statistical significance at P<0.05 using a student t test. There is a small decrease in Xbra
(16%, not significant) and a robust increase in both Chd (187%) and Gsc (230%) which
are rescued by the injection of the ADAM19 mRNA.
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Figure 2.6: ADAM19 is critical for neural crest induction. (A) Whole mount in situ
hybridization of neurula (stage 15) embryos using Slug and Sox8 to detect neural crest
cells. The injected side is to the left. Embryos injected with MO19 show a decrease in
expression of both neural crest markers (red arrowhead). (B) Real time PCR analysis at
stage 15. The level of gene expression was measured by the 2CT method and
normalized to alpha-tubulin. Results are presented as the Log2 of the fold change
compared to non injected embryos. Variation of Sox2, Sox8, and Slug are all significant
(p<0.01) in embryos injected with MO19 when compared to the control MO. (C) Lateral
view of tailbud stage embryos (stage 24) visualizing GFP. Embryos were injected at the
16-cell stage in a dorso-lateral-animal blastomere to target neural crest cells. In the
control, GFP is found in all CNC segments (white arrows). This is absent in 33% of the
embryos injected with MO19.
48

49

Figure 2.7: Gene Expression analysis of ADAM19 knock down at the tailbud stage.
(A) Whole-mount in situ hybridization of tailbud stage embryos (stage 22-24). Embryos
were injected in one blastomere of the two-cell stage with 10 ng of CMO or MO19 with
mRNA encoding beta-galactosidase (-Gal) as a lineage tracer. The embryos were
processed by whole mount in situ hybridization with the markers Myosin Light Chain
(MLC), N-tubulin, NRP1, Sox2 and ADAM11. The injected side, as detected by -Gal
activity (light blue), is on the left side for all embryos. The percentages of embryos
displaying these phenotypes are indicated and represent the average of 3 independent
experiments. The black arrowheads point to the area of decreased gene expression. For
Twist the embryo heads are presented as a side view and the injected side of each embryo
is to the left. A decrease in xTwist expression is visible (arrowhead) in embryos injected
with MO19. (B) Quantitative real-time PCR was performed on embryos injected at the
one-cell stage with either the MO19 alone or with the ADAM19 rescue mRNA
(MO19+A19R) and allowed to develop until neurula (stage 17) and tailbud stage (stage
24). On the right, the MO19 was injected in two dorsal-animal blastomeres at the 8-cell
stage (MO19 Ectoderm) to target dorsal ectoderm but not mesoderm derivatives. All
genes were compared to non-injected control embryos. The relative abundance of MLC,
N-tubulin, Sox2 and ADAM11 gene expression was measured by the 2-CT method and
normalized to alpha-tubulin. Results are presented as the Log2 of the fold change and
error bars correspond to the standard error. Asterisks represent a p<0.05 using a standard
t test assuming unequal variance.
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Figure 2.8: ADAM19 is essential for somite organization and muscle differentiation.
Histological and molecular analysis of embryos with reduced ADAM19 protein. (A-F)
Frozen sections of tailbud stage embryos. (A-D) Immunofluorescence using the rabbit
polyclonal antibody to the ADAM19 cytoplasmic domain (AP C3). (A) Frontal section,
anterior is to the left. The ADAM19 protein is localized to the intersomitic boundary
(arrowhead), the notochord (n), the neural tube (nt) and in the branchial arches (ba). (B)
Transverse section. ADAM19 is in red, the muscle marker 12-101 in green and the nuclei
(DAPI) in blue. ADAM19 staining appears associated with the ventral basal side of the
neural tube (arrowhead) and the notochord (n). (C) Magnification of the somite from a
frontal section, ADAM19 is in red, the arrowhead points to the intersomitic boundary.
(D-F) Frontal sections of tailbud stage embryos injected at the two-cell stage in one cell
with 5 ng of MO19. The injected side is labeled (yellow dots) and was detected either by
using the ADAM19 antibody C3 (D and E) or GFP-myc (F) that was co-injected with the
MO19. The injection of MO19 completely abolished staining of the intersomitic
boundary by the ADAM19 antibody. While the intersomitic boundary is still visible, the
nuclei are not aligned on the injected side (white line). (E) ADAM19 is in green (left),
12-101 in red (center) and the merge presented with DAPI staining (right). There is a
clear reduction of 12-101 staining on the injected side (MO19). (F) The MO19 was coinjected with GFP-myc to detect the cells that were targeted using the 9E10 mAb.
Positive cells are visible in the right somites and some of the cells that contribute to the
notochord (n). Fibronectin was detected using a rabbit polyclonal antibody (32F). Some
of the FN staining is absent in part of the intersomitic boundary (arrowhead). (G)
Western blot using 12-101 on total protein extract. Stage 7 extract is used as a negative
control. At stage 22, MO19 injected embryos but none of the other injected embryos
have less 12-101 protein. (H) Whole mount immunostain using mAb 4H2 to detect
fibronectin. The injected side was detected prior to fixation using GFP fluorescence.
The side injected with the MO19 shows an abnormal pattern of FN staining at some of
the intersomitic boundaries (arrowhead).
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Figure 2.9: ADAM19 may interfere with EGF signaling. (A) Western blot using an
antibody to phosphorylated AKT, -catenin, phosphorylated MAP kinase, and PACSIN2.
Embryos were injected at the one-cell stage with either the control MO (CMO) or MO19
and developed to late gastrula (stage 12). Total protein 0.5 embryo equivalent were used
for each blot. (B) Histogram representing the quantification of the western blot from 3
independent injection experiments. All measures were normalized to PACSIN2.
Variations in pMAPK were not significant while the decrease in pAKT and -catenin
was significant (p<0.05). (C) Real time PCR analysis of Slug expression. Embryos were
treated with 10 µM of Marimastat (Mar), 100 µM of AG1478 or DMSO (1/1000) as a
control, between stage 10 and stage 12, based on the blastopore size (none of the
treatment affected gastrulation timing in these conditions). Marimastat decreased Slug
expression by an average of 34% while AG1478 decrease Slug by 60%.
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Primer
Xbrachyury
ADAM11
Chordin
Goosecoid
SOX2
MLC
N-tubulin
Alpha-tubulin
ADAM19
Slug
SOX8
HNF3beta

Sense
TTCTGAAGGTGAGCATGTCG
AGAGGATTCGTGGGCTGCTATTT
CCTCCAATCCAAGACTCCAGCAG
CACACAAAGTCGCAGAGTCTC
GAGGATGGACACTTATGCCCAC
CCAGAACCAGAAAAGCCCAAAGCA
GATCTACGCAAACTGGCTGTCAAC
TACAGGCAGTTATTCCACCCAGAG
ACGGAACCAGATTTGCTTTGATG
AAACACTTCAACACGACCAAAAA
AAGGTCTCTGGTGGCTGAAA
CCATCCAGCAGTCCCCCAACAA

Antisense
GTTTGACTTTGCTAAAAGAGACAGG
AAGAGGTGAGTGGTGTCGCTATG
GGAGGAGGAGGAGCTTTGGGACAA
GGAGAGCAGAAGTTGGGGCCA
GGACATGCTGTAGGTAGGCGA
TCCTCTTGGCGTTCATCTCCTCAG
GCATCTGTTCATCTACCTCCTTCA
ACAGCAGAGAGGTGAATCCAGAAC
AATGCTGCCCCCGTTACCTGTCT
GCTGACCCGACCTAAAGATGAA
CACCGCCACATTTCAGAGTA
ATCAGGGTGTAGGGTCCAGAAG

Table 2.1: Quantitative Real Time PCR Primer Sets used in Chapter II.
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Target
Control (CMO)
xADAM13
xADAM19

Morpholino Sequence
CCTCTTACCTCAGTTACAATTTATA
GTCCCAGCCGACCCTCCGACCCCAT
GAGTCCTGTAGCTCCTTCCATCCGA

Table 2.2: Morpholino Sequences used in this Thesis
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CHAPTER III

ADAM13 AND ADAM19 PROTEIN REGULATION

All of the work presented in this chapter is data completed by myself and is unpublished.

Abstract

This chapter focuses on ADAM13 and ADAM19 protein regulation in cultured
cells and in the embryo. I show that a loss of ADAM13 protein reduces the level of
ADAM19 protein by 50%. In addition, a loss of ADAM19 protein reduces the level of
ADAM13 protein by 50%. This suggests that both ADAM13 and ADAM19 are required
to maintain a proper protein level in the embryo.

I propose this outcome may be

explained by physical interactions of ADAM13 and ADAM19 in a cell. The ADAM19
Proform binds to the ADAM13 Proform in cultured cells. Through domain analysis, I
show that ADAM19 binds specifically to the cysteine-rich domain of ADAM13. When
co-overexpressed in a cell, the level of Mature ADAM13 (compared to the Proform) is
reduced suggesting a complex form of regulation. Lastly, I propose a few models that
could explain how ADAM19 regulates the level of ADAM13 in a cell.

SECTION I: Introduction

Cell surface membrane bound proteins undergo a number of post-translational
modifications before reaching their final destination in a cell. The importance of these
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modifications allows a cell to have a rapid response to changes within its
microenvironment. Members of the ADAM family of metalloproteases are known to
function as rapid responders to cellular events, such as inflammation (Murphy, 2009).
ADAM proteins are synthesized in the endoplasmic reticulum where a number of
glycosylations occur post-translationally. The proper folding of an ADAM protein, based
on data for ADAM10 and ADAM17, involves the ER chaperone ERp57 in conjunction
with calnexin and calreticulin (Jessop et al., 2007). Once folded, the ADAM protein is
transported from the ER and through the Golgi network. Newly synthesized ADAM
proteins emerge in an inactive state called a Proform. The ADAM Proform is kept
catalytically inactive through a „cysteine switch‟ mechanism where a single cysteine
residue in their prodomain interacts with the Zinc atom located in the active site of their
Metalloprotease domain (Van Wart and Birkedal-Hansen, 1990). This mechanism keeps
the Prodomain in close contact with the Metalloprotease domain rendering the enzyme
inactive. Further maturation occurs in the Trans Golgi compartment where a proprotein
convertase, specifically Furin, cleaves the prodomain of an ADAM at the consensus
recognition site, RxKR (Loechel et al., 1998). This processing event is shown for some
ADAM members to be a key step toward ADAM “activation” into the active state called
a Mature form (Figure 1.3). At this point, the Mature ADAM protein can be transported
to the cell surface to carry out its function. This is the „classical‟ post-translational
modification route for an ADAM protein.
Not all ADAM proteins can function at the cell surface and depending on the cell
type; many ADAM proteins are stored in a perinuclear compartment believed to be the
ER-Golgi complex (Schlondorff et al., 2000). Furthermore, potential ADAM substrates
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localize to various cellular compartments as well as travel a similar post-translational
modifications route in a cell. It is determined that two ADAM members, ADAM17 and
ADAM19, cleave the EGF ligand Neuregulin1 (NRG1) in a cell (Horiuchi et al.,
2005). ADAM19 cleaves NRG1 in the Golgi complex while ADAM17 cleaves NRG1
at the cell surface (Yokozeki et al., 2007). These experiments were carried out by
western blotting for ADAM17 and ADAM19 on subcellular fractionation extracts
(Yokozeki et al., 2007).

Additionally for ADAM19, experiments using a NRG1

construct that is N-terminally fused to GFP were analyzed under fluorescence correlation
spectroscopy (FCS). FCS is used to detect fluctuations of fluorescent intensity in a
confocally defined volume in living cells.

Thus, the trafficking and subcellular

localization of ADAM proteins and their substrates may provide spatial and temporal
control of how and where an ADAM protein functions within a cell (Murphy, 2009).
The overexpression of an ADAM and a potential substrate protein in cell culture
results in the ectodomain shedding of the substrate into the cell supernatant.

This

technique generated an initial list of potential biologically relevant substrates to ADAM
family members (Table 1 in (Huovila et al., 2005)).

In addition, multiple ADAM

proteins can cleave the same substrate in a cell, showing that ADAM family members
have overlapping functions (Schlondorff and Blobel, 1999). Studies done on knockout
mice have provided some clues into ADAM protein function during embryogenesis.
However, single knockout of many ADAM members (ADAM8, ADAM9, ADAM12,
ADAM15) result in viable mice with no observable phenotype (Horiuchi et al., 2003;
Kelly et al., 2005; Kurisaki et al., 2003; Weskamp et al., 2002). Even the double
(ADAM 9/15-/-) and triple (ADAM 9/12/15-/-) knockout mice are viable with no
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observable phenotype (Sahin et al., 2004).

It is highly unlikely that these ADAM

members do not function during embryogenesis because they have broad expression
patterns in the embryo. Therefore, it is more likely that ADAM family members have
overlapping functions during embryogenesis in vivo (Alfandari et al., 2009).
Since multiple ADAM members are capable of cleaving the same substrates, it is
suggested that ADAM proteins may work as a team in a tissue specific manner
(Hartmann et al., 2002). The idea that two ADAM family members can function together
may be an integral part of ADAM metalloprotease regulation. For example, the first two
ADAM family members discovered were ADAM1 and ADAM2, also known as Fertilin and Fertilin- respectively. Both proteins form a heterodimer complex on the plasma
membrane of sperm and are important for sperm migration into the oviduct and binding
to the zona pellucida of the oocyte (Nishimura et al., 2007; Yamaguchi et al., 2009). In
this chapter I will show that both ADAM13 and ADAM19 are required to maintain a
proper protein level in the embryo. Furthermore, this regulation may occur at the protein
level through their physical interaction in a cell.

Results

SECTION II: ADAM13 and ADAM19 Regulation in the Embryo

Xenopus ADAM13 and ADAM19 are members of the meltrin subfamily of
ADAM metalloproteases (Alfandari et al., 1997; Neuner et al., 2009). The full length
proteins share 41% identity at the amino acid level with the Disintegrin domain sharing
the highest identity (64%) and the Cytoplasmic domain sharing the lowest identity (13%)
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(Table 3.1). ADAM13 and ADAM19 have predicted N-glycosylation sites (NxS/T)
located in their extracellular region (Gooley et al., 1991). N-glycosylation occurs in the
ER and, based on data for ADAM10 and ADAMTS13, is important for further
processing and stability of the full length protein (Escrevente et al., 2008; Zhou and Tsai,
2009). In addition, N-glycosylation of ADAM10 is important for enzymatic activity in
vitro (Escrevente et al., 2008).

A conserved Metalloprotease active site

(HExGHxxGxxHD) is found in the Metalloprotease domain. The Disintegrin domain
contains a “Disintegrin Loop” motif that, in its three-dimensional structure, is shown to
fold into a -turn believed to bind directly to integrin receptors (McLane et al., 1998;
Norris et al., 2003). The Cysteine-rich domain is important for substrate selectivity and
for ADAM13, is the site for autocatalysis or self-shedding (Gaultier et al., 2002). The
cytoplasmic domain contains a number of SH3 binding motifs capable of protein-protein
interactions. In addition, a number of Serine and Threonine phosphorylation sites are
predicted throughout ADAM13 and ADAM19 cytoplasmic domains, as well as, a
predicted Tyrosine phosphorylation site in the cytoplasmic domain of ADAM19 (Blom et
al., 1999) (Figure 3.1).

Phosphorylation of membrane bound proteins is a form of

regulation that modifies their intrinsic properties or creates a docking site for interacting
with other proteins (Deribe et al., 2010).
ADAM13 is expressed as a maternal transcript with zygotic expression beginning
from early gastrulation through tailbud formation. During gastrulation, ADAM13 and
ADAM19 are expressed in the dorsal mesoderm of the dorsal blastopore lip (Neuner et
al., 2009; Wei et al., 2010). Throughout early embryonic development, ADAM13 has a
more restricted expression pattern, compared to ADAM19, being localized to the somitic
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mesoderm and cranial neural crest cells (Alfandari et al., 1997). Since ADAM13 and
ADAM19 are expressed in similar tissues, I investigated whether ADAM13 and
ADAM19 functionally interacted.
Antisense Morpholino oligonucleotides corresponding to the sequence near the
ATG start codon for ADAM13 (MO13) and ADAM19 (MO19) were used to prevent
protein translation (Table 2.1). Embryos injected with MO13 showed a clear absence of
ADAM13 protein at the tailbud stage (st. 22) confirming the specificity of both our
morpholino sequence and our antibodies (Figure 3.2).

This result was shown by

glycoproteins purified on Concanavalin-A agarose beads and by immunoprecipitation for
ADAM13.

Embryos injected with MO13 showed a 50% reduction in the level of

ADAM19 at the tailbud stage (st. 22) (Figure 3.3). In the reverse experiment, embryos
injected with MO19 showed a clear absence of ADAM19 protein at the tailbud stage
confirming the specificity of both our morpholino sequence and our antibodies (Figure
3.3). Embryos injected with MO19 showed a 50% reduction in the level of ADAM13 at
the tailbud stage (Figure 3.2). The results suggest that both ADAM13 and ADAM19
need to be present in the embryo in order to maintain a proper protein level.
I propose two hypotheses explaining why ADAM13 and ADAM19 are both
required to maintain a proper protein level in the embryo.

One hypothesis is that

ADAM13 and ADAM19 regulate each other‟s gene expression. Our lab has shown that
the cytoplasmic domain of ADAM13 is cleaved off and translocates into the nucleus to
regulate gene expression important for CNC cell migration (Cousin et al., 2010). In
addition, the cytoplasmic domain of ADAM19 can also modulate gene expression and
promote CNC cell migration (Cousin et al., 2010). A loss of ADAM19 affects the
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expression of a number of genes involved in CNC induction and muscle differentiation
(Neuner et al., 2009). Since the expression pattern of ADAM13 is restricted to these
tissues and that ADAM11 expression is reduced in CNC cells; it is possible that
ADAM19 regulates ADAM13 gene expression. Therefore, ADAM13 and ADAM19
could regulate gene expression through the function of their cytoplasmic domain in the
nucleus. To investigate gene expression, I will extract RNA from embryos injected with
MO13 or MO19 for real time PCR. In embryos lacking ADAM13, ADAM19 gene
expression will be measured. In embryos lacking ADAM19, ADAM13 gene expression
will be measured. Since both ADAM13 and ADAM19 are required in the embryo to
maintain a proper protein level, my second hypothesis is that ADAM13 and ADAM19
act as chaperones for each other. This is important to regulate their protein stability in a
cell. The second hypothesis will be investigated next in Section III of this chapter.

SECTION III: ADAM13 and ADAM19 Physical Interaction in Cultured Cells

To determine if ADAM13 and ADAM19 act as chaperones for protein stability, I
transfected 293T cells with ADAM13, ADAM19, or in combination. Total protein
extracts were used to determine ADAM13 and ADAM19 protein levels.

When

ADAM13 and ADAM19 are cotransfected together, the level of ADAM13 is
significantly reduced compared to ADAM13 alone (Figure 3.4A, left middle gel lane 2
versus lane 4). However, there is no change in the level of ADAM19 (Figure 3.4A, left
middle gel lane 3 versus lane 4). Although the overall level of ADAM13 is reduced,
there is a stronger reduction in the Mature form (100kD). The ratio of Proform to Mature
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form is approximately 2:1 when compared to ADAM13 alone with an approximate ratio
of 1:1. This suggests that the transition from Proform to Mature form of ADAM13 may
be regulated by ADAM19.
To determine if ADAM13 and ADAM19 physically interact, I transfected 293T
cells with ADAM13, ADAM19, or in combination and total protein extracts were
prepared for coimmunoprecipitation. Using an antibody to immunoprecipitate ADAM13
(6615F), a 120kD band was detected by the ADAM19 antibody (2C5 E1) in the
cotransfected sample (Figure 3.4A, left).

This band corresponds to the Proform of

ADAM19. In the reverse experiment, using an antibody to immunoprecipitate ADAM19
(2C5 E1), a 120kD band was detected by the ADAM13 antibody (6615F) in the
cotransfected sample (Figure 3.4A, left).

This band corresponds to the Proform of

ADAM13. The results suggest that both ADAM13 Proform and ADAM19 Proform
physically interact when overexpressed in 293T cells.
The coimmunoprecipitation experiment was repeated using the frog cell line,
XTC. This cell line endogenously expresses ADAM13 (Alfandari et al., 1997), but does
not express ADAM19. I transfected XTC cells with GFP alone or ADAM19 alone and
total protein extracts were prepared for coimmunoprecipitation. Using an antibody to
immunoprecipitate ADAM13 (6615F), the Proform of ADAM19 (120kD) was detected
by the ADAM19 antibody (2C5 E1) only in the ADAM19 transfected sample. In the
reverse experiment, using an antibody to immunoprecipitate ADAM19 (2C5 E1), the
Proform of ADAM13 and the Mature form of ADAM13 were detected by the ADAM13
antibody (6615F) only in the ADAM19 transfected sample. As a control, ADAM13 was
immunoprecipitated from red fluorescent protein (RFP) expressing XTC cells to detect
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endogenous ADAM13 in our experiment (Figure 3.4B).

The results show that

endogenous ADAM13 Proform and Mature form physically interact with overexpressed
ADAM19 Proform in XTC cells.
To identify the domain of interaction between ADAM13 and ADAM19, I
transfected 293T cells that overexpress different myc-tagged ADAM13 constructs. The
Disintegrin Domain alone (D13), the Cysteine Rich Domain alone (CR13), or the
Disintegrin-Cysteine Rich Domain (DC13) were cotransfected with full length ADAM19
and total protein extracts were prepared for coimmunoprecipitation. Using an antibody to
immunoprecipitate the myc-tagged ADAM13 constructs (9E10), the Proform of
ADAM19 was detected by the ADAM19 antibody (C3) (Figure 3.5, first gel). In the
reverse experiment, using an antibody to immunoprecipitate ADAM19 (C3), both DC13
and CR13 were detected by the myc-tag antibody (9E10) (Figure 3.5, second gel).
Interestingly, DC13 and CR13 strongly interacted with ADAM19 while D13 showed a
weaker interaction with ADAM19 (Figure 3.5, second gel). Total cell extract was probed
for the myc-tagged ADAM13 constructs and ADAM19 to ensure proper transfections.
The results show that ADAM19 binds preferentially to the Cysteine Rich Domain of
ADAM13.
Previous work has suggested that ADAM19 may function primarily within a cell
at a perinuclear compartment with very little ADAM19 at the cell surface (Murphy, 2009;
Yokozeki et al., 2007). To determine where in a cell Xenopus ADAM19 may function, I
investigated the subcellular localization of ADAM19 by immunofluorescence.
Transfected XTC cells that overexpress ADAM19 were fixed and processed for
immunofluorescence. Using an antibody to ADAM19 (2C5 E1) and an antibody to the
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ER-specific protein Calnexin, I observed strong colocalization of ADAM19 and Calnexin
in the ER (Figure 3.6). Very little to no expression of ADAM19 was found at the plasma
membrane in lamellipodia. Since the outer membrane of the nucleus is continuous with
the ER, some punctuate expression of Calnexin was observed in the nucleus and this is
consistent with previous observations (Gilchrist and Pierce, 1993; Wada et al., 1991).
The results show that overexpressed ADAM19 localizes to the endoplasmic reticulum of
XTC cells.
Since ADAM13 and ADAM19 physically interact in XTC cells, I investigated
where in a cell ADAM13 and ADAM19 interact. Transfected XTC cells that overexpress
ADAM19 were fixed and processed for immunofluorescence. Using an antibody to
ADAM19 (2C5 E1) and an antibody to ADAM13 (6615F), I observed strong
colocalization of overexpressed ADAM19 and endogenous ADAM13 (Figure 3.7). The
colocalization occurs within a perinuclear compartment, possibly the endoplasmic
reticulum. Endogenous ADAM13 was also observed at the cell surface in lamellipodia
(white arrows) consistent with previous observations (Cousin et al., 2000). The results
show that ADAM13 and ADAM19 colocalize to a perinuclear compartment of XTC
cells.

SECTION IV: Discussion

ADAM Metalloprotease ER Retention

Protein subcellular localization is a major part of the post translational
modification mechanism.

The sorting process begins in the endoplasmic reticulum
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immediately upon protein folding and is further refined in the Golgi complex. A protein
can be retained in the endoplasmic reticulum if it contains a specific amino acid sequence
known as an ER retention signal (Wieland et al., 1987). Arginine motifs such as „RR‟ or
RxR‟ (where „x‟ is any amino acid) are one class of ER retention signals that do not need
to be exposed at the C-terminus of a membrane protein but rather incorporated into the
intracellular domain (Michelsen et al., 2005; Zhou et al., 2002).

For example, ER

retention mediated by an RxR motif is shown for the NMDA receptor (Scott et al., 2001).
Upon cell treatment with PMA, a known PKC activator, cell surface expression of the
NMDA receptor increased. When two predicted PKC phosphorylation sites adjacent to
the RxR motif were mutated to alanine, it completely abolished the affects of PMA.
Thus no cell surface expression of the NMDA receptor was observed. Therefore, the
receptors release from the endoplasmic reticulum is regulated by PKC phosphorylation of
serine residues adjacent to the ER retention signal. This class of ER retention signals has
also been found in the cytoplasmic domains of a number of ADAM family members
(Table 3.2).
In addition to phosphorylation regulating ER exit, the recruitment of 14-3-3
proteins to the cytoplasmic tail of the KATP channel  subunit, Kir6.2 is shown to be
important for regulating ER retention (Nufer and Hauri, 2003; Yuan et al., 2003). Upon
phosphorylation at a serine residue adjacent to the RxR motif, 14-3-3 is recruited and
binds to the cytoplasmic tail of Kir6.2. This masks the ER retention signal allowing for
anterograde transport through the secretory pathway and increases the level of Kir6.2 at
the cell surface. Furthermore, the authors show that -COPI directly competes with 143-3 binding at this motif to regulate retrograde transport back to the endoplasmic

66

reticulum. The same mechanism for the regulation of a protein at the cell surface is
reported for the MHCII chain, lip35 (Khalil et al., 2003), the HIV co-receptor GPR15
(Shikano et al., 2005), and the neuronal 4 acetylcholine receptor (O'Kelly et al., 2002).
Therefore, at least for some membrane bound proteins, their regulation to the cell surface
involves both phosphorylation of residues close to the RxR motif and 14-3-3 interaction.
14-3-3 proteins are involved in similar biological functions as ADAM
metalloproteases such as cell signaling (Radhakrishnan and Martinez, 2010; van Hemert
et al., 2001), cell migration (Deakin et al., 2009; Hou et al., 2010; Lu et al., 2009), and
cell-cycle regulation (Douglas et al., 2010; Kasahara et al., 2010). The consensus binding
motif for 14-3-3 proteins as well as SH3 binding motifs are present in the cytoplasmic
domain of a number of ADAM family members (Table 3.2). For example, 14-3-3
proteins bind to the cytoplasmic domain of ADAM22.

This interaction masks the

adjacent ER retention signal (RxR) to regulate the level of ADAM22 at the cell surface
(Godde et al., 2006). In addition, -COPI was identified as a binding partner to the
cytoplasmic domain of ADAM19 in fetal brain tissue (Huang et al., 2002).

For

ADAM10 and ADAM12, it is hypothesized that adaptor proteins bind to their
cytoplasmic domains to regulate their exit from the endoplasmic reticulum to the cell
surface (Cao et al., 2002; Hougaard et al., 2000; Marcello et al., 2010). Therefore, it is
believed that the regulation of an ADAM protein to the cell surface is regulated through
the interaction of adaptor proteins such as 14-3-3 with the ADAM cytoplasmic domain.
More importantly, this might contribute to the deregulation of an ADAM protein in
disease such as cancer.
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How Does ADAM19 Regulate ADAM13 in a Cell?

When overexpressed the Proforms of ADAM13 and ADAM19 physically interact
in a cell. Both ADAM13 Proform and ADAM19 Proform can still physically interact,
via

coimmunoprecipitation,

without

the

cytoplasmic

domain

of

ADAM13

(ADAM13cyto) or their metalloprotease activity (ADAM13 E/A and ADAM19 E/A)
(data not shown). Therefore, the physical interaction is independent of the ADAM13
cytoplasmic domain and the proteolytic activity of ADAM13 or ADAM19. ADAM19
binds to the Cysteine-rich Domain of ADAM13 within a perinuclear compartment,
possibly the endoplasmic reticulum. Previous work has suggested that ADAM19 may
function primarily within a cell at a perinuclear compartment with very little ADAM19 at
the cell surface (Murphy, 2009; Yokozeki et al., 2007). Our observations show that
overexpressed ADAM19 strongly localizes to the endoplasmic reticulum.

The

cytoplasmic domain of ADAM19 contains four ER retention signals (RxR) suggesting
that ADAM19 may localize and function primarily in the endoplasmic reticulum. When
ADAM13 and ADAM19 are co-overexpressed in a cell, the overall level of ADAM13 is
reduced. Furthermore, there is a strong reduction specifically in the Mature form of
ADAM13. This occurs without changing the protein level of ADAM19. Previously, our
lab has shown that only the Mature form of ADAM13 is expressed at the cell surface
(Alfandari et al., 1997). Therefore, the results suggest that ADAM19 may regulate the
protein stability of ADAM13 and possibly, the level of Mature ADAM13 that localizes to
the cell surface.
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I propose that ADAM19 regulates ADAM13 through two different hypotheses.
One hypothesis is that ADAM19 cleaves ADAM13 in its extracellular domain. This
cleavage event would shed a soluble form of ADAM13 outside of the cell. When
ADAM13 is detected in the embryo by western blot four molecular weight bands are
observed; the Proform (120kD), the Mature form (100kD), soluble ADAM13 (50kD) and
the cytoplasmic tail (17kD). The different forms of ADAM13 are deduced from their
predicted molecular weights and are considered to be functional in the embryo.
Previously our lab has shown that ADAM13 is autocatalytic by cleaving itself within the
Cysteine-rich Domain (Gaultier et al., 2002). The shed fragment of ADAM13 (50kD)
retains biological function outside of a cell. Soluble ADAM13 binds to the HepII domain
of fibronectin and cleaves fibronectin in vitro (Gaultier et al., 2002). Additionally, an
autocatalytic processing event is important in vitro for the proteolytic function of
ADAMTS4 (Flannery et al., 2002), ADAM8 (Schlomann et al., 2002) and ADAM19
(Kang et al., 2002).
Therefore, the working hypothesis model is that ADAM19 cleaves ADAM13 into
a soluble form to promote an interaction between soluble ADAM13 and fibronectin. This
cleavage event would be important for remodeling the fibronectin matrix outside of a cell
and more importantly, the cells ability to adhere and migrate on fibronectin (Figure 3.8).
To investigate if ADAM19 cleaves ADAM13, I would detect soluble ADAM13 from the
cell supernatant of co-transfected cultured cells compared to ADAM13 alone and
ADAM13E/A alone. Since ADAM13 is autocatalytic, the ADAM13 alone sample is a
positive control and the ADAM13E/A alone sample is a negative control to determine
baseline levels of soluble ADAM13 shed into the supernatant.
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It is possible that ADAM19 does not cleave ADAM13. Since ADAM19 binds
specifically to the Cysteine-Rich Domain of ADAM13, this physical interaction could
directly perturb ADAM13 cleavage. My second hypothesis is that ADAM19 binds to
ADAM13 in a perinuclear compartment and functions to sequester ADAM13 from
further processing.

ADAM19 could function by preventing the autocatalysis of

ADAM13 into soluble ADAM13 by masking the cleavage site in the Cysteine-Rich
Domain (Figure 3.8). This would reduce soluble ADAM13 from being shed outside of
the cell to interact with fibronectin. As a result, this would affect fibronectin matrix
remodeling and the cells ability to adhere and migrate on fibronectin.
The above models only address the in vitro results on ADAM13 and ADAM19
co-overexpression. However in the embryo, a loss of ADAM13 protein reduces the level
of ADAM19 protein by 50%. In addition, a loss of ADAM19 protein reduces the level of
ADAM13 protein by 50%. This suggests that both ADAM13 and ADAM19 are required
to maintain a proper protein level in the embryo.

This conclusion was also seen

previously for ADAM13 expression (Figure 4 in (McCusker et al., 2009)). However, the
level of ADAM19 was not reduced because the conditions using a combination of the
ADAM19 antibodies had not been determined yet (Figure 4 in (McCusker et al., 2009)).
I propose an alternative hypothesis where ADAM13 and ADAM19 proteins function as
chaperones to stabilize each other in a perinuclear compartment. This is important to
regulate the level of each ADAM protein that translocates to the cell surface. Once at the
cell surface, the ADAM protein carries out its proteolytic function by cleaving a potential
substrate (Figure 3.8). For example, ADAM19 could regulate the level of ADAM13
protein that translocates to the cell surface of CNC cells. This would regulate cell-cell
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adhesion by affecting the ability of ADAM13 to cleave the cell adhesion molecule
Cadherin-11 (McCusker et al., 2009). To investigate if ADAM19 affects the level of
ADAM13 at the cell surface in vivo, I would detect ADAM13 by western blot from cell
surface biotinylated CNC cells (or dorsal mesoderm cells) from embryos that were
injected with CMO or MO19. Embryos injected with MO13 would be used as a negative
control. The ADAM13 Mature form will only be analyzed since it is the only form of
ADAM13 present on the cell surface.

SECTION V: Materials and Methods used in Chapter III

Cell Culture
293T cells were cultured in RPMI media supplemented with 10U/ml Pen/Strep, 2mM LGlutamine, 0.11mg/ml Sodium Pyruvate and 10% Fetal Bovine Serum (Hyclone).
Transient transfections were performed using Fugene 6 reagents (Roche) following the
manufacturer‟s instructions. XTC cells were cultured in L15 media supplemented with
10U/ml Pen/Strep, 2mM L-Glutamine and 10% Fetal Bovine Serum (Hyclone).
Transient transfections for XTC cells were performed using Fugene HD reagents (Roche)
following the manufacturer‟s instructions.

Immunofluorescence
After 48 hours of expression, XTC cells were trypsinized and seeded onto glass
coverslips coated with 10g/ml of Fibronectin for 12 hours. Cells were fixed for 20
minutes in 3.7% formaldehyde in MBS at room temperature, permeablized in PBS 0.5%
Triton X100 for 5 minutes at room temperature and blocked in 1% BSA in PSB 0.1%
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Tween20 overnight at 4C. Antibody incubations were performed sequentially (one hour
at room temperature for each antibody) in 1% BSA in PBS 0.1% Tween20. The primary
antibodies used: ADAM13 (6615F) 1:200; ADAM19 (2C5 E1) 1:200; and Calnexin
(Assay Designs, Stressgen) 1:200. DAPI was used at 1:1000 to stain the nuclei. All
secondary antibodies were used at 1:500 and purchased from Jackson Labs.
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Figure 3.1: Amino Acid Alignment of Xenopus ADAM13 to Xenopus ADAM19.
The individual amino acid domains are labeled. The consensus N-glycosylation sites
(NxS/T) are shown in red (Gooley et al., 1991), the consensus Furin cleavage site of the
Prodomain is shown in blue, the Metalloprotease active site is shown in yellow, the
Disintegrin Loop is shown in grey (McLane et al., 1998), the Transmembrane domain is
boxed, the SH3 Binding Motif (RPxPxxP) is shown in green (Cicchetti et al., 1992), and
the Predicted Serine/Threonine/Tyrosine Phosphorylation sites (NetPhos 2.0) are shown
in pink (Blom et al., 1999).
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Amino Acid Percent Identity
of Xenopus ADAM13 to
Xenopus ADAM19
Full Length Protein

41%

Prodomain
Metalloprotease
Domain
Disintegrin Domain
Cysteine-Rich Domain
EGF-like Domain
Transmembrane
Domain
Cytoplasmic Domain

31%
56%
64%
47%
58%
18%
13%

Table 3.1: Amino Acid Percent
Identity of Xenopus ADAM13 to
Xenopus ADAM19. Each amino
acid domain is aligned and the
percent identity is shown.
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Figure 3.2: ADAM13 Expression in ADAM19 Knockdown Embryos. Western blot
of protein extract from embryos injected with a control morpholino (CMO) or a
morpholino to either ADAM13 (MO13) or ADAM19 (MO19). The morpholinos (10 ng)
were injected at the one cell-stage and embryos were extracted at stage 22. (A)
Glycoproteins from 10 embryos were purified on Concanavalin A-agarose beads,
separated by SDS-PAGE and probed with a rabbit polyclonal antibody to the ADAM13
cytoplasmic domain (6615F from (Alfandari et al., 1997)). (B) The densitometric
analysis of the blot depicted shows that the ADAM13 protein is reduced by
approximately 50% in MO19 embryos when normalized to Integrin 1 expression level
(8C8 from (Gawantka et al., 1992)). (C) Immunoprecipitation of ADAM13 using the
goat ADAM13 antibody from five embryos (St. 22), separated by SDS-PAGE and probed
with a rabbit polyclonal antibody to the ADAM13 cytoplasmic domain (6615F). A
monoclonal antibody to GAPDH was used as a loading control.
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Figure 3.3:
ADAM19 Expression in ADAM13 Knockdown
Embryos. Western blot of protein extract from embryos injected with a
control morpholino (CMO) or a morpholino to either ADAM13 (MO13)
or ADAM19 (MO19). The morpholinos (10 ng) were injected at the one
cell-stage and embryos were extracted at stage 22. Immunoprecipitation
of ADAM19 using the goat DC19 antibody from 20 embryos (St. 22),
separated by SDS-PAGE and probed with a rabbit polyclonal antibody
to the ADAM19 cytoplasmic domain (C3). A monoclonal antibody to
GAPDH was used as a loading control. The densitometric analysis of
the blot depicted shows that the ADAM19 protein is reduced by
approximately 50% in MO13 embryos when normalized to the GAPDH
expression level.
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Figure 3.4: ADAM13 and ADAM19 Physically Interact in Transfected 293T and
XTC Cells. (A) Transfected 293T cells (left panel) that overexpress ADAM13 alone
(A13+CS2), ADAM19 alone (A19+CS2) or ADAM13 and ADAM19 (A13+A19) were
extracted for coimmunoprecipitation. A 120kD band was detected in the cotransfected
(A13+A19) sample, corresponding to the Proform of ADAM13 (second blot) or the
Proform of ADAM19 (top blot). Total cell extract was separated by SDS-PAGE and
probed with an antibody to ADAM13 (6615F), ADAM19 (C3), and GAPDH as a loading
control. Transfected XTC cells (right panel) that overexpress GFP-myc tagged (GFPmt)
or ADAM19 were extracted for coimmunoprecipitation.
XTC cells endogenously
express ADAM13 (Alfandari et al., 1997). A 120kD band was detected for the Proform
of ADAM19 (top blot) and ~120kD and 90kD bands was detected for the Proform and
Mature form of ADAM13 (second blot). Total cell extract was separated by SDS-PAGE
and probed with an antibody to ADAM13 (6615F), ADAM19 (C3), GAPDH as a loading
control, 9E10 (myc-tag), and PACSIN2 as a second loading control.
(B)
Immunoprecipitation of endogenous ADAM13 from RFP-expressing XTC cells as a
control.
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Figure 3.5: ADAM19 Binds to the Cysteine-Rich Domain of ADAM13. Transfected
293T cells that overexpress RFP or ADAM19 with full length ADAM13 (A13+A19), a
myc tagged disintegrin-cysteine-rich domains of ADAM13 (DC13), a myc tagged
disintegrin domain of ADAM13 (D13), or a myc tagged cysteine-rich domain of
ADAM13 (CR13) were extracted for coimmunoprecipitation. A 120kD band was
detected in the cotransfected (A13+A19) sample, corresponding to the Proform of
ADAM13 (second blot) or the Proform of ADAM19 (top blot).
The
coimmunoprecipitation with an antibody to ADAM19 (C3) (second blot) showed a strong
physical interaction to DC13 and to CR13. Total cell extract was separated by SDSPAGE and probed with an antibody to ADAM13 (6615F), ADAM19 (C3), 9E10 (myctag) and GAPDH as a loading control.
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Figure 3.6: ADAM19 Localizes to the Endoplasmic Reticulum in XTC Cells.
Immunofluorescence of transfected XTC that overexpress ADAM19 (red) was visualized
using an antibody to the cytoplasmic domain of ADAM19 (2C5 E1). Localization to the
endoplasmic reticulum is shown by using an antibody to the ER-specific protein,
Calnexin (green). Strong colocalization of ADAM19 with Calnexin is shown in the
Merge (yellow). DAPI (blue) was used to stain the nuclei. Very little to no expression
was seen for ADAM19 at the plasma membrane.
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Figure 3.7: ADAM13 and ADAM19 Colocalize to a Perinuclear Compartment in
XTC Cells. Immunofluorescence of transfected XTC that overexpress ADAM19 (red)
was visualized using an antibody to the cytoplasmic domain of ADAM19 (2C5 E1).
Immunofluorescence of endogenous ADAM13 (green) was visualized using an antibody
to the cytoplasmic domain of ADAM13 (6615F). Colocalization of ADAM19 with
ADAM13 is shown in the Merge (yellow). DAPI (blue) was used to stain the nuclei.
ADAM13 colocalizes with ADAM19 within a perinuclear compartment. Endogenous
ADAM13 also localizes to the cell surface in lamellipodia (white arrowheads).
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Cytoplasmic
Domain
Xenopus
A9-Cyto
A10-Cyto
A13-Cyto
A19-Cyto
Mouse
A10-Cyto
A12-Cyto
A19-Cyto
A33-Cyto
Human
A10-Cyto
A12-Cyto
A19-Cyto
A33-Cyto

Amino
Acids

ER Retention
Signals

SH3 Binding
Motifs

14-3-3
Binding
Motifs

158
55
196
160

(RxR)
0
2
1
4

(RR)
2
0
0
2

(RPxPxxP)
1
0
3
2

(Rxx(S/T)xP)
0
0
1
0

55
176
192
71

2
0
1
0

1
0
1
2

0
2
2
0

0
3
2
0

53
180
194
88

3
0
1
0

1
1
1
1

0
2
2
0

0
1
2
0

Table 3.2: Amino Acid Analysis of Different ADAM Cytoplasmic Domains.
Consensus ER Retention signals are described in (Wieland et al., 1987). Consensus SH3
Binding Motifs are described in (Ren et al., 1993). Consensus 14-3-3 Binding Motifs are
described in (Uchida et al., 2006).
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Figure 3.8: Models Explaining How ADAM19 Regulates ADAM13 in a Cell. (A)
Hypothesis 1: ADAM19 binds and cleaves ADAM13 into a soluble form. Soluble
ADAM13 is shed into the extracellular environment as an active protease to remodel a
fibronectin matrix. This is important to regulate cell adhesion and migration on
fibronectin. (B) Hypothesis 2: ADAM19 binds to ADAM13 and sequesters ADAM13 in
a perinuclear compartment. This interaction inhibits the autocatalysis of ADAM13 into a
soluble form and prevents remodeling of a fibronectin matrix. This is important to
regulate cell adhesion and migration on fibronectin. Alternatively in (C), ADAM19
regulates the processing of ADAM13. More importantly, ADAM19 regulates the level of
Mature ADAM13 at the cell surface. This interaction regulates cell-cell adhesion and
cell migration. 14-3-3 dimers may be a key adaptor protein involved in this process.
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CHAPTER IV

XENOPUS ADAM13 AND ADAM19 ARE IMPORTANT FOR
PROPER CONVERGENCE AND EXTENSION OF THE NOTOCHORD

All of the work presented in this chapter is data completed by myself and is unpublished.

Abstract
This chapter focuses on the role of ADAM13 and ADAM19 in the dorsal
mesoderm during gastrulation. Through a loss of function approach using antisense
morpholino oligonucleotides to ADAM13 or ADAM19, I show that ADAM19 affects
gene expression important for the A-P polarity of the notochord while ADAM13 does
not.

The changes in gene expression can be partially rescued by the EGF ligand

Neuregulin1, a known substrate for ADAM19 in the mouse. I show that a loss of
ADAM13 or ADAM19 affects convergence and extension movements during notochord
formation. Specifically, a loss of ADAM13 or ADAM19 causes a delay in mediolateral
cell intercalation resulting in a significantly wider notochord compared to control
embryos. These defects occur without affecting dishevelled intracellular localization or
the activation of the PCP signaling pathway. However, a loss of ADAM13 or ADAM19
reduces dorsal mesoderm cell spreading on a fibronectin substrate through 51 integrin.
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SECTION I: Introduction

Cellular movements are essential during gastrulation and can be classified into
four evolutionary conserved movements; internalization, epiboly, convergence and
extension (Solnica-Krezel, 2005). Internalization marks the beginning of gastrulation and
in amphibians, creates the dorsal blastopore lip. The involuting mesoderm enters through
the blastopore and migrates on the inner surface of the blastocoel roof. This migration
event is highly dependent upon the extracellular matrix protein fibronectin, which is
expressed along the blastocoel roof (Boucaut and Darribere, 1983 41; Lee et al., 1984 2).
Epiboly movements spread tissue by increasing the surface area and decreasing thickness.
The driving force behind epiboly occurs when cells interdigitate themselves between
deep and superficial layers; a process known as radial intercalation (Keller, 1980).
The dorsal mesoderm undergoes dynamic movements that converge the tissue
while extending along the anterior-posterior axis; a process called convergence and
extension (Keller et al., 1985). Dorsal mesoderm cells undergo this type of movement by
displaying mediolateral polarized protrusions to gain traction on neighboring cells and
the surrounding extracellular matrix. These cellular behaviors are known as mediolateral
cell intercalation. On the ventral side of the gastrulating embryo, both the lateral and
ventral mesoderms undergo dynamic movements to converge the tissue without
extension; a process called convergence and thickening (Keller and Danilchik, 1988). As
a result of these morphogenetic movements during gastrulation, the physical forces
generated cause the blastopore to close asymmetrically towards the ventral side of the
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embryo (Figure 1.2) (Keller and Shook, 2008). Mediolateral cell intercalation continues
after gastrulation in both the paraxial (somites) and axial (notochord) mesoderm. This
drives the process of convergence and extension in order to properly lengthen the embryo
along the anterior-posterior axis. These cellular movements are essential for the embryo
to develop and survive to the tailbud stage.
Members of the ADAM family of metalloproteases play an active role in the
process of cell migration. ADAM proteins can function in cell migration either directly
through cleavage of cell surface adhesion molecules such as cadherins (Kohutek et al.,
2009; McCusker et al., 2009; Schulz et al., 2008) or indirectly through cleavage of cell
signaling molecules such as EGF ligands involved in activating cell migration signaling
pathways (Bakken et al., 2009; Sun et al., 2010; Zheng et al., 2009). ADAM10 can
cleave E-cadherin (Maretzky et al., 2005) and N-cadherin (Reiss et al., 2005) in the
extracellular domain affecting both cell-cell adhesion and cell migration in the embryo.
Our lab has shown that both ADAM9 and ADAM13 cleave cadherin-11 in the
extracellular domain affecting CNC cell migration in Xenopus embryos (McCusker et al.,
2009). The ADAM mediated cleavage of cadherin-11 promotes CNC cell migration and
shows that the cadherin-11 cleavage product retains biological activity in the embryo. It
is hypothesized that the cadherin-11 cleavage product promotes CNC cell migration by
acting as a signaling molecule; however an exact mechanism remains to be determined
(unpublished work, communication with Catherine McCusker 2009).
Recent work has uncovered a new role for ADAM13 in the closely related frog
species Xenopus tropicalis, for neural crest development (Wei et al., 2010). During
gastrulation, ADAM13 cleaves ephrinB1 and ephrinB2 ligands in the dorsal mesoderm.
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This cleavage event is important to regulate forward ephrin signaling through the Eph
receptor. The ADAM13 cleavage of ephrinB1/B2 upregulates canonical Wnt signaling
and in turn, activates the expression of the CNC marker snail2.

Reduction of the

ADAM13 protein reduces CNC induction by the suppression of the Canonical Wnt/snail2
signaling pathway. This mechanism is important for the initial induction of the CNC and
provides a functional role for ADAM13 during gastrulation.
Similar to the role in normal development, ADAM proteins are upregulated in
disease such as cancer and are involved in the epithelial-to-mesenchymal transition
(EMT) during cancer metastasis (Dittmer et al., 2009; Duffy et al., 2009; Fry and Toker,
2010). This further supports their prominent role in cell adhesion and cell migration
events.

In this chapter I will investigate the contribution of ADAM13 and

ADAM19 to convergence and extension movements of the notochord during gastrulation.

Results

SECTION II: Role of ADAM19 in Establishing the A-P Polarity of the Notochord

Previously I observed alterations in gene expression at the gastrula stage in
ADAM19 knock down embryos (Neuner et al., 2009). Gene expression analysis shows a
specific loss of Xbrachyury expression concomitant with an upregulation of Chordin
expression in the notochord (Figure 2.4).

These two genes are expressed in a

countergradient along the anterior-posterior axis in the axial mesoderm (Ninomiya et al.,
2004). Chordin is a marker of anterior notochord polarity and Xbrachyury is a marker of

87

posterior notochord polarity. Together, these two genes establish the anterior-posterior
(A-P) polarity of the developing notochord. Therefore, I investigated how ADAM19 is
disrupting the A-P polarity of the notochord. In addition, I determined if ADAM13 is
involved in establishing notochord A-P polarity.

Using whole mount in situ

hybridization for Xbrachyury (Xbra), I observed a loss of Xbra expression (40%)
specifically in the notochord in MO19 injected embryos when compared to control
embryos (0%) (Figure 4.1). The defect could be partially rescued by co-injection of full
length ADAM19 RNA, but not the catalytically inactive mutant ADAM19 E/A. This
suggests that the proteolytic activity of ADAM19 is important for maintaining Xbra
expression in the notochord.
In mice, ADAM19 can cleave some members of the EGF family of ligands
including Neuregulin1NRG1 (Shirakabe et al., 2001).

In Xenopus, NRG1

expression begins during gastrulation and continues through tailbud formation (Yang et
al., 1999; Yang et al., 1998a; Yang et al., 1998b). Purified recombinant NRG1 can
induce naïve animal cap cells to become mesoderm and express Xbrachyury (Chung and
Chung, 1999). Therefore, I investigated whether overexpression of NRG1 could rescue
gene expression in MO19 injected embryos. Co-injection of full length NRG1 RNA
(NRG-FL) did not rescue Xbra expression in the notochord. However, co-injection of the
extracellular region of NRG1 (NRG-EC), a form that mimics a potential cleavage
product of ADAM19, did rescue Xbra expression in the notochord. Therefore, our data
suggests that ADAM19 mediated shedding of NRG1 is important to maintain Xbra
expression in the notochord.
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Using whole mount in situ hybridization for Chordin, I observed a shift to a more
anterior localization of Chordin expression (50%) in MO19 injected embryos when
compared to control embryos (0%) (Figure 4.2). The defect could be partially rescued by
co-injection of full length ADAM19 RNA, but not the catalytically inactive mutant
ADAM19 E/A. Furthermore, gene expression could be partially rescued by co-injection
of NRG-EC RNA, but not full length NRG-FL RNA. Therefore, our data suggests that
ADAM19 mediated shedding of NRG1 is important to maintain Chordin expression in
the posterior notochord.
To determine if ADAM13 is important for notochord A-P polarity, I observed
Xbra and Chordin expression in MO13 injected embryos.

Xbrachyury expression

appeared normal compared to control embryos (Figure 4.3). Chordin expression was
wider compared to control embryos, but did not shift to a more anterior localization
similar to MO19 injected embryos. In addition, ADAM13 RNA could not rescue gene
expression in MO19 injected embryos (Figure 4.3). These results suggest that ADAM19
(not ADAM13) mediated shedding of Neuregulin1 is important to establish the A-P
polarity of the developing notochord (Figure 4.4). Interestingly, I observed that the
expression patterns of Chordin and Xbrachyury appear to be wider in MO13 and MO19
injected notochords compared to control notochords. This suggests that the notochord
morphology might be perturbed as a result of a loss of ADAM13 or ADAM19. The
morphology of the notochord will be investigated next in Section III of this chapter.
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SECTION III: ADAM13 and ADAM19 Delay Convergence and Extension
in the Notochord

The notochord is a temporary, rod-shaped structure that provides mechanical
support for the developing embryo. It is located directly below the neural tube dictating
the primary body axis.

In addition, the notochord is important for patterning the

surrounding tissues such as the ventral half of the neural tube (floor plate), the paraxial
mesoderm (somites), and in controlling L-R asymmetry (Stemple, 2005). To visualize
the morphology of the notochord, I performed a double whole mount immunostain using
the monoclonal antibody Tor70 to stain the notochord. In addition, the monoclonal
antibody 12/101 was used to visualize the surrounding somites (Figure 4.5). Embryos
were injected with MO13 or MO19 at the one-cell stage and allowed to develop until the
tailbud stage (stage 24). The notochord appears morphologically wider in MO13 and
MO19 injected embryos compared to control embryos. In MO19 injected embryos, the
notochord was frequently bent or misshapen and is thus likely to contribute to the
embryos overall shorter and wider body size. The wide notochords observed in embryos
lacking ADAM13 or ADAM19 could be explained by defects in convergence and
extension movements of the axial mesoderm.

The somites appear morphologically

normal in MO13 injected embryos but have gross defects in MO19 injected embryos.
The overall segmentation of each somite is not affected in embryos lacking ADAM19;
however some of the individual somitic cells are mislocalized and protrude into the
intersomitic boundary (Figure 2.8 and 4.4). In addition, the overall level of 12/101
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expression is lower in MO19 injected embryos confirming previous results where a
reduction of this marker was observed (Figure 2.8, (Neuner et al., 2009)). These results
support the role of ADAM19 in muscle differentiation. In final, I observed that the
archenteron or internal cavity is significantly larger in MO19 injected embryos. At this
point, it is unclear whether this is a direct result of defects in endoderm formation or an
indirect result of the embryo being shorter and wider due to defects in the dorsal
mesoderm. For the remainder of this chapter I will focus my efforts on exploring the
defects observed in the notochord.
To investigate if convergence and extension movements are affected in MO13 or
MO19 injected embryos, I analyzed the axial mesoderm ex vivo by fluorescence time
lapse microscopy. The microdissection of the dorsal mesoderm from a late gastrula stage
embryo is a well established assay called an „Open Face Explant‟ (Wilson et al., 1989).
The explants are dissected from embryos that were microinjected twice.

The first

injection is at the one-cell stage with either a control Morpholino, MO13 or MO19. The
second injection is with RNA encoding for a fluorescent membrane-bound Cherry protein
(mbCherry) into one blastomere at the two cell stage (Figure 4.6).

Since the first

cleavage bisects the embryo into left and right halves, the second injection with
mbCherry RNA enabled us to visualize the contribution of the axial mesoderm from one
half of the embryo to the non-injected half. More importantly, I could observe axial
mesoderm cell movements during notochord formation.

The dorsal mesoderm was

dissected into an Open Face Explant at the end of gastrulation once the blastopore has
closed (stage 12.5/13) and observed by fluorescence time lapse microscopy. In all three
explants (CMO, MO13, MO19), the axial mesoderm cells can be seen undergoing
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convergence and extension movements to lengthen the embryo along the anteriorposterior axis. Time lapse montages of the recorded movies are shown for CMO in
Figure 4.7, MO13 in Figure 4.8 and MO19 in Figure 4.9.
To investigate axial mesoderm cell morphology, the mbCherry localization of
four cells was pseudo-colored black to improve visualization. Axial mesoderm cells in
the control explant have a bipolar morphology and show directed protrusions along the
mediolateral axis (Figure 4.10A). This type of cell morphology is essential for proper
mediolateral cell intercalation. The axial mesoderm cells in explants lacking ADAM13
or ADAM19 have a multipolar morphology without directed protrusions along the
mediolateral axis. This type of cell morphology suggests that the axial mesoderm will
not undergo proper mediolateral cell intercalation. The length-to-width (L:W) ratio of an
individual axial mesoderm cell was quantified by measuring the mediolateral length and
anterior-posterior width (Figure 4.10B). Axial mesoderm cells lacking ADAM13 or
ADAM19 have reduced L:W ratios compared to control cells, suggesting cell
morphology is being affected. To determine if mediolateral cell intercalation is being
perturbed, I traced three axial mesoderm cells in six explants to follow the cell
movements over an eight hour time course in three independent experiments. Control
axial mesoderm cells properly extend from one side of the notochord-somite boundary to
the opposite side (Figure 4.11A). This allows for each cell to align in a row along the
anterior-posterior axis as the notochord forms. However, axial mesoderm cells from
explants lacking ADAM13 or ADAM19 do not properly extend from one side of the
notochord-somite boundary to the opposite side. This suggests that there is a delay in the
process of mediolateral cell intercalation.
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Moreover, the delay in mediolateral cell

intercalation may explain why the notochords are wider in embryos lacking ADAM13 or
ADAM19.
To investigate notochord morphology, the length and width of the notochord was
measured at three different time points during notochord formation. These measurements
were used to calculate a length-to-width (L:W) ratio from fourteen different cell pairs in
three independent experiments. The length of the notochord was measured between two
axial mesoderm cells approximately 150m apart. The width of the notochord was
measured between both notochord-somite boundaries. In control notochords, the L:W
ratio increased over time, showing that the notochord tissue converged and extended
properly (Figure 4.11B). However in explants lacking ADAM13 or ADAM19, the
notochord L:W ratios were reduced at all three time points.

The notochords from

explants lacking ADAM13 or ADAM19 do converge and extend, just not at the same rate
as the control explants. Therefore, there is a delay in axial mesoderm convergence and
extension movements in embryos lacking ADAM13 or ADAM19 resulting in a
significantly wider notochord compared to control embryos.

SECTION IV: The Mislocalization of ECM Proteins in the Notochord

Axial mesoderm cells begin the process of mediolateral cell intercalation after
coming in contact with one side of the notochord-somite boundary. This is described as
the mechanism of „boundary capture‟ (Keller and Tibbetts, 1989; Shih and Keller, 1992).
This mechanism occurs when the border of the cell in contact becomes quiescent and no
longer sends protrusions in its lateral direction. Therefore, the cell forms a stable contact
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or is „captured‟ by the extracellular matrix proteins that make up the notochord-somite
boundary.

This event is critical for the proper convergence and extension of the

notochord (Keller et al., 2000). To investigate if the notochord-somite boundary is intact,
I performed a double immunostain on open face explants. I visualized two extracellular
matrix (ECM) proteins fibronectin and laminin for their localization at the notochordsomite boundary by fluorescence microscopy. In control explants, both ECM proteins
localized to either side of notochord and at the intersomitic boundaries (Figure 4.12). In
explants lacking ADAM13, both ECM proteins are localized on either side of the
notochord and at the intersomitic boundaries. However, punctate localization of both
ECM proteins was also found mislocalized in the notochord (arrows). In explants lacking
ADAM19, strong mislocalization of both ECM proteins is found throughout the
notochord. This result was seen previously for fibronectin expression in MO19 injected
embryos (Figure 2.8, (Neuner et al., 2009)). Therefore, the notochords of embryos
lacking ADAM13 or ADAM19 appear to have normal notochord-somite boundaries but
an abnormal presence of ectopic fibronectin and laminin in the notochord. Since the
notochord-somite boundary is formed simultaneously as the notochord develops, it is
unclear whether the mislocalization of fibronectin and laminin cause the delay in
mediolateral cell intercalation or that their mislocalization is a result.

Previously,

fibronectin localization by confocal microscopy showed that fibronectin fibrils are
cleared from the dorsal (floor plate) and ventral (archenteron) sides of the developing
notochord during gastrulation (Davidson et al., 2004). As the fibronectin fibrils are
remodeled they become enriched along the lateral notochord-somite boundaries. Our lab
has previously shown that ADAM13 can cleave and remodel a fibronectin matrix in
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cultured cells (Alfandari et al., 2001). Therefore if the dorsal mesoderm cells from
embryos lacking ADAM13 or ADAM19 actively secrete fibronectin into the extracellular
environments, not having a proper level of ADAM13 at the cell surface to remodel the
fibronectin matrix could cause a delay in mediolateral cell intercalation.

Future

experiments should repeat the double immunostain for fibronectin and laminin in open
face explants utilizing a confocal microscope. A Z-stack reconstruction of the entire
notochord will determine if the ECM proteins are being mislocalized inside of the
notochord or to the dorsal and ventral sides where they are normally absent (Davidson et
al., 2004).

The mislocalization of fibronectin in the somites of explants lacking

ADAM19 is evident of the strong defects occurring in this tissue. Previously, I observed
that cell organization within each somite is affected and that two muscle differentiation
markers are reduced in embryos lacking ADAM19 (Neuner et al., 2009).

Future

experiments should investigate whether individual somitic cell organization and the
formation of the intersomitic boundary are linked to muscle differentiation.
The major signaling pathways that are critical for establishing convergence and
extension movements during gastrulation are the Planar Cell Polarity Pathway (or the
Non-canonical Wnt signaling pathway) (Yin et al., 2008) and the interaction between
Integrins and the extracellular matrix, specifically fibronectin (Davidson et al., 2006;
Rozario et al., 2009). The PCP Signaling Pathway is essential for establishing dorsal
mesoderm cell polarity. The interaction between integrin receptors such as 51 integrin
and fibronectin are critical for dorsal mesoderm cell adhesion. I propose that ADAM13
and ADAM19 function in convergence and extension movements by regulating dorsal
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mesoderm cell polarity or cell adhesion to fibronectin. These two hypotheses will be
investigated in the next section of this chapter.

SECTION V: Does ADAM13 and ADAM19 Affect Dorsal Mesoderm Cell Polarity
or Cell Adhesion to Fibronectin?

Role of ADAM13 and ADAM19 in Dorsal Mesoderm Cell Polarity

The Planar Cell Polarity pathway is functionally conserved from flies to
vertebrates and is essential for the morphogenetic movements during gastrulation. In
Drosophila, components of this pathway are specifically localized to cell borders in order
to establish cell polarity and coordinate cell motility (Adler, 2002; Zallen and Wieschaus,
2004). Vertebrate counterparts of the PCP pathway are required for convergence and
extension movements during gastrulation (Goto and Keller, 2002; Keller, 2002). A loss
of any of the pathway components results in the failure of the dorsal mesoderm to
undergo convergence and extension (Roszko et al., 2009; Torban et al., 2004).
Moreover, it is khown that activation of the PCP pathway can be visualized through the
translocation of dishevelled (Dsh), an intracellular signaling component, from the cytosol
to the plasma membrane in dorsal mesoderm undergoing convergence and extension
(Wallingford et al., 2000). This translocation event was not observed in the posterior
dorsal mesoderm because this tissue does not undergo convergence and extension.
Therefore, there is a direct link between the PCP signaling pathway in establishing cell
polarity with the convergence and extension movements of gastrulation.
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To investigate if the activation of the PCP signaling pathway is affected, I
analyzed the localization of dishevelled in the axial mesoderm of embryos lacking
ADAM13 or ADAM19.

This technique was performed on embryos that were

microinjected twice. The first injection is at the one-cell stage with either a control
Morpholino, MO13 or MO19.

The second injection is with RNA encoding for

dishevelled fused to green fluorescent protein (GFP-dishevelled) into the two dorsal
blastomeres at the four cell stage. Overexpression of dishevelled can block convergence
and extension movements (Sokol, 1996). However, if the level of RNA is titrated down
to a small finite dosage (50pg) of GFP-Dishevelled RNA this does not affect normal
development. More importantly, this assay can be used as a tool for visualizing the
activation of the PCP signaling pathway in vivo (Marsden and DeSimone, 2001;
Wallingford et al., 2000). The injected embryos were allowed to develop until the late
gastrula stage.

Open face explants were dissected and analyzed for dishevelled

localization by confocal microscopy. In explants lacking ADAM13 or ADAM19, the
localization of dishevelled is found at the plasma membrane similar to control explants
(Figure 4.13).

To determine if there is a quantitative difference in dishevelled

localization, I normalized the level of GFP-dishevelled by co-injecting RNA encoding
monomeric red fluorescent protein (RFP) (Figure 4.14A). The same dose of RFP RNA
and GFP-dishevelled RNA were coinjected into one dorsal blastomere at the four cell
stage.

In the open face explants, the fluorescence profile of GFP-dishevelled was

measured using Axiovision software along the anterior-posterior axis and the mediolateral axis of the notochord.

The fluorescence profiles of GFP-dishevelled were

normalized to the fluorescence profiles of RFP (Figure 4.14B). Compared to control
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notochords, there was no significant difference in the GFP-dishevelled fluorescence
profiles of notochords lacking ADAM13 or ADAM19. Therefore, these results suggest
that ADAM13 and ADAM19 do not affect the activation of the PCP signaling pathway of
the dorsal mesoderm during gastrulation.

Role of ADAM13 and ADAM19 in Dorsal Mesoderm Cell Adhesion to Fibronectin

During gastrulation, the involuting mesoderm enters through the blastopore and
migrates on the inner surface of the blastocoel roof. This migration event is highly
dependent upon the extracellular matrix protein fibronectin (FN), which is expressed
along the blastocoel roof (Boucaut and Darribere, 1983; Lee et al., 1984; Ramos and
DeSimone, 1996).

Cell adhesion to FN involves many cell-extracellular matrix

interactive sites (Hynes, 2009; Rozario and DeSimone, 2010).

The central binding

domain for many cell types to FN is found at the tripeptide sequence RGD site
(Pierschbacher and Ruoslahti, 1984). Together with an adjacent site called the synergy
site, these two domains act cooperatively to support cell adhesion (Aota et al., 1994;
Bowditch et al., 1994). Cell attachment to the RGD site, in cooperation with the synergy
site, is mediated through the 51 integrin receptor that recognizes fibronectin at the cell
surface (Pytela et al., 1985). During dorsal mesoderm cell migration on the blastocoel
roof, the notochord-somite boundary is formed and cells begin to undergo convergence
and extension. To investigate if the dorsal mesoderm cells can properly spread on a
fibronectin substrate, I dissociated the dorsal mesoderm cells from MO13 or MO19
injected embryos and plated the cells onto FN. Dorsal mesoderm cells were dissected
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from the dorsal blastopore lips of early gastrula (stage 10.5) embryos. The cells were
dissociated in calcium and magnesium-free media, plated onto a FN substrate and
analyzed by time lapse microscopy. After one hour, 85% of the dorsal mesoderm cells
from control embryos spread on FN (Figure 4.15). In MO13 injected embryos, only 60%
of the dorsal mesoderm cells spread on FN. In MO19 injected embryos, only 70% of the
dorsal mesoderm cells spread on FN. If both ADAM13 and ADAM19 were knocked
down by injecting MO13 and MO19, only 60% of the dorsal mesoderm cells spread on
FN.

Since an additive affect was not observed, this suggests that the function of

ADAM13 and ADAM19 do not compensate in cell adhesion to fibronectin.
To determine if the defects were due to the involvement of 51 integrin, I
repeated the cell adhesion assay by plating the cells on a GST fusion protein containing
only the RGD and synergy site called 9.11 (Ramos and DeSimone, 1996). The same
results as seen on FN were observed for dorsal mesoderm cells to spread on 9.11. After
one hour, 85% of the dorsal mesoderm cells from control embryos spread on 9.11 (Figure
4.15). In MO13 injected embryos, only 60% of the dorsal mesoderm cells spread on
9.11. In MO19 injected embryos, only 70% of the dorsal mesoderm cells spread on 9.11.
In MO13 and MO19 injected embryos, only 60% of the dorsal mesoderm cells spread on
9.11 suggesting that the function of ADAM13 and ADAM19 do not compensate in cell
adhesion to FN. Therefore, dorsal mesoderm cells from embryos lacking ADAM13 and
ADAM19 have a reduced ability to spread on a FN substrate. The defects observed may
affect the interaction of 51 integrins with fibronectin.
To investigate if the expression of 1 integrin is affected, I determined the protein
level of 1 integrin in the dorsal mesoderm of MO13 or MO19 injected embryos.
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Compared to control embryos, there was no significant change in the overall protein level
of 1 integrin in the dorsal mesoderm (Figure 4.18). However, this assay only analyzed
the total protein level of 1 integrin. An additional experiment should be completed to
determine the cell surface expression of 1 integrin. Immunoprecipitation of 1 integrin
from cell surface biotinylated dorsal mesoderm cells of CMO, MO13 or MO19 injected
embryos will determine if ADAM13 or ADAM19 affect the protein level of 1 integrin
at the plasma membrane.
To rescue the cell adhesion defects on FN and 9.11, I injected RNA encoding for
full length ADAM13 or full length ADAM19 into the two dorsal blastomeres at the four
cell stage. ADAM13 RNA was able to partially rescue the MO13 effect on 9.11 but did
not rescue on FN (Figure 4.16). ADAM19 RNA was able to partially rescue the MO19
effect on both FN and 9.11, as well as, the MO13 effect on 9.11 (Figure 4.16B and 4.17).
The ability of ADAM19 to rescue MO13 cell adhesion on 9.11 further supports the
intimate relationship between ADAM13 and ADAM19 proteins in the embryo.
Our lab has shown that the cytoplasmic domain of ADAM13 is cleaved off,
translocates into the nucleus and promotes cranial neural crest cell migration in vivo
(Cousin et al., 2010). Injection of RNA encoding the cytoplasmic domain of ADAM13
fused to GFP (GFP-C13) in the dorsal mesoderm was able to partially rescue the MO19
cell adhesion defects on both FN and 9.11 (Figure 4.17). This suggests that GFP-C13 has
an independent biological function in the embryo. GFP-C13 did not rescue the MO13
effect on FN and 9.11 suggesting that the extracellular domain of ADAM13 is important
for cell adhesion on FN. An alternative hypothesis could be explained by GFP-C13
acting through a positive feedback mechanism important for upregulating ADAM13
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expression in the embryo (Figure 4.19). In the presence of a MO13 background, the level
of ADAM13 could not be rescued because of the effects of the morpholino. However, in
the presence of a MO19 background, the protein level of ADAM13 rescues to near
control levels. This experiment is preliminary and needs to be repeated.
When GFP-C13 translocates into the nucleus it regulates gene expression by an
unknown mechanism. Xenopus Marginal Coil (Xmc) is a cytoplasmic coiled-coil protein
that is regulated by GFP-C13 and plays an important role in regulating gastrulation
movements (Frazzetto et al., 2002). To determine if Xmc is able to rescue the cell
adhesion defects in the dorsal mesoderm, I injected RNA encoding full length Xmc
containing an N-terminal myc tag (Xmc-MT) into the two dorsal blastomeres at the four
cell stage. However, Xmc-MT RNA could not rescue dorsal mesoderm cell spreading on
FN and 9.11 in MO13 or MO19 injected embryos (Figure 4.16 and 4.17). This result
suggests that Xmc does not function with ADAM13 or ADAM19 in regulating dorsal
mesoderm cell adhesion to FN.
In addition, PI3K signaling and the downstream component AKT are shown to
regulate cell adhesion to FN (Nie and Chang, 2007a; Somanath and Byzova, 2009;
Somanath et al., 2007). To determine if PI3K is able to rescue the cell adhesion defects
in the dorsal mesoderm, I injected RNA encoding the constitutively active p110 subunit
of PI3K (Nie and Chang, 2007a).

However, p110 RNA could not rescue dorsal

mesoderm cell spreading on FN and 9.11 in MO13 or MO19 injected embryos (Figure
4.16 and 4.17). Previously at the gastrula stage, I showed a significant reduction in active
phosphorylated AKT in embryos lacking ADAM19 (Figure 2.9). Therefore, I analyzed
the level of phosphorylated AKT (AKTp) in the dorsal mesoderm. However in MO13 or
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MO19 injected embryos, there was no significant change in the level of AKTp in the
dorsal mesoderm (Figure 4.18). The effects on AKT by ADAM19 were seen previously
at the late gastrula stage where the expression level of ADAM19 is much higher
compared to the early gastrula stage in this assay (Figure 2.1 and 2.9). These results
suggest that ADAM13 or ADAM19 regulation of cell spreading to fibronectin is not
mediated by PI3K/AKT.

SECTION VI: Discussion

In this chapter I have shown that ADAM13 and ADAM19 proteins are important
for gastrulation. ADAM19 affects gene expression important for establishing the A-P
polarity of the notochord, while ADAM13 does not. Both ADAM13 and ADAM19 are
important for convergence and extension movements. Embryos lacking ADAM13 or
ADAM19 have a delay in mediolateral cell intercalation of the axial mesoderm, resulting
in a significantly wider notochord compared to control embryos. The defects seen in
convergence and extension movements do not appear to affect the activation of the PCP
signaling pathway. However, dorsal mesoderm cells from embryos lacking ADAM13 or
ADAM19 have a reduced ability to spread on fibronectin.
My results show that a loss of ADAM13 or ADAM19 in the embryo does not
affect the activation of the PCP signaling pathway by the translocation of dishevelled to
the plasma membrane. Dishevelled sub-cellular localization has been studied extensively
before to determine the activation state of the PCP signaling pathway in Xenopus
embryos (Axelrod et al., 1998; Marsden and DeSimone, 2001; Tada and Smith, 2000;
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Wallingford et al., 2000). However, dishevelled protein is also essential for controlling
signal transduction of the canonical Wnt signaling pathway via -catenin (Boutros and
Mlodzik, 1999).

Dishevelled is an intercellular protein that interacts with the Wnt

receptor Frizzled at the plasma membrane and deciphers the Wnt signal to activate the
appropriate intracellular signaling cascade (Canonical vs Non-canonical) (Roszko et al.,
2009). Therefore, to definitively show that the PCP signaling pathway is affected in
embryos lacking ADAM13 or ADAM19 further experiments need to be done. I would
propose to investigate the downstream PCP target genes for any changes in gene
expression profiles.
My results suggest that ADAM13, and possibly ADAM19, function by regulating
dorsal mesoderm cell spreading on fibronectin. A single knock down of ADAM13
reduces cell spreading on FN to 60%. A single knock down of ADAM19 reduces cell
spreading on FN to 70%. A double knock down of ADAM13 and ADAM19 reduces cell
spreading on FN to 60%, showing there is not an additive effect by the loss of both
ADAM proteins. This suggests that the function of ADAM13 and ADAM19 do not
compensate in cell spreading on fibronectin. Since the double knock down cell adhesion
levels are similar to the knock down of ADAM13 alone, I propose that dorsal mesoderm
cell spreading on FN is largely due to ADAM13 with minimal contribution from
ADAM19. Moreover, a loss of ADAM19 reduces ADAM13 protein levels at the tailbud
stage (Figure 3.2) and at the early gastrula stage (Figure 4.19). Therefore, my results
suggest that the dorsal mesoderm cell spreading defects observed in MO19 injected
embryos are an indirect result of a reduction in ADAM13 protein levels.
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Dorsal mesoderm cell spreading on the fusion protein 9.11 or full length
fibronectin were similar. A single knock down of ADAM13 reduces cell spreading on
9.11 to 60%. A single knock down of ADAM19 reduces cell spreading on 9.11 to 70%.
A double knock down of ADAM13 and ADAM19 reduces cell spreading on 9.11 to 60%,
showing there is not an additive effect by the loss of both ADAM proteins. This strongly
suggests that our defect in dorsal mesoderm cell spreading to FN is mediated through the
RGD/synergy site via the 51 integrin receptor and not through other cell-ECM
interactive sites. Previously, the disintegrin and cysteine rich domains of ADAM13 were
shown to promote cell adhesion through an interaction with activated 1 integrin
(Gaultier et al., 2002). Therefore, ADAM13 (and possibly ADAM19) may function
through 51 integrin to promote dorsal mesoderm cell adhesion to FN. Since ADAM13
or ADAM19 do not appear to affect the overall expression of 1 integrin (Figure 4.18), it
is likely that either the cell surface protein level of 51 integrin or the activation of
51 integrin could be regulated by ADAM13. Integrins are cell surface heterodimers
functioning as receptors in cell adhesion and migration to the extracellular matrix (Hynes,
2009). Using three-dimensional models, it is shown that the integrin  and  tails of
51 form a heterodimer and exist in a low affinity state or closed conformation. In this
inactive state, 51 can bind to the RGD site of fibronectin. In order to change to a high
affinity state and to become activated, changes in their three-dimensional conformation
occur in relation to the position of each tail and relative to the plasma membrane. Once
activated, 51 integrin has an open conformation and can bind to both the RGD and
Synergy sites on fibronectin.

Furthermore, once an integrin heterodimer becomes

activated this promotes a physical interaction with the intracellular adaptor protein talin
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to the  cytoplasmic tail (Tadokoro et al., 2003). The two main kinases downstream of
an activated integrin heterodimer are focal adhesion kinase (FAK) and Src kinase. These
kinases regulate other downstream proteins that control the small GTPases Rac1 and
RhoA to induce cytoskeletal changes. This is essential for proper cell adhesion and
migration on fibronectin.
Two techniques have been developed in zebrafish and humans to analyze
activated integrin heterodimers in vivo. Bimolecular Fluorescence Complementation
(BiFC) can visualize active integrin heterodimers in vivo (Julich et al., 2009). The 5
integrin was tagged at the C-terminus with the N-terminal fragment of Venus yellow
fluorescent protein (5-nVenus). The 1 integrin was tagged at the C-terminus with the
C-terminal fragment of Venus yellow fluorescent protein (1-cVenus).

RNA was

transcribed for both constructs and injected into zebrafish embryos. Co-expression of
5-nVenus and 1-cVenus produced strong fluorescence at the intersomitic boundaries
compared to weak fluorescence within individual somitic cells. This suggests an active
integrin heterodimer forms at the intersomitic boundaries. The second technique utilizes
a monoclonal antibody (MAB2079Z) made against human 1 integrin (amino acids 355425, Millipore) that specifically recognizes its active conformation (Barberis et al., 2004).
For our system, injection of human 1 integrin RNA would enable us to visualize
activated integrin heterodimers in the dorsal mesoderm by immunohistochemistry. These
techniques will allow us to investigate if ADAM13 (or ADAM19) affects 51 integrin
activation.
Reintroducing ADAM13 RNA (200pg) in the dorsal mesoderm was able to
partially rescue cell spreading on 9.11 but not on full length FN (Figure 4.16). ADAM13
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is known to bind to the second heparin-binding domain (Hep II) of fibronectin in order to
cleave and remodel a fibronectin matrix (Alfandari et al., 2001; Gaultier et al., 2002). It
is likely that reintroducing ADAM13 in the dorsal mesoderm cells allows ADAM13 to
bind and cleave FN. This would cause a decrease in cell adhesion to full length FN. I
observed an even further reduction (42%) in cell adhesion when injecting a high dosage
(400pg) of ADAM13 RNA (Figure 4.16A). Furthermore, our lab has shown that a loss of
ADAM13, as well as, ADAM13 overexpression in the embryo delays blastopore closure
by two hours. Therefore, it is possible that a finite dosage of ADAM13 is needed to
obtain a complete rescue on full length FN. Since the 9.11 substrate does not contain the
Hep II domain, this might explain why ADAM13 can rescue on the 9.11 substrate but
cannot rescue cell adhesion on full length FN. These results suggest that ADAM13
functions through 51 integrin to regulate cell adhesion on fibronectin, in addition to
having a role in binding and cleaving fibronectin.
Work completed by our lab on ADAM13 and another group on ADAM10 has
recently shown that the cytoplasmic domains are cleaved off by -secretase and
translocate into the nucleus to perform an independent function in the embryo (Cousin et
al., 2010; Tousseyn et al., 2009). Our lab has shown that overexpression of a GFP fusion
to the cytoplasmic domain of ADAM13 (GFP-C13) in cranial neural crest cells affects
gene expression in approximately 2000 genes.

Co-expression with the extracellular

domain of ADAM13 (ADAM13cyto) is capable of rescuing CNC cell migration in vivo.
In addition, the cytoplasmic domain of ADAM19 (GFP-C19) co-expressed with the
ADAM13cyto is capable of rescuing CNC cell migration in vivo. This suggests that the
ADAM13 cytoplasmic domain (and possibly ADAM19 cytoplasmic domain) regulates
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gene expression when inside the nucleus and that the overlapping functions of ADAM13
and ADAM19 may be explained by the actions of their cytoplasmic domains.
GFP-C13 can rescue dorsal mesoderm cell spreading on FN and 9.11 in MO19
injected embryos but not in MO13 injected embryos (Figure 4.17). In addition, the coinjection at the one cell stage of MO19 and GFP-C13 RNA (1ng) can upregulate
ADAM13 protein level to near control levels (Figure 4.19). This result was not seen by
co-injection of MO13 and GFP-C13 RNA (1ng) because of the effects of the morpholino.
Therefore, GFP-C13 may function through a positive feedback mechanism to regulate
ADAM13 gene expression. To determine if GFP-C13 can function through a positive
feedback mechanism to upregulate ADAM13 transcription, I propose to isolate RNA
from embryos overexpressing GFP-C13. I will detect ADAM13 gene expression by real
time PCR. The PCR primer sets will have to recognize a specific sequence in the
extracellular domain of ADAM13 to avoid amplification of the cytoplasmic domain and
cross-reactivity with other ADAM members.

Furthermore, our lab has shown the

cytoplasmic domain of ADAM19 (GFP-C19) can compensate for GFP-C13 by rescuing
CNC cell migration in vivo (Cousin et al., 2010). If GFP-C19 can compensate for GFPC13 in CNC cells, it would be interesting to determine if GFP-C19 could rescue dorsal
mesoderm cell spreading on FN and 9.11 substrates. Lastly, it would be interesting to
determine if GFP-C19 may function in a similar positive feedback mechanism.
Although ADAM13 and ADAM19 proteins are required for normal
morphogenetic movements during gastrulation, my data suggests they function through
different mechanisms. I propose that ADAM19 functions by shedding Neuregulin to
help establish gene expression for the A-P polarity of the notochord. I propose that

107

ADAM13 functions to control dorsal mesoderm cell adhesion on fibronectin by
regulating the activation of 51 integrin. These hypotheses will be explored further in
Chapter V of this thesis.

SECTION VII: Materials and Methods used in Chapter IV

Embryo Dissections - Open Face Explants
Embryos were injected in the animal pole region at the one-cell stage with either CMO, a
Morpholino to ADAM13 (MO13), or MO19 to knock down protein expression in the
entire embryo. The same embryos were injected again into one blastomere at the twocell stage with mRNA encoding a membrane bound Cherry (mbCherry) to visualize
individual cells.

The resultant embryos were allowed to develop until the end of

gastrulation (stage 12.5). At this point, the dorsal mesoderm was dissected from each
embryo and the resulting open face explant was prepared as described previously
(Wilson, 1989). Time lapse movies were made using an Axiovert inverted microscope
(Zeiss) equipped with a Ludl XY-stage control and an Orca camera (Hamamatsu) and
controlled by the OpenLab software (Improvision).
develop until approximately early tailbud (stage 22).

The explants were allowed to
Individual cell tracking and

notochord measurements were done using the OpenLab software. At the end of each
time lapse movie, the explants were fixed in MEMFA and dehydrated in methanol for
Whole Mount Immunostain analysis.
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Double Whole Mount Immunostain
Embryos were fixed at tailbud stage (st. 24) using MEMFA and stored in methanol.
Whole mount immunostaining was performed as previously described (Dent et al., 1989).
The Tor70 antibody was a generous gift from Dr. Richard Harland at the University of
California, Berkeley.

The 12/101 antibody was purchased from the Developmental

Studies Hybridoma Bank (Iowa City, Iowa).

Cell Adhesion Assay
Embryos were injected in the animal pole region at the one-cell stage with CMO, MO13,
or MO19 to knock down protein expression in the entire embryo. The resultant embryos
were allowed to develop until the beginning of gastrulation (stage 10.5), at which point
the dorsal mesoderm was dissected from each embryo. Dorsal mesoderm cells were
dissociated on an agarose coated plastic dish in calcium and magnesium free media (1X
CMF) for 30 minutes. The cells were plated onto a fibronectin (FN) substrate or a GSTfusion protein containing only the RGD/synergy site of fibronectin (GST-9.11) as
described previously (Ramos, 1996). Time lapse movies were made using an Axiovert
inverted microscope (Zeiss) equipped with a Ludl XY-stage control and an Orca camera
(Hamamatsu) and controlled by the OpenLab software (Improvision). Dorsal mesoderm
cell spreading was analyzed at the one hour time point for all experiments.

Confocal Microscopy
GFP-dishevelled RNA was injected into the two dorsal blastomeres at the four-cell stage
and allowed to develop until late gastrula (stage 12.5/13). Open face explants were
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dissected as described above. The explants were cultured in Danilchik media on glass
bottom petri dishes. The live explants were allowed to heal for one hour and then imaged
at approximately stage 14 using a Zeiss Confocal Scanning Laser Microscope equipped
with LSM 510M software. The images were captured under an oil immersion 25x
magnification objective lens.
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Figure 4.1: A-P Polarity Analysis for Xbrachyury Expression at the
Gastrula Stage. Embryos were microinjected with 10 ng of MO19 or a
control MO at the one-cell stage and allowed to develop until gastrula
stage (stage 12). Embryos were also co-injected at the one-cell stage with
RNA encoding full length ADAM19 (250pg), ADAM19E/A (250pg), full
length Neuregulin1 (NRG-FL) (100pg) or the extracellular region of
Neuregulin1 (NRG-EC) (100pg). Whole mount in situ hybridization was
performed using the marker Xbrachyury. For all embryos, the dorsal view
is presented with the anterior up. The frequencies of the morphotypes
observed are indicated in the bottom graph.
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Figure 4.2: A-P Polarity Analysis for Chordin Expression at the
Gastrula Stage. Embryos were microinjected with 10 ng of MO19 or a
control MO at the one-cell stage and allowed to develop until gastrula
stage (stage 12). Embryos were also co-injected at the one-cell stage with
RNA encoding full length ADAM19 (250pg), ADAM19E/A (250pg), full
length Neuregulin1 (NRG-FL) (100pg) or the extracellular region of
Neuregulin1 (NRG-EC) (100pg). Whole mount in situ hybridization was
performed using the marker Chordin. For all embryos, the dorsal view is
presented with the anterior up and the red bar indicates the relative
distance from the blastopore. The frequencies of the morphotypes
observed are indicated in the bottom graph.
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Figure 4.3: ADAM13 affect on the A-P Polarity of the Notochord.
Embryos were microinjected with 10 ng of MO13, MO19 or a control MO
at the one-cell stage and allowed to develop until gastrula stage (stage 12).
MO19 embryos were also co-injected at the one-cell stage with RNA
encoding full length ADAM13 (200pg).
Whole mount in situ
hybridization was performed using the marker Xbrachyury and Chordin.
For all embryos, the dorsal view is presented with the anterior up and the
red bar indicates the relative distance from the blastopore. The
frequencies of the morphotypes observed are indicated in the bottom
graph.
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Figure 4.4: Visual Summary showing the A-P Polarity of the Notochord at the
Gastrula Stage. Wild type notochords are compared to ADAM13 knock down,
ADAM19 knock down, and NRG-EC Rescue notochords showing Xbrachyury (blue) and
Chordin (red) expression profiles. Anterior (A), posterior (P). ADAM13 knock down
notochords do not affect A-P polarity gene expression. The expression patterns are wider
compared to control notochords, suggesting possible notochord morphology defects.
ADAM19 knock down notochords do affect A-P polarity gene expression. Specifically,
a loss of Xbrachyury concomitant with an anterior shift in Chordin expression. Gene
expression can be rescued by co-injecting the extracellular fragment of Neuregulin1
RNA, a form that mimics a potential cleavage product of ADAM19.
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Figure 4.5: Double Whole Mount Immunostain on Embryos Lacking
ADAM13 or ADAM19. The monoclonal antibody, Tor70, stains the
notochord in brown (Kushner, 1984). The monoclonal antibody, 12/101,
stains the somites in green (Kintner and Brockes, 1985). The notochord
morphologically appears wider in MO13 and MO19 injected embryos.
The somites morphologically appear normal in MO13 injected embryos
but show gross morphology in MO19 injected embryos. The defects
observed in these two dorsal tissues are also evident in the smaller and
shorter body size of MO19 injected embryos.
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Figure 4.6: Microdissection of an Open Face Explant. (A) Bisect a late gastrula
(stage 12.5/13) embryo along the dotted line. (B) Peel away the underlying „sticky‟
endoderm layer, exposing the dorsal mesoderm. (C) Cut away the ends to shape the
explant into a rectangle. (D) Place the explant mesoderm face down onto a glass bottom
Petri dish filled with Danilchik media. Place four small droplets of vacuum grease
around the explant and position a glass coverslip on top. Press down gently. (E) All
Open Face Explants are positioned with the Anterior at the top and Posterior at the
bottom. The notochord is in the center surrounded by the developing somites. This
figure was adapted from (Wilson et al., 1989).
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Figure 4.7: Time Lapse Microscopy of a Control Open Face Explant. Explants from
embryos injected with CMO at the one-cell stage. Membrane bound Cherry RNA was
injected into one blastomere at the two-cell stage to visualize axial mesoderm cell
movement from one half of the embryo. The montage represents an image every 30
minutes from a ten hour time lapse movie. The movie file is included with this Thesis.
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Figure 4.8: Time Lapse Microscopy of MO13 Injected Open Face Explant. Explants
from embryos injected with MO13 at the one-cell stage. Membrane bound Cherry RNA
was injected into one blastomere at the two-cell stage to visualize axial mesoderm cell
movement from one half of the embryo. The montage represents an image every 30
minutes from a ten hour time lapse movie. The movie file is included with this Thesis.
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Figure 4.9: Time Lapse Microscopy of MO19 Injected Open Face Explant. Explants
from embryos injected with MO19 at the one-cell stage. Membrane bound Cherry RNA
was injected into one blastomere at the two-cell stage to visualize axial mesoderm cell
movement from one half of the embryo. The montage represents an image every 30
minutes from a ten hour time lapse movie. The movie file is included with this Thesis.
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Figure 4.10: Axial Mesoderm Cell Morphology. (A) Open face explants from
embryos injected with CMO, MO13 or MO19 at the one-cell stage. Membrane
bound Cherry RNA was injected into one blastomere at the two-cell stage. Four
cells are outlined in black to better visualize the axial mesoderm cell morphology.
(B) Axial mesoderm cell length-to-width ratio. The mediolateral length and
anterior-posterior width were measured in axial mesoderm cells of open face
explants at the end of gastrulation (st. 13). The graph represents 20 cells from four
independent experiments.
Control axial mesoderm cells have a bipolar
morphology. Axial mesoderm cells from embryos lacking ADAM13 or ADAM19
have a multipolar morphology with reduced axial mesoderm cell L:W ratios.
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Figure 4.11: Mediolateral Cell Intercalation of the Axial Mesoderm. Open face
explants from embryos injected with CMO, MO13 or MO19 at the one-cell stage.
Membrane bound Cherry RNA was injected into one blastomere at the two-cell stage.
Three cells were outlined in different colors to better visualize the axial mesoderm cell
movement over an eight hour time period. The length was measured between two cells at
each time point and divided by the width of the notochord. This generated a length-towidth ratio (L:W). The graph below represents 14 different L:W measurements from
three independent experiments. In embryos lacking ADAM13 or ADAM19, the L:W did
not change, showing a delay in mediolateral cell intercalation.
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Figure 4.12: Notochord-Somite Boundary Analysis. Open face explants from
embryos injected with CMO, MO13 or MO19 at the one-cell stage. The explants were
allowed to develop in Danilchik media until approximately stage 20 and then fixed.
Double immunostain was done using antibodies to the extracellular matrix proteins
fibronectin (4H2, red) and laminin (anti-rabbit-laminin, Sigma, green). These proteins
accumulate at the notochord-somite boundary and at the intersomitic boundaries. In
MO13 injected embryos, punctate expression of both ECM proteins was found in the
notochord (white arrowheads). In MO19 injected embryos, abnormal expression of both
ECM proteins was found throughout the notochord. The images represent maximum
projections taken under fluorescence microscopy using an Apotome and Axiovision 4.5
software analysis.
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Figure 4.13: GFP-Dishevelled Localization in the Dorsal Mesoderm. Open face
explants from embryos injected with CMO, MO13 or MO19 at the one-cell stage. 50pg
of GFP-dishevelled RNA was injected into the two dorsal blastomeres at the four-cell
stage. The explants were allowed to develop in Danilchik media while the images were
captured with confocal microscopy. The approximate developmental stage of each image
is stage 14. The localization of GFP-dishevelled was found at the plasma membrane
under all three conditions.
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Figure 4.14: GFP-Dishevelled Localization Normalized to mRFP in the Dorsal
Mesoderm. (A) Open face explants from embryos injected with CMO, MO13 or MO19
at the one-cell stage. 50pg of GFP-dishevelled RNA and monomeric-RFP RNA was
injected into one dorsal blastomere at the four-cell stage. The explants were allowed to
develop in Danilchik media while the images were captured with confocal microscopy.
The approximate developmental stage of each image is stage 14. The localization of
GFP-dishevelled was found at the plasma membrane under all three conditions with
mRFP localized throughout the cytosol. (B) The fluorescence profile of GFP-dishevelled
is normalized to the fluorescence profile of mRFP and the average ratios are plotted in
the graph. (C) All of the ratio data is plotted in a Box and Whisker Plot. For both data
representations, the ratio for GFP-dishevelled does not change under all three conditions.
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Figure 4.15: Dorsal Mesoderm Cell Adhesion Assay. (A) Dorsal mesoderm cells
were taken from CMO, MO13, MO19, or MO13+MO19 (2MO) embryos, dissociated
and plated onto a fibronectin (FN) or 9.11 substrate. Cell attachment and spreading was
analyzed after one hour. (B) In control embryos, 85% of the cells spread on FN and 9.11.
In MO13 injected embryos, 60% of the cells spread on FN and 9.11. In MO19 injected
embryos, 70% of the cells spread on FN and 9.11. In 2MO injected embryos, 60% of the
cells spread on FN and 9.11. The images represent cells from one experiment. The
graphs shown below represent data from twelve experiments.
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Figure 4.16: Summary of Rescue Experiments in Dorsal Mesoderm of MO13
Injected Embryos. Dorsal mesoderm cells were taken from MO13 embryos injected
with various rescue RNA constructs into the two dorsal blastomeres at the four-cell stage.
The cells were dissociated and plated onto a (A) fibronectin (FN) or (B) 9.11 substrate.
Cell attachment and spreading was analyzed after one hour and compared to Control
cells. The rescue RNA is full length ADAM13 (A13), full length ADAM19 (A19), the
cytoplasmic domain of ADAM13 (C13), Xenopus marginal coil (Xmc-MT), and the
constitutively active p110 subunit of PI3K (p110). The dosages are indicated in
parentheses.
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Figure 4.17: Summary of Rescue Experiments in Dorsal Mesoderm of MO19
Injected Embryos. Dorsal mesoderm cells were taken from MO19 embryos injected
with various rescue RNA constructs into the two dorsal blastomeres at the four-cell stage.
The cells were dissociated and plated onto a (A) fibronectin (FN) or (B) 9.11 substrate.
Cell attachment and spreading was analyzed after one hour and compared to Control
cells. The rescue RNA is full length ADAM13 (A13), full length ADAM19 (A19), the
cytoplasmic domain of ADAM13 (C13), Xenopus marginal coil (Xmc-MT), and the
constitutively active p110 subunit of PI3K (p110). The dosages are indicated in
parentheses.
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Figure 4.18: Protein Expression in the Dorsal Mesoderm.
Embryos were injected with CMO, MO13 or MO19 at the one-cell
stage and allowed to develop to early gastrula (stage 10.5). Total
protein extract from five dissected dorsal blastopore lips was
probed for integrin 1 (8C8 antibody) and phosphorylated AKT
(AKTp, anti-rabbit-AKTp, Cell Signaling Technology). GAPDH
(Millipore) was probed as a loading control. The below graph
shows percent change from three independent experiments
normalized to GAPDH expression.
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Figure 4.19: C13 Affect on ADAM13 Expression. Embryos were
injected with CMO, MO13 or MO19 together with GFP-C13 RNA (1ng) at
the one-cell stage and allowed to develop to early gastrula (stage 10.5).
Total protein extract from five embryos were immunoprecipitated using our
goat ADAM13 antibody and probed with our rabbit ADAM13 antibody
(6615F). GAPDH (Millipore) was probed as a loading control. The below
graph shows the percent change of ADAM13 Proform and ADAM13
Mature form when normalized to GAPDH.
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CHAPTER V

EXPLORING THE FUNCTIONS OF ADAM13 AND ADAM19
IN THE DORSAL MESODERM

All of the work presented in this chapter is data completed by myself and is unpublished.

Abstract
This chapter will explore the roles of ADAM13 and ADAM19 in the dorsal
mesoderm. I will focus on determining how each protein contributes to convergence and
extension movements during gastrulation. Previous data from Chapter IV of this thesis
suggests that ADAM13 and ADAM19 have different functions during gastrulation.
ADAM13 appears to function in regulating cell movements while ADAM19 appears to
function in regulating cell signaling. In addition, ADAM19 may function to regulate cell
movements indirectly through the function of ADAM13 or through the function of
Xbrachyury in the notochord. I propose and discuss a few models for ADAM13 and
ADAM19 function in gastrulation.

SECTION I: Introduction

Gastrulation is a morphogenetic process that reorganizes the primary germ layers
to shape the internal and external features of an early embryo. The main focus on this
thesis is to investigate the roles of ADAM13 and ADAM19 during gastrulation. Both
ADAM family members are expressed in the dorsal mesoderm of the dorsal blastopore
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lip. This tissue is known as the Spemann Organizer and is essential for regulating
gastrulation movements and for early tissue patterning in the embryo.

Although

ADAM13 and ADAM19 are expressed in the same tissue and are required for normal
morphogenetic movements during gastrulation, my data suggests they have different
functions. ADAM13 appears to function in regulating cell movements while ADAM19
appears to function in regulating cell signaling.
ADAM13 functions to regulate cell movements during gastrulation.

This

hypothesis is supported by three main observations. First, embryos lacking ADAM13
delay blastopore closure by two hours showing that ADAM13 is required for proper
blastopore closure. This is specific to ADAM13 because blastopore closure was not
affected in embryos lacking ADAM19 (Figure 2.4). Second, ADAM13 regulates dorsal
mesoderm cell adhesion to fibronectin cell autonomously. Dorsal mesoderm cells from
embryos lacking ADAM13 reduce cell spreading on FN to 60%. This is compared to
dorsal mesoderm cells from control embryos that have 85% of the cells spreading on FN.
In a similar assay, dorsal mesoderm cells from embryos lacking ADAM13 reduce cell
spreading on the fusion protein 9.11 to 60%. The 9.11 fusion protein only contains the
integrin binding domain (RGD and Synergy sites) suggesting that the cell adhesion
defects involve 51 integrin.

Third, ADAM13 is important for convergence and

extension movements in the embryo.

Embryos lacking ADAM13 have a delay in

mediolateral cell intercalation in the axial mesoderm. This defect results in a wider
notochord compared to control embryos.

The cell adhesion defects on FN likely

contribute to the defects observed in convergence and extension as well as blastopore
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closure in the embryo. Therefore, I propose that ADAM13 functions to regulate cell
movements during gastrulation.
ADAM19 functions to regulate cell signaling during gastrulation.

This

hypothesis is supported by three main observations. First, ADAM19 regulates gene
expression important for the A-P polarity of the notochord. Embryos lacking ADAM19
have a specific loss of Xbrachyury expression concomitant with an anterior shift of
Chordin expression in the notochord (Figure 2.5, 4.1 and 4.2). Gene expression is
unaffected in embryos lacking ADAM13 at the gastrula stage, suggesting a specific role
for ADAM19 (Figure 4.3).

Second, embryos lacking ADAM19 have reduced

phosphorylated AKT levels (Figure 2.9). AKT is a downstream target of the EGF
signaling pathway.

This is specific to ADAM19 because phosphorylated AKT is

unaffected in embryos lacking ADAM13. Third, ADAM19 may affect the canonical Wnt
signaling pathway.

Embryos lacking ADAM19 have reduced total -catenin levels

(Figure 2.9). -catenin is an intracellular target of the canonical Wnt signaling pathway.
This is specific to ADAM19 because -catenin levels are unaffected in embryos lacking
ADAM13. Therefore, I propose that ADAM19 functions to regulate cell signaling during
gastrulation.
In addition, ADAM19 may have an indirect role in regulating cell movements
during gastrulation. This hypothesis is supported by two main observations. First,
ADAM19 may function to regulate dorsal mesoderm cell adhesion to FN.

Dorsal

mesoderm cells from embryos lacking ADAM19 reduce cell spreading on FN and 9.11 to
70%. This is compared to dorsal mesoderm cells from control embryos that have 85% of
the cells spreading on FN and 9.11. Second, ADAM19 is important for convergence and
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extension movements in the embryo.

Embryos lacking ADAM19 have a delay in

mediolateral cell intercalation in the axial mesoderm. These defects result in a wider
notochord compared to control embryos. However, the ADAM19 observations may be
an indirect result by affecting ADAM13 protein. Embryos lacking ADAM19 strongly
reduce ADAM13 protein levels at the early gastrula stage (Figure 4.19) and at the tailbud
stage (Figure 3.2). Therefore, I propose that ADAM19 may function to regulate cell
movements indirectly through the function of ADAM13 or through the function of
Xbrachyury in the notochord.

Both ADAM13 and ADAM19 functions during

gastrulation will be explored further in Section II and Section III of this chapter.

SECTION II: ADAM13 Contributes to Convergence and Extension by Regulating
Dorsal Mesoderm Cell Adhesion to Fibronectin

Integrin activation and integrin heterodimer clustering at the cell surface are
important for increased adhesion to a fibronectin matrix (Larsen et al., 2006).
Disruptions in integrin function with the extracellular matrix have led to defects in cell
adhesion and cell migration. Mice null for the 5 integrin subunit die early in gestation
due to mesoderm defects such as abnormal posterior somite development and
degeneration of the notochord tissue (Goh et al., 1997). A loss of FN in the embryo
results in convergence and extension defects in zebrafish (Latimer and Jessen, 2009) and
in Xenopus (Rozario and DeSimone, 2010). Moreover, studies using function blocking
antibodies to 51 integrin randomize cell protrusions that are important for mediolateral
cell intercalation, thus causing defects in convergence and extension (Davidson et al.,
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2006). In addition to the interaction between 51 integrin and FN, the physical state of
FN fibril assembly also regulates convergence and extension movements in the embryo
(Rozario et al., 2009). Therefore, the interaction between 51 and fibronectin plays an
essential role in the morphogenetic movements during gastrulation. Dorsal mesoderm
cells adhere and migrate on a fibronectin matrix along the blastocoel roof. These cell
movements are critical for proper blastopore closure during gastrulation. I propose that
ADAM13 (and possibly ADAM19) functions to promote dorsal mesoderm cell adhesion
to a fibronectin matrix. ADAM13 promotes cell adhesion by regulating the activation of
51 integrin.

This regulation may occur through two different cell autonomous

mechanisms; an intracellular mechanism or an extracellular mechanism.

How does ADAM13 Regulate 51 Integrin Activation Cell Autonomously?

ADAM metalloproteases are regulated through a variety of different posttranslational modifications (Murphy, 2009).

One form of regulation is through

intracellular binding partners that interact with the ADAM metalloprotease cytoplasmic
domain. The proteins physically interact with SH3 binding motifs and proline rich
domains found in the ADAM cytoplasmic domain. A large number of the proteins
identified so far are important for regulating ADAM protein subcellular localization and
trafficking within a cell. However, some important intracellular kinases have also been
identified such as PCK, Src, PI3K and ERK (Diaz-Rodriguez et al., 2002; Izumi et al.,
1998; Kang et al., 2001; Poghosyan et al., 2002). This suggests that ADAM cytoplasmic
domains and the attached kinases may have an intracellular function.
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The Src family of tyrosine kinases are a large protein kinase family that function
downstream of different cell surface receptors (Bradshaw, 2010). Src kinases together
with focal adhesion kinase (FAK) are important for regulating the downstream signaling
events upon integrin engagement with the ECM (Pellinen and Ivaska, 2006). Src and
FAK kinases regulate guanine nucleotide exchange factors (GEF proteins) which activate
the small GTPases RhoA and Rac1. RhoA and Rac1 regulate cytoskeletal changes within
a cell and are essential for cell adhesion and cell migration. Src kinases were identified
as binding partners to the cytoplasmic domains of many different ADAM proteins such
as ADAM9 (Weskamp et al., 1996), ADAM12 (Suzuki et al., 2000), ADAM13 (Cousin
et al., 2000), and ADAM15 (Poghosyan et al., 2002).
Src kinases can regulate an ADAM protein through two different mechanisms.
First, Src kinase binds and phosphorylates the ADAM cytoplasmic domain to regulate the
extracellular function of the ADAM metalloprotease. This is important for regulating the
ectodomain shedding of an ADAM substrate from a cell. For example, c-Src kinase
binds and phosphorylates the cytoplasmic domain of ADAM15.

This increases

ectodomain shedding of the ADAM15 substrate, fibroblast growth factor receptor 2
(FGFR2) (Maretzky et al., 2009). FGFR2 was not shed in cells treated with a Src kinase
inhibitor or in c-Src(-/-) cells but FGFR2 shedding was rescued by reintroducing Src in cSrc(-/-) cells. This shows that c-Src regulates the ectodomain shedding of FGFR2 by
ADAM15. Second, ADAM proteins may enhance Src kinase activity in cultured cells.
This occurs when an ADAM protein recruits Src kinase to large protein complexes at the
cell surface. For example, ADAM12 and Src kinase co-localize to actin-rich structures
along membrane ruffles in cultured cells (Stautz et al., 2010). ADAM12 enhances Src
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kinase phosphorylation when cells are plated on the extracellular matrix protein
vitronectin. This suggests that upon integrin engagement to vitronectin, ADAM12 can
enhance Src kinase activity. Therefore, ADAM proteins may recruit Src kinases to
specific locations in a cell as a way to regulate their own metalloprotease activity.
My results suggest that ADAM13 promotes dorsal mesoderm cell adhesion to
fibronectin by regulating the activation of 51 integrin. This occurs cell autonomously
because in my assay the dorsal mesoderm cells were dissociated. Src kinase is capable of
binding to the cytoplasmic domain of ADAM13 (Cousin et al., 2000). Therefore, I
propose that ADAM13 recruits Src kinase to specific adhesion complexes containing
51 integrin at the cell surface. Once 51 integrin binds fibronectin and becomes
activated, Src kinase phosphorylates FAK to regulate downstream Rho/Rac signaling
events and cytoskeletal changes. This intracellular mechanism allows the cell to spread
on a fibronectin substrate and to promote proper cell adhesion (Figure 5.1A).
Alternatively, ADAM13 may regulate the activation of 51 integrin through an
extracellular mechanism involving the cleavage of fibronectin (Figure 5.1A). ADAM13
binds to the HepII domain of fibronectin and cleaves fibronectin. This mechanism could
promote cell migration on a fibronectin matrix.
In the absence of ADAM13, Src is not properly recruited to the specific adhesion
complexes containing 51 integrin. As a result, Src activity is reduced, FAK activity is
reduced and ADAM13 is not present to cleave fibronectin (Figure 5.1B). Therefore, cells
will remain round and not be able to spread on a fibronectin substrate. To test the
ADAM13 model, I propose the following experiments. First, to investigate Src kinase
activity in MO13 injected embryos, I propose to determine phosphorylated Src protein
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levels by western blot. Second, to investigate FAK kinase activity in MO13 injected
embryos, I propose to determine phosphorylated FAK protein levels by western blot.
The ADAM13 model focuses on explaining how ADAM13 could regulate cell adhesion
on fibronectin cell autonomously. The next section will discuss the possibility that
ADAM13 may function in a non-cell autonomous mechanism to regulate dorsal
mesoderm cell adhesion to fibronectin during convergence and extension movements.

How does ADAM13 Regulate 51 Integrin Activation Non-Cell Autonomously?

Ephrin receptors (Eph) and ligands (ephrin) have prominent roles in vascular
development (Wang et al., 1998), repulsive guidance of neurons (Cheng et al., 1995), and
establishment of tissue boundaries in the embryo (Gale et al., 1996). For example, the
differential expression of Eph receptors and ephrin ligands prevents intermixing of cells
during CNC migration (Smith et al., 1997). Moreover, it is believed that some ephrins
can regulate a cell‟s affinity towards different ECM substrates through cross talk with
integrin receptors. In forward Eph-ephrin signaling, the EphA2 receptor (de Saint-Vis et
al., 2003) or EphA4 receptor (Bourgin et al., 2007) regulate dendritic cell adhesion to FN
via 1 integrin. In reverse Eph-ephrin signaling, the ephrinB1 ligand (Huynh-Do et al.,
2002) and ephrinB2 ligand (Meyer et al., 2007) regulate endothelial cell adhesion to FN
via 51 integrin. Therefore, the cross talk between ephrins and integrin activation
appears to be mediated through an inside-out signaling mechanism. Although an exact
molecular mechanism has yet to be determined, it appears to involve intracellular kinases
(PI3K, Akt, Src, FAK) and the small GTPases (RhoA and Rac1) to induce cytoskeletal
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changes that regulate cell-cell adhesion (Arvanitis and Davy, 2008; Pasquale, 2008;
Somanath and Byzova, 2009).
ADAM10 was the first ADAM metalloprotease shown to cleave a member of the
ephrin signaling pathway. In neurons, ADAM10 cleaves the ephrinA2 ligand in cis
important for axon detachment and termination of signaling (Hattori et al., 2000).
Another group showed that the ADAM10 cysteine-rich domain binds to the EphA3
receptor in complex with the ephrinA5 ligand (Janes et al., 2005).

This physical

interaction positions ADAM10 for cleavage of ephrinA5 in trans, with ADAM10 and its
substrate on opposing cells.

Moreover, ADAM19 can bind the EphA4 receptor in

complex with the ephrinA5 ligand (Yumoto et al., 2008). However, no cleavage event
occurs but this interaction is important for blocking the endocytosis of the EphA4ephrinA5 complex. Therefore, ADAM19 functions to stabilize neuronal synapses in the
formation of neuromuscular junctions.

ADAM13 can cleave the ephrinB1 and B2

ligands to regulate forward ephrin signaling in the dorsal mesoderm of a closely related
species Xenopus tropicalis (Wei et al., 2010). Regardless of proteolytic activity, the Ephephrin signaling complex may be a physiologically relevant substrate for ADAM
metalloproteases.

I propose that ADAM13 cleavage of ephrinB1/B2 in the dorsal

mesoderm may affect the activation of 51 integrin.

Specifically through reverse

signaling of ephrinB1/B2, cleavage may regulate the intracellular kinase activity of Src
and FAK in complex with 51 integrin (Figure 5.2). This cleavage event would be
important for regulating cell-cell adhesion on a fibronectin matrix. More importantly,
ADAM13 cleavage of ephrinB ligands may contribute to the dorsal mesoderm cell
movements during gastrulation.
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SECTION III: ADAM19 Mediated Shedding of Neuregulin Contributes to
Convergence and Extension

Gene expression is altered in MO19 injected embryos at the late gastrula stage
(Neuner et al., 2009). Specifically, Xbrachyury expression is lost concomitant with an
anterior shift of Chordin expression in the notochord (Figure 2.5, 4.1 and 4.2). Gene
expression was unaffected in embryos lacking ADAM13 at the gastrula stage, suggesting
a specific role for ADAM19 (Figure 4.3). Xbrachyury and Chordin are known to be
expressed in a countergradient fashion in the axial mesoderm (Ninomiya et al., 2004).
Chordin is a marker of anterior notochord and Xbrachyury is a marker of posterior
notochord. Together, these two genes help establish the A-P polarity of the developing
notochord. Both genes are required for proper convergence and extension movements in
explants and in the embryo. This was the first study in Xenopus linking A-P tissue
polarity to mesoderm convergence and extension (Ninomiya et al., 2004). Additionally, I
show that Brachyury and Chordin gene expression are dependent on ADAM19
proteolytic activity (Figure 4.1 and 4.2). This is shown by a partial rescue in gene
expression by co-injection of ADAM19 RNA but not with a catalytically inactive mutant
ADAM19 E/A RNA. It is possible that ADAM19 functions by cleaving an unknown
protein important for establishing A-P polarity of the notochord. The unknown protein
may be a growth factor that stimulates signal transduction to activate Xbrachyury and
Chordin expression in the notochord.
In mice, ADAM19 can cleave some members of the EGF family of ligands
including Neuregulin1 (Shirakabe et al., 2001). Neuregulin1 binds to the ErbB3 or
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ErbB4 receptors to activate the ErbB signaling pathway (Esper et al., 2006; Eto et al.,
2006). In Xenopus, the ErbB2/ErbB3 receptors and NRG1 expression begins during
gastrulation and continues through tailbud formation (Nie and Chang, 2007b; Yang et al.,
1999; Yang et al., 1998a; Yang et al., 1998b). Purified recombinant NRG1, as well as,
the overexpression of ErbB2 or ErbB3 receptors can induce naïve animal cap cells to
become mesoderm and express Xbrachyury (Chung and Chung, 1999; Nie and Chang,
2007b).

Moreover, blocking ErbB receptors through injection of a Morpholino or

dominant-negative RNA, can affect the convergence and extension movements during
gastrulation (Nie and Chang, 2006; Nie and Chang, 2007b). I show that expression of the
extracellular domain of NRG1 (NRG-EC) is capable of rescuing Xbrachyury expression
in the notochord while full length NRG1 does not rescue (Figure 4.1 and 4.2).
Therefore, it is possible that ADAM19 mediated shedding of NRG1 allows soluble
NRG-EC to interact with the ErbB receptor to activate signal transduction cell
autonomously in the axial mesoderm. The NRG1-ErbB signaling pathway may induce
Xbrachyury gene expression specifically as the notochord develops.
Brachyury has been extensively studied in a number of chordates and nonchordates for its prominent role in the morphogenetic movements during gastrulation
(Yamada et al., 2010). For example, Brachyury knockout mice have abnormal primitive
streaks due to aberrant mesoderm cell migration (Wilson et al., 1995). In Xenopus, loss
of Xbrachyury prevents convergence and extension movements during gastrulation
(Conlon et al., 1996; Conlon and Smith, 1999; Kwan and Kirschner, 2003). As a
transcription factor, Xbrachyury controls convergence and extension by activating gene
expression for Wnt11, a known target gene (Tada and Smith, 2000). Wnt11 is a Wnt
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family ligand that binds to the Frizzled receptor and signals through dishevelled to
regulate downstream RhoA/Rac1 cytoskeletal changes.

Signaling through Wnt11 is

essential for convergence and extension movements during gastrulation (Smith et al.,
2000; Tada et al., 2002; Tada and Smith, 2000). The Xbrachyury-Wnt11-PCP Signaling
pathway is briefly outlined in Figure 5.3. Therefore in embryos lacking ADAM19, the
loss of Xbrachyury in the notochord may be indirectly linked to the convergence and
extension defects. I propose that ADAM19 functions to cleave NRG1 to maintain
expression of Xbrachyury in the notochord (Figure 5.4A). Axial mesoderm cells that
express Xbrachyury are bipolar and actively undergo mediolateral cell intercalation
through the Wnt11-PCP Signaling Pathway.

This is a cell autonomous hypothesis

because ADAM19 and Xbrachyury are both expressed in the notochord.
In the absence of ADAM19, NRG1 is not cleaved in an axial mesoderm cell.
This reduces ErbB signaling by reducing phosphorylated AKT levels and Xbrachyury
gene expression in the notochord (Figure 5.4B). Furthermore, a loss of Xbrachyury in
the notochord may reduce the Wnt11-PCP Signaling Pathway important for mediolateral
cell intercalation. Therefore, cells will remain round or multipolar and delay mediolateral
cell intercalation. To test the ADAM19 model, I will propose the following experiments.
First, to investigate if the Wnt11-PCP Signaling Pathway is affected in embryos lacking
ADAM19, I propose to analyze Wnt11 gene expression by real time PCR. I predict that a
loss of Xbrachyury in the notochord would result in a loss of Wnt11 gene expression in
the notochord. Second, to investigate if the loss of Xbra contributes to mediolateral cell
intercalation, I propose to inject Xbrachyury RNA in the dorsal mesoderm of MO19
injected embryos. Given the known role of Xbrachyury in regulating convergence and
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extension movements, I predict this experiment should rescue defects in MO19 injected
embryos. However, inappropriate expression of Xbrachyury can cause ectopic posterior
mesoderm formation (Cunliffe and Smith, 1992). Therefore, a targeted injection of a
finite dosage of Xbrachyury RNA specifically in the axial mesoderm would need to be
completed. Lastly, it would be interesting to determine if expression of NRG1 (NRGFL vs NRG-EC) in the dorsal mesoderm could rescue convergence and extension defects
in embryos lacking ADAM19.

Concluding Remarks

ADAM metalloproteases function as ectodomain sheddases through the cleavage
of other membrane bound proteins. A significant amount of research in the ADAM field
has focused on identifying a number of substrates to different ADAM family members.
To a lesser extent, some of the research in the ADAM field has focused on investigating
the function of ADAM proteins in cell migration. Most of this work was completed in
single cell assays investigating the epithelial to mesenchymal transition in vitro. While
ADAM proteins appear to be important for individual cell migration, very little is known
about the role of ADAM metalloproteases in tissue movements. Tissue movements
require coordinated cell migration with respect to surrounding cells. This is the primary
focus of research in our laboratory.
My work has focused on understanding the role of ADAM13 and ADAM19 in
tissue movements known as convergence and extension. Although both ADAM proteins
are required for convergence and extension movements, my data suggests that ADAM13
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and ADAM19 have different functions. ADAM13 appears to function in regulating cell
movements through cell spreading on fibronectin while ADAM19 appears to function in
regulating cell movements through the transcription factor Brachyury. The research
presented in this thesis has furthered our understanding of how ADAM metalloproteases
can function in coordinated cell movements during early embryogenesis.

More

importantly, this type of cell migration is recapitulated in abnormal development. The
knowledge learned from this research can be applied to better understand disease
progression such as cancer metastasis.
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Figure 5.1: Model for the Cell Autonomous Function of ADAM13. (A) In control
dorsal mesoderm cells, ADAM13 functions to recruit Src kinase to adhesion complexes
containing 51 integrin. Src kinase together with FAK kinase regulates the small
GTPases RhoA/Rac1 to induce cytoskeletal changes. In addition, ADAM13 binds to the
HepII domain of fibronectin to cleave fibronectin. Both mechanisms regulate the
activation of 51 integrin and allow a cell to spread properly on fibronectin. (B) In
MO13 dorsal mesoderm cells, Src kinase activity is reduced because it is not recruited
properly to adhesion complexes containing 51 integrin. This reduces both Src and
FAK kinase activity causing 51 integrin to not be activated properly. In addition,
fibronectin is not cleaved. These defects cause a cell to round up and reduce cell
spreading on fibronectin.

144

Figure 5.2: Model for the Non-cell Autonomous Function of ADAM13. (A) In
control dorsal mesoderm cells, upon Eph-ephrin engagement ADAM13 cleaves ephrinB
ligands. This promotes dorsal mesoderm cell-cell de-adhesion during the migration on
the blastocoel roof. (B) In MO13 dorsal mesoderm cells, Eph-ephrin engagement is not
properly regulated because ephrinB ligands are not cleaved. This affects dorsal
mesoderm cell-cell de-adhesion during the migration on the blastocoel roof. EphephrinB signaling may increase Src and FAK kinase activity creating an imbalance in
RhoA/Rac1 cytoskeletal changes.
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Figure 5.3: Xbrachyury Signaling Pathway. As a transcription
factor Xbrachyury induces expression of the target gene, Wnt11
(Tada and Smith, 2000). Wnt11 is a Wnt family ligand important
for activating the Non-canonical Wnt (or PCP) Signaling Pathway.
The PCP Signaling pathway is essential for controlling
convergence and extension movements during gastrulation.
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Figure 5.4: Model for ADAM19 Function in the Axial Mesoderm. (A) In control
axial mesoderm cells, ADAM19 cleaves NRG1. Soluble NRG1 activates ErbB
signaling cell autonomously. Through PI3K/AKT signal transduction, Xbrachyury gene
expression is induced. This allows a cell to become bipolar and undergo mediolateral
cell intercalation. (B) In MO19 axial mesoderm cells, NRG1 is not cleaved. This
reduces ErbB signaling, phosphorylated AKT, and Xbrachyury gene expression. These
defects cause a cell to become multipolar and delay mediolateral cell intercalation.

147

APPENDIX I
GENERATION OF ADAM19 ANTIBODIES
The goal at the onset of the project was to identify another meltrin subfamily
member that could compensate for ADAM13 function, specifically in the cranial neural
crest. Of the other meltrin subfamily members, ADAM19 had the highest sequence
homology at the amino acid level to ADAM13 making it an ideal candidate. At this time,
there were no ADAM19 antibodies available that could be used to study the endogenous
protein in Xenopus. Thus one of the first major objectives was to generate a number of
antibodies that could recognize different structural domains of the ADAM19 protein.
Three antibodies were successfully made to the ADAM19 protein and are briefly
described:
1. 2C5 E1: Mouse monoclonal antibody directed against the cytoplasmic domain of
ADAM19
2. C2 and C3: Rabbit polyclonal antibody directed against both variants (C2 and C3)
of the cytoplasmic domain of ADAM19
3. DC19: Goat polyclonal antibody directed against the disintegrin-cysteine rich
domains of ADAM19
Monoclonal Antibody 2C5 E1
To generate the monoclonal antibody 2C5 E1, I cloned cDNA encoding the first
127 COOH-terminal amino acid residues of the ADAM19 cytoplasmic domain (A19cyto)
into the pET-His expression vector (Novagen). Fusion proteins were purified using
standard methods. 100 microgram of protein was combined with complete Freund‟s
adjuvant and injected intraperitoneal into Balb/c mice over a series of immunizations.
After each immunization, blood samples were taken to test for the reactivity against
A19cyto.
A fusion was performed with Splenocytes from an immunoreactive mouse and the
immortal myeloma SP20 cells. The fusion protocol was based on “Antibodies: A
Laboratory Manual” by Ed Harlow and David Lane. The resulting hybridoma colonies
were first screened by ELISA for reactivity against A19cyto. Out of 47 colonies tested,
33 colonies had an OD value between 0.2 and 0.25, 12 colonies had an OD value
between 0.25 and 0.3, and two colonies had an OD value greater than 0.3. The top five
ELISA hits were further subcloned and re-tested by ELISA. The top four hits were 1F1,
2C2, 2C5, and 2C8 having an OD value of greater than 3.0. There were subcloned again
and the 2C5 E1 colony was discovered for further testing. Media from 2C5 E1 colony
was tested by Western Blot and it strongly recognized the A19cyto fusion protein, as well
as, a multitude of proteins in stage 45 embryo extract compared to stage 6 embryo extract
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(Figure A1.1A). The 2C5 E1 supernatant had minimal cross-reactivity with A9cyto and
A13cyto, therefore this monoclonal antibody was further used in our experiments.
Immune IgG were purified on a His-tag fusion protein column containing the
same COOH-terminal amino acid residues used for immunization (NHS-sepharose,
Pharmacia). The affinity purified 2C5 E1 antibody was tested on ADAM19 transfected
XTC cells for detection by western blot (Figure A1.1B). This antibody did not recognize
endogenous ADAM19 from total embryo extract and glycoproteins purified on
Concanavalin-A beads from 10 embryos (data not shown). Further testing by western
blot should be completed to get the antibody‟s right working conditions. The 2C5 E1
antibody is used for ADAM19 overexpression studies and works beautifully for
immunoprecipitation and immunofluorescence.
The resulting Affinity Purified
ADAM19 2C5 E1 was used for experiments described in Chapter III of this Dissertation.

Figure A1.1: Western Blots using mAb 2C5 E1. (A)
First screen using supernatant from 2C5 E1 hybridoma
colony on total embryo extract (stage 6 vs stage 45) and the
different ADAM cytoplasmic domains (A9, A13, A19).
(B) Affinity Purified 2C5 E1 Western Blot on transfected
XTC cells.

Polyclonal Antibody C2 and C3

To generate the rabbit polyclonal antibody C2 and C3, I cloned cDNA encoding
the first 146 COOH-terminal amino acid residues of the ADAM19 cytoplasmic domain
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(A19cyto) into the pGEX-KG vector (Guan and Dixon, 1991). This construct was called
A19 C2. In addition, I cloned cDNA encoding the first 160 COOH-terminal amino acid
residues of the ADAM19 cytoplasmic domain (A19cyto) into the pGEX-KG vector
(Guan and Dixon, 1991). This construct was called A19 C3. Both cytoplasmic domains
were used because I discovered both variants in 3‟ RACE PCR from cDNA. The A19 C3
construct is most common to the X. tropicalis sequence and was submitted to GenBank
(EU770696). Fusion proteins were purified using standard methods. Prior to
immunization, I pre-screened six rabbits to select rabbits that had a low immunoreactivity
in Xenopus embryos. Through a multi-channel western blot apparatus, I tested the
preimmune rabbit serum against stage 35 embryos (Figure A1.2). I selected rabbit #2, #3
and #5 for further immunization because they had the least immunoreactive background
by western blot.

Figure A1.2: Pre-screen of Rabbit serum
by Western Blot. Non-immune serum was
obtained from six New Zealand white
rabbits. The serum was tested by western
blot at primary antibody concentrations of
1:100 (first lane) and 1:1000 (second lane)
for each sample against stage 35 Xenopus
embryo extract. Rabbits #2, #3, and #5 were
chosen for further immunization because of
their low immunoreactivity.
150 microgram of each protein (total = 300 microgram) was combined with
complete Freund‟s adjuvant and injected into New Zealand white rabbits over a series of
immunizations. After each immunization, blood samples were taken to test for
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immunoreactivity against A19 C2 and C3 by ELISA and western blot. The ELISA
results showed an increasing OD value of >1.0 after each immunization. The
immunization schedule was monitored by Aileen Thomas at the Immunization Facility
here at UMass. Immune IgG were purified on a His-tag fusion protein (pET vectors,
Novagen) column containing the same COOH-terminal amino acid residues used for
immunization (NHS-sepharose, Pharmacia). The A19 C2 and C3 antibodies are used for
ADAM19 overexpression and endogenous ADAM19 studies. A western blot example of
the affinity purified antibody is shown for ADAM19 transfected Cos-7 cells (Figure
A1.3). The resulting Affinity Purified ADAM19 C3 was used for experiments described
in Chapter II and IV of this Dissertation.

Figure A1.3: ADAM19 expression in Cos7 cells. Affinity purified A19 C2 and C3
were mixed at the primary concentration of
1:2000 to detect ADAM19FL2 (C2) and
ADAM19FL3 (C3).
The Proform of
ADAM19 (120kD) is predominantly
expressed in Cos-7 cells.
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Polyclonal Antibody DC19

To generate the polyclonal antibody DC19, I cloned cDNA encoding the
Disintegrin and Cysteine-Rich amino acid residues of the ADAM19 domains into the
pET-His vector (Novagen). Fusion proteins were purified using denaturing standard
methods. 1.0 milligram of protein was combined with complete Freund‟s adjuvant and
injected into two Boer goats over a series of immunizations. Each goat received 0.5
milligram of fusion protein by Intramuscular injection and multiple subcutaneous
injections. The goats were numbered 704 and 711 at the Hadley Farm and weighed 70
and 80 pounds, respectively. The immunizations were performed by two undergraduate
students, Lauryn Benson and Vincent Patanio. The goats were monitored by Dr. Mark
Huyler and Alice Newth.
After each immunization, blood samples were taken to test for immunoreactivity
against A19 by ELISA and western blot. The ELISA results showed an increasing OD
value of >1.5 after each immunization. Immune IgG were purified on a His-tag fusion
protein (pET vectors, Novagen) column containing the same disintegrin-cysteine rich
amino acid residues used for immunization (NHS-sepharose, Pharmacia). The DC19
antibody is used for ADAM19 overexpression studies and by immunoprecipitation to
detect endogenous ADAM19. A western blot example of the affinity purified antibody is
shown for ADAM19 transfected Cos-7 cells (Figure A1.4). The resulting Affinity
Purified DC19 was used primarily by immunoprecipitation for experiments described in
Chapter II and IV of this Dissertation.

Figure A1.4: ADAM19 expression in Cos-7 cells. Affinity
purified DC19 was used at the primary concentration of 1:2000 to
detect ADAM19FL2 and ADAM19FL3.
The Proform of
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ADAM19 (120kD) is predominantly expressed in Cos-7 cells. The
high background is due to the secondary anti-goat-HRP antibody.

153

APPENDIX II
MISCELLANEOUS DATA

Xenopus laevis Heart Analysis

This Appendix will focus on various data that I have completed in my analysis of
ADAM19 in the early embryo. The first piece of data that I would like to discuss
supports the role for ADAM19 in heart development. Knockout mice for ADAM19 die
perinatally due to defects seen in heart formation (Zhou et al., 2004), confirming the
importance of ADAM19 in heart morphogenesis. Conditional knockout of ADAM19
specifically in the cardiac neural crest cells reproduced the heart phenotype suggesting
that ADAM19 is critical for cardiac neural crest cell specification and or function but not
migration (Komatsu et al., 2007). I have shown in Xenopus that ADAM19 knock down
reduces three heart specific genes; NKX2.5 (transcription factor), MLC2 (Myosin Light
Chain2, terminal differentiation marker), and MHC (Myosin Heavy Chain , terminal
differentiation marker) (Figure A2.1). This suggests that ADAM19 is also involved in
heart development in amphibians.
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Figure A2.1: Heart Gene Expression Analysis. Embryos were injected
at the one‐cell stage with CMO or MO19 and allowed to develop until
stage 28 for Whole Mount in situ Hybridization (N=30). Myosin Light
Chain2 (MLC2), Myosin Heavy Chain‐α (MHCα) and NKX2.5.
Percentages are of the morphotype shown.

Xenopus laevis Neural Response Analysis

Percentage of Embryos

In addition to ADAM19‟s prominent role in cardiac morphogenesis, the
ADAM19 knockout mice have also a minor neural phenotype. ADAM19 is expressed in
the peripheral nervous system and plays a regulatory role in the formation of
neuromuscular junctions (Yumoto et al., 2008). ADAM19 physically interacts with the
Ephrin receptor, EphA4, to stabilize the EphA4-ephrinA5 complex (Receptor-ligand)
from being internalized. This results in the negative regulation of contact-dependent
repulsion of neurons at the neuromuscular junction. I briefly analyzed Xenopus tailbud
stage embryos for their ability to respond to a touch stimulus and swim away. This assay
was performed in MO9 or MO19 injected embryos at stage 27 (Figure A2.2). MO9
injected embryos showed a slight reduction in their ability to respond to touch and swim
away. MO19 injected embryos showed a more robust inability to respond to touch and
swim away. These observations could be a result of poorly developed skeletal muscles
(reduction in muscle specific genes MLC and 12/101) or poorly developed
neuromuscular junctions.

100
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60
50
40
30
20
10
0

Touch
Response
Ability to
Swim

NI (n=39)

CMO
(n=28)

MO9
(n=17)

MO19
(n=31)

Figure A2.2: Neural Touch Response Assay. Embryos were injected at the
one‐cell stage with CMO, MO9 or MO19 and allowed to develop until stage 27.
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The embryos ability to respond to touch and whether the embryo was capable of
swimming away from the stimulus were recorded. The knockdown embryos
were compared to CMO and to NI (non-injected) embryos. The percentages are
shown in the graph.

Neuregulin1

In mice, ADAM19 can cleave some members of the EGF family of ligands
including Neuregulin1 (Shirakabe et al., 2001). In Xenopus, the NRG1 expression
pattern overlaps with the expression pattern of ADAM19 (Neuner et al., 2009; Yang et
al., 1999; Yang et al., 1998a; Yang et al., 1998b). Our lab has obtained all three Xenopus
NRG1 clones; IgNRG1α2, IgNRG1β2, and CRDNRG1β2. Our initial focus is on
IgNRG1β2 because it is a known substrate of mouse ADAM19. I cloned the full length
gene into the pCS2+ vector and added a Flag epitope after the extracellular Ig-like
domain but before the EGF-β2 domain. In addition to the full-length gene, I introduced a
stop codon immediately before the transmembrane domain to mimic a possible cleavage
product containing only the extracellular domain (IgNRG1β2-EC). The Flag epitope
location was selected in hopes that an extracellular cleavage fragment could be detected.
This location may not be ideal because detection of IgNRG1β2 by western blot has
presented some problems. Transfection into Cos-7 cells and glycoproteins purified by
Concanavalin-A beads from the cell extract could not detect NRG1 (data not shown).
Microinjection of RNA for NRG1 into Xenopus embryos has shown a faint band of the
predicted molecular weight size (Figure A2.3).

Figure A2.3: Neuregulin1 Western Blot. Embryos
were injected at the one-cell stage with 1ng of RNA
encoding NRG-FL. Glycoproteins were purified from 10
embryos by Concanavalin-A beads, separated by SDSPAGE and detected using an antibody to Flag.
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However, injection of 1ng of RNA from glycoproteins purified from ten embryos
should yield a much stronger band by western blot. Cloning of NRG1 into pCS2+MT
(myc tag) should enable successful detection by western blot. A successfully tagged
construct could also be used to determine if any of the Xenopus ADAM members can
cleave NRG1.
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APPENDIX III
LIST OF SUPPLEMENTARY MOVIE FILES (ON CD)
Movie 1 – Open Face Explant from a CMO embryo
Explants from embryos injected with CMO at the one-cell stage. Membrane
bound Cherry RNA was injected into one blastomere at the two-cell stage to
visualize axial mesoderm cell movement from one half of the embryo. The
time lapse movie lasts ten hours.
Movie 2 – Open Face Explant from a MO13 injected embryo
Explants from embryos injected with MO13 at the one-cell stage. Membrane
bound Cherry RNA was injected into one blastomere at the two-cell stage to
visualize axial mesoderm cell movement from one half of the embryo. The
time lapse movie lasts ten hours.
Movie 3 – Open Face Explant from a MO19 injected embryo
Explants from embryos injected with MO19 at the one-cell stage. Membrane
bound Cherry RNA was injected into one blastomere at the two-cell stage to
visualize axial mesoderm cell movement from one half of the embryo. The
time lapse movie lasts ten hours.
Movie 4 – Dorsal Mesoderm Cell Spreading and Migration on
Fibronectin
Dissociated dorsal mesoderm cells from a CMO embryo were plated on a
fibronectin substrate. Time lapse analysis of a three hour movie shows cell
spreading and cell migration on FN.
Movie 5 – Dorsal Mesoderm Cell Spreading and Migration on
Fibronectin
Dissociated dorsal mesoderm cells from a MO13 injected embryo were plated
on a fibronectin substrate. Time lapse analysis of a three hour movie shows
cell spreading and cell migration on FN.
Movie 6 – Dorsal Mesoderm Cell Spreading and Migration on
Fibronectin
Dissociated dorsal mesoderm cells from a MO19 injected embryo were plated
on a fibronectin substrate. Time lapse analysis of a three hour movie shows
cell spreading and cell migration on FN.
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Movie 7 – Dorsal Mesoderm Cell Spreading and Migration on
Fibronectin
Dissociated dorsal mesoderm cells from a 2MO (MO13+MO19) embryo were
plated on a fibronectin substrate. Time lapse analysis of a three hour movie
shows cell spreading and cell migration on FN.

Movie 8 – Dorsal Mesoderm Cell Spreading and Migration on 9.11
Dissociated dorsal mesoderm cells from a CMO embryo were plated on a 9.11
substrate. Time lapse analysis of a three hour movie shows cell spreading and
cell migration on 9.11.
Movie 9 – Dorsal Mesoderm Cell Spreading and Migration on 9.11
Dissociated dorsal mesoderm cells from a MO13 injected embryo were plated
on a 9.11 substrate. Time lapse analysis of a three hour movie shows cell
spreading and cell migration on 9.11.
Movie 10 – Dorsal Mesoderm Cell Spreading and Migration on 9.11
Dissociated dorsal mesoderm cells from a MO19 injected embryo were plated
on a 9.11 substrate. Time lapse analysis of a three hour movie shows cell
spreading and cell migration on 9.11.
Movie 11 – Dorsal Mesoderm Cell Spreading and Migration on 9.11
Dissociated dorsal mesoderm cells from a 2MO (MO13+MO19) embryo were
plated on a 9.11 substrate. Time lapse analysis of a three hour movie shows
cell spreading and cell migration on 9.11.
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APPENDIX IV
REPRINT 1

Mechanism of Development (Neuner et al., 2009)
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